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Summary 
The main aim of this Ph.D. project is to engineer microorganisms to increase their production 
capabilities for the group of secondary metabolites known as isoprenoids and to develop and 
explore methods and approaches that may in the future be utilized to this end. The research was 
primarily focused on engineering Saccharomyces cerevisiae, but improved isoprenoid production 
in Escherichia coli was also addressed. We applied a two-pronged approached composed of 
rational and random engineering strategies. A summary of the aim of the research presented in 
each chapter combined with the primary results from this research can be found in the present 
section. 
Chapter 1 is a minireview detailing the usage of colored metabolites as reporters for 
identification of microorganisms overproducing secondary metabolites. This chapter does not 
exclusively focus on isoprenoid reporter metabolites, but also reviews the application of colored 
polyketides and flavonoids. Former studies on the utilization of colored metabolite reporters are 
reviewed in conjunction with the potential applications of colored metabolites, which have 
recently been demonstrated to be heterologously produceable in microbes, for the setup of novel 
high-throughput screening methods. Because this review was written after finishing the result 
chapters of this thesis that are intended for publication, references to these results has been 
included. No further results generated as part of this Ph.D. project are presented within this 
chapter. 
Chapter 2 encompasses our research into functional expression of the 2-C-methyl-D-erythritol 
(MEP)-pathway in S. cerevisiae. This has previously been attempted, but has probably failed due 
to problems of functionalizing heterologously expressed bacterial iron-sulfur cluster proteins 
within the yeast cytosol. We therefore attempted to graft the E. coli iron-sulfur cluster assembly 
machinery into S. cerevisiae. We were able to integrate the 16 genes, which we based on 
literature hypothesized would constitute this machinery, in a S. cerevisiae strain expressing the 
genes encoding the MEP-pathway. The results of HPLC-MS and labeling experiments showed 
that the pathway was indeed functional until the two last steps. These two steps are catalyzed by 
the iron-sulfur cluster proteins IspG and IspH. We finally demonstrated that S. cerevisiae in not 
completely unable to functionally express bacterial iron-sulfur cluster proteins in the cytosol by 
complementing a deficiency of the cytosolic iron-sulfur protein encoded by LEU1 with the 
hetero-dimeric iron-sulfur cluster protein from E. coli encoded by leuC and leuD. It remains 
unknown why IspG and IspH were not functionally expressed in this organism. 
Chapter 3 presents our research aiming to identify novel over-expression targets from gDNA 
libraries that can increase isoprenoid production in S. cerevisiae. We constructed a library based 
on S. cerevisiae gDNA integrated in a single-copy vector. The gDNA fragments were inserted 
downstream of the strong TDH3 promoter to search for endogenous targets that upon over-
expression could increase isoprenoid production. For screening large libraries an effective screen 
is imperative, so we engineered S. cerevisiae to produce the reporter metabolite lycopene. This 
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resulted in an orange-red phenotype enabling us to visually inspect colonies of library 
transformants, and hereby identify mutants with increased color intensity. We identified several 
mutants capable of increased lycopene production, but when the plasmids were rescued and re-
transformed into S. cerevisiae only one of them was able to reconstitute the overproducing 
phenotype. When this plasmid was sequenced, it was found not to harbor an ORF. We further 
found that inspection through visual assessment of colony color was labor-intensive and difficult. 
Chapter 4 presents our efforts towards establishing a high-throughput screening method based on 
the fluorescent carotenoids (a subgroup of the isoprenoids) β-carotene and astaxanthin, in 
conjunction with fluorescence activated cell sorting (FACS). We here demonstrate that the 
pathway resulting in lycopene formation (presented in Chapter 3) can be extended quite 
efficiently to yield β-carotene and astaxanthin producing S. cerevisiae strains; our engineered 
astaxanthin producing strain had an almost 9 fold higher astaxanthin yield compared to the best 
astaxanthin yield published for S. cerevisiae. When the carotenogenic S. cerevisiae strains were 
tested, it was found that the fluorescence was too weak to enable the application of FACS. 
Chapter 5 describes the development of an image analysis algorithm for picking out the most 
intensively red colonies of lycopene producing S. cerevisiae. The algorithm is based on the 
analysis of digitally acquired agar plate pictures with the open source software ImageJ. We 
utilized the algorithm to pick 250 transformants from a transformation of lycopene producing S. 
cerevisiae with a Saccharomyces kluyveri cDNA library, and by comparing their ability to 
produce lycopene in liquid cultures to the same ability of 250 randomly picked transformants 
from the same population, we showed that the image analysis method was effective at picking 
out mutants with higher lycopene production. 
Chapter 6 covers our effort towards the development of a novel transposon mutagenesis system 
for in vivo mutagenesis of S. cerevisiae. The system is based on the transposase from the 
bacterial Tn5 transposon. The system also encompasses a plasmid suicide mechanism based on 
the homing endonuclease I-SceI and the corresponding recognition site. The system is designed 
to insert a given DNA fragment randomly into the genome, and the preliminary results suggest 
that the system functions as intended, but further experiments are required. 
Chapter 7 encompasses the construction and optimization of E. coli for production of squalene. 
Heterologous squalene production was mediated by the S. cerevisiae ERG9 gene. To improve the 
production, we co-expressed the iscA gene from E. coli, encoding a FPP synthase. The plasmid 
harboring these two genes was tested in strains with different levels of overexpressions of four 
MEP-pathway genes. Based on the strain testing, we found that cell growth was affected by the 
heterologous production of squalene, which appears to limit the yield of squalene on biomass. 
Chapter 8 discusses the results provided in Chapters 2 to 7 in combination with an overall 
conclusion intended to put this thesis into a wider perspective. Since most of the results have 
already been discussed and concluded upon in the individual chapters, much of the discussion 
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presented in Chapter 8 is of a more speculative character. In addition to the discussion and the 
overall conclusion, the chapter also describes a few experiments designed and performed after 
comparing the results from the result chapters. The additional results suggest that identification 
of novel genotypes causing increased isoprenoid production was hampered by an unintentional 
selection of respiratory deficient mutants. 
Chapter 9 provides protocols for gDNA and cDNA library construction. The construction of high 
quality genetic libraries is not trivial and has been a big challenge, so to help others who have to 
perform library construction these protocols have been included. The protocols are more detailed 
than the descriptions found in the material and methods sections for Chapters 3 and 5 and should 
therefore be a better reference in the endeavor of genetic library construction. 
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Dansk sammenfatning 
Hovedformålet med dette Ph.D. projekt er at konstruere mikroorganismer med øget 
produktionskapacitet for gruppen af sekundære metabolitter kendt som isoprenoider, samt at 
udvikle og undersøge metoder og fremgangsmåder, som har dette endemål. Arbejdet har primært 
været fokuseret på Saccharomyces cerevisiae, men det har også omfattet forbedret isoprenoid-
produktion i Escherichia coli. Mine medforfattere og jeg har anvendte en fremgangsmåde 
bestående af både rationelle og tilfældige strategier. I nærværende afsnit har jeg sammenfattet 
målene for forskningen præsenteret i hvert kapitel samt resultaterne deraf. 
Kapitel 1 er et minireview, som beskriver anvendelsen af farvede metabolitter, som rappotører til 
identifikation af mikroorganismer, som overproducerer sekundære metabolitter. Dette kapitel 
omfatter ikke kun isoprenoider, men også anvendelsen af farvede polyketider og flavonoider. 
Tidligere studier, der har gjort brug af farvede metaboliter, bliver her gennemgået sammen med 
potentiel anvendelse af andre farvede metabolitter, som nyligt er fundet mulige at producere 
heterologt i mikroorganismer, til at konstruere nye høj-effektive screenings-metoder. Eftersom 
kapitel 1 er blevet udarbejdet efter færdiggørelsen af de øvrige af de kapitler i denne afhandling, 
som er skrevet med henblik på publication, vil referencer til disse være inkluderet. Ingen andre 
resultater genereret i dette Ph.D. projekt præsenteres i dette kapitel. 
Kapitel 2 inkluderer vores forskning i funktionel ekspression af 2-C-methyl-D-erythritol (MEP)-
biosyntesevejen i S. cerevisiae. Dette er tidligere blevet forsøgt, men ser ud til at være mislykket 
på grund af problemer med funktionel ekspression af heterologe bakterielle FeS-cluster-proteiner 
i gærs cytosol. Vi forsøgte derfor at overføre maskineriet for konstruktion af FeS-clusters fra E. 
coli til S. cerevisiae. I en S. cerevisiae stamme, der I forvejen var konstrueret til at udtrykke de 
gener, som koder for MEP-biosyntesevejen, integrerede vi såleds 16 gener, som vi med baggrund 
i litteraturen antog, ville udgøre dette maskineri. Resultaterne af HPLC-MS og mærkningsforsøg 
viste, at biosyntesevejen netop var funktionel, indtil de reaktioner, der katalyseres af FeS-cluster-
proteinerne, IspG og IspH, men ikke fungerede. Endeligt viste vi, at S. cerevisiae ikke er helt ude 
af stand til funktionelt at udtrykke bakterielle FeS-cluste-proteiner i sit cytoplasma ved at 
komplementere en mangel på det cytosoliske FeS-cluster-protein kodet af LEU1 med det hetero-
dimeriske protein fra E. coli kodet af leuC samt leuD. Det er stadigt uvist, hvorfor IspG og IspH 
ikke kan udtrykkes funktionelt. 
Kapitel 3 præsenterer vores forsøg på identifikation af S. cerevisiae gener, som ved 
overudtrykkelse kan øge produktionen af isoprenoider i S. cerevisiae. Vi konstruerede et 
bibliotek baseret på S. cerevisiae gDNA indsat efter den stærke TDH3 promoter i et lav-kopi 
plasmid. For at kunne screene et så stort bibliotek effektivt konstruerede vi en S. cerevisiae 
stamme, som syntetiserer reporter-metabolitten lycopen, som resulterer i at cellerne får en 
orange-rød farve. Vi kunne hervedvisuelt indentificere adskillige kolonier af gærceller, som 
producerede en øget mængde af isoprenoider, men når vi genudvandt plasmiderne fra disse 
transformanter og benyttede dem til at re-transformere S. cerevisiae, kunne kun et enkelt af disse 
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genskabe overproduktions-fænotypen. Da dette plasmid blev sekventeret, viste det sig, at 
insertionen ikke indeholdt en ORF. Vi fandt desuden, at den visuelle inspektion af kolonifarve 
var vanskelig og arbejdskrævende. 
Kapitel 4 præsenterer vores arbejde på at etablere en effektiv screenings metode baseret på de 
fluorescerende carotenoider (en undergruppe af isoprenoiderne) β-caroten og astaxanthin i 
samspil med ”fluorescence-activated cell sorting” (FACS). Vi viser her, at biosyntesevejen, som 
fører til dannelse af lycopen (jf. kapitel 3), kan forlænges så S. cerevisiae kan producere β-
caroten og astaxanthin med god effektivitet. Vores astaxanthin-producerende stamme gav et 9 
gange højere astaxanthin-udbytte sammenlignet med det bedste udbytte offentliggjort for S. 
cerevsiae. Da de carotenoid-producerende stammer blev testet med FACS, viste det sig, at 
fluorescens-niveauet var for lavt til, at denne metode kan anvendes som screeningsmetode. 
Kapitel 5 beskriver udviklingen af en algoritme for billedanalyse til udvælgelse af de mest 
intenst røde kolonier af S. cerevisiae. Algoritmen er baseret på analyse af digitale billeder af 
kolonier på agar plader med open-source programmet ImageJ. Vi anvendte algoritmen til at 
udvælge 250 transformanter fra en konstrueret lycopene-producerende S. cerevisiae stamme med 
et Saccharomyces kluyveri cDNA bibliotek. Vi sammenlignede disses evne til at producere 
lycopen i flydende medium med same egenskab ved 250 kolonier, som blev udvalgt tilfældigt fra 
den samme population. Vi kunne herved vise, at billedanalysen var i stand til at udvælge 
transformanter med forøget produktion af lycopen. 
Kapitel 6 beskriver vores indsats henimod udviklingen af et nyt system for in vivo transposon-
mutagenese af S. cerevisiae. Systemet er baseret på transposasen fra det bakterielle Tn5 
transposon. Det indeholder endvidere en plasmid-”suicide-mechanism” baseret på I-SceI homing 
endonukleasen og den hertil hørende genkendelses-sekvens. Systemet er designet til at integrere 
en given DNA-sekvens et tilfældigt sted i genomet, og de foreløbige resultater antyder, at 
systemet virker efter hensigten, men flere eksperimenter er påkrævet. 
Kapitel 7 omfatter konstruktion og optimering af en E. coli stamme til produktion af squalen. 
Heterolog squalen produktion er opnået ved hjælp af ERG9 genet fra S. cerevisiae. Vi indførte 
desuden iscA genet fra E. coli, som koder for en FPP synthase, for at forbedre produktionen 
yderligere. Plasmidet, som huser disse to gener, blev testet i stammer med forskellige niveauer af 
over-udtrykkelse af fire gener i syntesevej til IPP. På denne måde fandt vi, at cellevæksten blev 
påvirket negativt af den heterolog produktion af squalen, hvorved udbyttet af squalen på 
biomasse ser ud til at blive begrænset. 
Kapitel 8 diskuterer resultaterne fremlagt i kapitel 2 til 7, kombineret med en overordnet 
konklusion, som har til hensigt at sætte hele afhandlingen ind i et større perspektiv. Eftersom de 
fleste af resultaterne allerede har været diskuteret og konkluderet på i de individuelle kapitler, 
har det været naturligt at udvide diskussionen præsenteret i kapitel 8 til at være af en mere 
spekulativ karakter. Udover denne diskussion og den overordnede konklusion indeholder kapitlet 
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også nogle få resultater fra eksperimenter, som blev designet og udført, efter at resultaterne fra 
de andre kapitler blev sammenlignet. Disse resultater peger på, at identifikationen af nye 
genotyper, som øger produktionen af isoprenoider, blev vanskeliggjort af en utilsigtet udvælgelse 
af respiratoriske defekte mutanter. 
Kapitel 9 giver protokoller for konstruktion af gDNA og cDNA bibliotekerne. Konstruktion af 
genetiske biblioteker af høj kvalitet er ikke triviel og har været en stor udfordring. Så for at 
hjælpe andre, som skal konstruerer biblioteker, er disse protokoller blevet inkluderet. 
Protokollerne er mere detaljerede end de beskrivelser, som findes i material- og metode-
afsnittene i kapitlerne 3 og 5, og de udgør hermed en bedre reference til konstruktion af sådanne 
genetiske biblioteker. 
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Thesis outline 
The main topic of this thesis is heterologous microbial production of natural products with focus 
on isoprenoids. This thesis is organized in 9 chapters. Since I am planning to publish 4 of the 9 
chapters in scientific journals, I found it expedient to write them all in article format. Because the 
chapters are intended to be published in different journals, the formatting varies in some 
chapters, e.g. the method of citation. The article format also implies that each chapter contains its 
own introduction, which, due to extensive overlap in topic between chapters, will contain some 
redundancies. Due to this structure, and even more due to the fact that metabolic engineering and 
isoprenoids have been extensively reviewed in recent years, both in the scientific literature and 
by my predecessors working within these areas of research at CMB, I have chosen not to include 
a regular introduction in this thesis. I have instead chosen to write a mini-review (Chapter 1) 
regarding colorimetric surrogate metabolite screening, which will serve as introduction to the 
part of the thesis encompassing random approaches. After this initial chapter follows the first of 
two chapters where rational engineering strategies have been applied. The introduction to this 
chapter (Chapter 2) is thorough and detailed and gives a good introduction to isoprenoid 
biosynthesis. These two parts of the thesis will, in addition to the introduction to each chapter, 
therefore serve as the prerequisite knowledge offered to the reader; if more extensive background 
knowledge is required and to avoid the creation of further redundancies, the reader is referred to 
reviews and other literature cited in the thesis. 
Chapter 2 describes the efforts towards expressing the MEP-pathway and the expression of 
Escherichia coli cytosolic iron-sulfur cluster proteins in Saccharomyces cerevisiae, and it 
provides evidence that S. cerevisiae can functionally express at least one bacterial iron-sulfur 
cluster proteins within its cytosol. Chapters 3-6 encompass the efforts towards identification of 
novel genetic targets for improving isoprenoid biosynthesis in S. cerevisiae through random 
approaches. In Chapter 7, the rational engineering efforts for the construction of an E. coli strain 
for heterologous production of squalene is described. These six chapters comprise the 
experimental part of this thesis.  
To conclude the thesis, a chapter with future perspectives, suggestions for additional work and 
conclusions is included. This chapter is subdivided into sections based on the prior chapters in 
which experimental work is presented. Since the results of the individual chapters have been 
discussed herein, this section will be of more speculative character. The final chapter of the 
thesis contains protocols for gDNA and cDNA library constructions, since this has been one of 
the major challenges that I have faced during my laboratory work; by including these protocols I 
hope to enable others to easier construct these two types of libraries. 
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Aim of project 
Due to declining drug discovery rates from organic synthetic libraries, the pharmaceutical 
companies are again turning their attention towards secondary metabolites. Secondary 
metabolites have evolved to interact with other biomolecules, and the probability of identifying 
novel drugs from secondary metabolite libraries is therefore estimated to be much higher 
compared to the screening of synthetic libraries. However, secondary metabolites are in most 
cases only scarcely available in the native production organisms and need to be produced in an 
alternative way to large-scale extraction. The most common way of producing these compounds 
is by organic synthesis. However, organic synthesis can have serious disadvantages for 
production of secondary metabolites, such as low yields due to the complex structures, which can 
make this way of production economically unfeasible. An attractive alternative for producing 
secondary metabolites is to engineer microorganisms for heterologous production of the desired 
compound by transfer of biosynthetic genes. It is generally straightforward to scale up microbial 
production to meet actual demands, and it is also an environmentally benign production method 
compared to organic synthesis. 
Among isoprenoids only high value chemical entities such as pharmaceuticals can currently be 
produced cost-effectively in microorganisms, but concurrently with increasing oil prices and the 
development of more effective microbial production methods the microbial production of more 
general chemicals will be feasible due to improved cost-competitiveness. By improving 
microorganisms through engineering, we can facilitate the shift towards a more bio-based 
economy hereby liberating the production of chemical entities from petrochemical raw materials 
by substitution with renewables resources. 
Isoprenoids, also known as terpenoids, constitute the largest group of secondary metabolites 
identified to date, encompassing more than 55,000 different compounds including several 
blockbuster drugs such as paclitaxel and artemisinin. These compounds are all biosynthesized 
from the same precursor, called isopentenyl pyrophosphate (IPP), which is stepwise polymerized 
and diversified, giving rise to the enormous chemical and structural diversity. Thus it would be 
attractive to engineer a microorganism to produce high amounts of IPP and other immediate 
prenyl precursors such as geranyl pyrophosphate, farnesyl pyrophosphate and geranylgeranyl 
pyrophosphate; this organism could serve as cell factory for large-scale microbial production of 
isoprenoids. 
Microorganisms have evolved to adapt to different niches in nature and are therefore not 
generally optimized for the purpose of production of a specific secondary metabolite. 
Optimization of microorganisms can be a daunting task due to the complexity of metabolism. In 
order to optimize microorganisms, metabolic engineering was conceived almost 20 years ago as 
a systematic methodology designed to deal with the inherent problems arising from this 
complexity by applying iterative steps of modeling, characterization and rationally designed 
perturbations. Numerous examples of its application in optimizing microorganisms for secondary 
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metabolite production can be found in the literature. One of the most often applied 
microorganisms for isoprenoid production is Saccharomyces cerevisiae. Several metabolic 
engineering approaches for production of isoprenoids in S. cerevisiae have been published, but 
most of them are based on few types of perturbations. The identification of novel genetic targets 
is a prerequisite for the continued improvement of microbial isoprenoid production. The main 
aim of this project is therefore to optimize S. cerevisiae for isoprenoid production through 
identification of novel targets and pathway engineering. Furthermore, it is the aim of this thesis 
to develop and devise methodologies that will further the main aim. 
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1.1 Abstract  
Heterologous microbial production of natural products has been one of the focal points of 
biotechnology for the last three decades and has therefore been extensively reviewed and the 
introductory part of this review offers a short overview of these, before focusing on the 
application of colored metabolites in surrogate metabolite screens. We find that this niche within 
screening methodologies deserves more attention than it has had in previous reviews. The review 
is divided into sections based on the major groups of metabolites for which the individual 
surrogate metabolites have been applied. Furthermore, a section focusing on approaches for 
automation applicable for improving the throughput of these screening methods is included. 
Finally, criteria for a good surrogate metabolite is addressed, together with future perspectives of 
applying these screens in the endeavor of creating microbial cell factories for production of 
natural products. 
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1.2 Introduction 
Production of chemical compounds has to a large extent been based on fossil oil, but 
concurrently with rising oil prices and an increasing demand for specialty chemicals, 
heterologous microbial production is becoming an attractive alternative. The industrial and 
pharmaceutical biotechnology markets are therefore predicted to increase significantly over the 
next decade [Meyer and Turner 2009]. Several small molecule products and pharmaceuticals are 
already produced by microorganisms today, and microbial production generally offers several 
advantages, e.g. easy scale-up, chiral pure compounds can be obtained, environmentally benign 
production, and sometimes an opportunity to utilize inexpensive carbon sources such as waste 
products from other industries. Heterologous microbial production is also gaining further footing 
due to the renaissance of natural products as screening resource for pharmaceuticals [Dove 2003; 
Harvey 2007]. We have during the last couple of decades witnessed the initial steps towards a 
bio-based economy in which industrial biotechnology has a central role, in particular in the 
utilization of microbes to produce a wide range of chemical entities. This trend will very likely 
continue in the years to come [Octave and Thomas 2009]. 
Most microorganisms are not naturally optimized for production purposes, so after production of 
a desired molecule has been established, the given microorganism generally requires engineering 
to make the production as cost-effective as possible. For a general review on microbial strain 
improvement and the optimization of fermentative production see Parekh et al. (2000). 
Cultivation of some microorganisms in large tanks can be troublesome and many 
microorganisms have not been developed for genetic engineering, hampering their utilization 
[Chiang 2004]. However, by identifying the genetic basis for the production of the desired 
molecule within its natural host the production capability may be transferred to a heterologous 
microorganism for which genetic engineering, cultivation techniques and scale-up is well 
established. Some source organisms, such as many plants, suffer from other drawbacks, e.g. 
scarce availability of the desired molecule within the native producer and seasonal variations 
affecting production yields. These issues may also be solved by heterologous production in 
microorganisms. The established production microorganisms can then subsequently be optimized 
to create a microbial production platform. 
Several methodologies have been developed to improve the production capabilities of 
microorganisms. These methodologies can be divided into random/combinatorial and rational 
approaches. Available knowledge on the system chosen for engineering is a prerequisite for the 
application of any rational approach. Knowledge on microbial systems is gradually increasing, 
but random approaches have nonetheless been the prevalent method used for improving 
microorganisms. For a review on classical strain improvement see Rowlands (1984). The advent 
of modern genetics and microbiological techniques paved the way for the invention of directed 
evolution in the 1960’s [Mills et al. 1967]. Directed evolution can be applied to single enzymes, 
pathways or whole cells and can be regarded as a fast and highly directional version of 
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Darwinian evolution. Directed evolution consists of two parts; the creation of diversity and the 
screening or selection of the diversified population. Several methods for creating diversity within 
microbial population have been developed, and for comprehensive reviews on this topic the 
reader is referred to Zhao et al. (2002) and Chatterjee and Yuan (2006). 
The success of any random approach is dependent on the efficacy of the method applied for 
identifying the microbial cells with beneficial mutations. Identification of mutants from libraries 
can be performed by screening the population for a certain phenotype or applying a selection 
pressure that eliminates microbes not harboring the desired traits. Selecting for a certain 
phenotype is often a more powerful method than screening since the microbes do not have to be 
assessed individually. However, most phenotypes, e.g. many over-production phenotypes, are 
not easily amenable to selection for viability or growth and must therefore be identified through 
screening. The phenotypes that are most straightforward to screen are discrete phenotypes, i.e. 
those that can be screened in an “either-or” fashion. These screens will however only permit the 
investigator to identify all the mutants with a certain trait and not enable the identification of the 
best mutant within this population. On the other hand, screening for continuous phenotypes can 
be difficult, since a genotypic change might only manifest itself as a subtle change in phenotype. 
For general reviews on screening methods, the reader is referred to Olsen et al. (2000) and 
Reymond and Babiak (2007). 
Not all phenotypes can be readily screened for [Tyo et al. 2007], so in order to enable the 
construction of strains with high production capabilities, surrogate compounds synthesized from 
the same precursor metabolite as the desired compound can be applied to establish microbial 
production platforms with high flux towards the precursor molecule, increase the performance of 
a single enzyme, or improve the flux through an entire pathway. Screens for surrogate 
compounds can be based on various physical traits, e.g. fluorescence. This review presents the 
application of surrogate molecules for colorimetric screening of microbes with improved 
capabilities, with focus on heterologous production of natural products. 
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1.3 Isoprenoids 
More than 55,000 isoprenoids have been identified, making isoprenoids the largest group of 
natural products. This group of ubiquitous molecules holds a great potential for the isolation of 
compounds with novel activities useful to mankind, as witnessed by, e.g. paclitaxel (Taxol®) 
and artemisinin, two of the most pronounced blockbuster drugs identified within recent time, for 
treatment of cancer and malaria, respectively. All natural isoprenoids are produced from the 
universal precursor isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate 
(DMAPP). DMAPP is polymerized with different numbers of IPP molecules by length-specific 
prenyl transferases to form prenyl pyrophosphate molecules of various lengths, which undergo 
further modifications to form the wealth of isoprenoid molecules from the smallest, e.g. isoprene 
(from a single DMAPP molecule), to the largest, e.g. poly-isoprenoids, such as natural rubber, of 
which each molecule is derived from more than 1000 IPP molecules. For a review on 
isoprenoids, their biosynthesis, and heterologous production, the reader is referred to Ajikumar et 
al. (2008). 
The C-40 group of isoprenoid molecules known as carotenoids has been extensively used as 
pigments in colorimetric screens to improve heterologous isoprenoid production. Within this 
group of secondary metabolites, lycopene is the pigment with the shortest biosynthetic pathway 
from IPP and has been most commonly applied in screening methods. Ohnuma et al. (1994) 
utilized heterologous production of lycopene in Escherichia coli to set up a color 
complementation screen which they coined red-white screening. Lycopene is synthesized from 
the prenyl pyrophosphate known as geranylgeranyl pyrophosphate (GGPP), which is not 
naturally synthesized by E. coli. By omitting the GGPP synthase they integrated a heterologous 
pathway with a “gap”, allowing them to screen libraries in a discrete manner for novel enzymes 
with GGPP synthase activity. By applying this screening system and picking the colonies 
exhibiting the red lycopene production phenotype, they were able to isolate a novel GGPP 
synthase gene from a genomic DNA (gDNA) library from Sulfolobus acidocaldarius. Ohnuma et 
al. [1996] applied the same screening method in the creation of a novel GGPP synthase from the 
Bacillus Stearothermophillus farnesyl pyrophosphate (FPP) synthase. Following NaNO2 random 
mutagenesis they picked red colonies harboring mutated versions of the gene normally encoding 
FPP synthase activity now encoding GGPP synthase activity. By assessing the various mutations 
resulting in amino acid substitutions they were able to gain insight in moieties involved in 
determination of prenyl pyrophosphate chain length. A similar study was carried out by Lee et al. 
(2005), but instead of mutating a heterologous GGPP synthase they targeted the E. coli FPP 
synthase encoded by ispA, which they mutated by error-prone PCR. Furthermore, instead of 
using lycopene they utilized a mutated phytoene synthase which catalyzes the formation of two 
additional double bonds to yield tertradehydrolycopene which supposedly is more readily 
observed on a white filter background [Lee et al. 2005]. With the aim of improving heterologous 
production of the isoprenoid levopimaradiene in E. coli, Leonard et al. (2010) also targeted the 
activity of a GGPP synthase. They opted to use the Taxus canadensis GGPP synthase which was 
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modified by error-prone PCR, and its activity was screened by heterologous production of 
lycopene. As opposed to the previous studies where the screening was carried out in a discrete 
manner, Leonard et al. (2010) were interested in a GGPP synthase with increased flux towards 
GGPP and therefore had to apply a continuous screen, screening for colonies with more intense 
red coloration. With visual inspection, this screen is prone to mistakes, and further testing of the 
selected mutants did indeed reveal false positives. Nevertheless, the authors were able to isolate a 
GGPP synthase which when co-expressed with the native levopimaradiene synthase resulted in 
an 18 fold increase in levopimaradiene production. 
The carotenoid pathway can be readily extended to produce other carotenoids of commercial 
interest such as astaxanthin. Astaxanthin is in Brevundimonas produced from lycopene through 
β-carotene, which undergoes a series of oxidations catalyzed by 4,4’-β-ionone ring ketolase 
(CrtW) and 3,3’-β-ionone ring hydroxylase (CrtZ). In these oxidations, CrtW has been found to 
be the limiting step. To remedy this, Tao et al. (2006) sought to identify novel versions of CrtW 
and to modify these to improve the production of astaxanthin. They utilized the color change in 
phenotype brought upon E. coli heterologously expressing either β-carotene or hydroxylated 
versions hereof (yellow) compared to astaxanthin or the keto-derivatives of β-carotene 
(orange/reddish). The Sphingomonas sp. DC 18 isolated from freshwater (98 % similar to 
Sphingomonas melonis by 16S rDNA comparison) served as donor for the construction of a 
gDNA library. The library was screened in an E. coli strain heterologously producing β-carotene 
by selecting the colonies exhibiting an orange phenotype compared to the original yellow one. 
From the isolated colonies it was possible to obtain a gene encoding CrtW. When this new gene 
was co-expressed with crtZ in a β-carotene producing E. coli strain, the resulting strain produced 
12 % astaxanthin, 88 % intermediates between β-carotene and astaxanthin. By mutating the crtW 
gene using error-prone PCR and picking colonies with increased red colony coloration it was 
possible to obtain mutants producing an increased proportion of astaxanthin. The best mutant 
obtained produced 83 % astaxanthin. Besides improvement of enzyme functionality and 
carotenoid production, colorimetric screens have also been utilized for isolation of genes 
producing non-native carotenoids such as the aforementioned tetradehydrolycopene and in 
combinatorial studies taking advantage of the promiscuous nature of carotenoid biosynthetic 
enzymes to probe carotenoid molecular space. For a comprehensive review of this work see 
Umeno et al. (2005). 
The so far mentioned examples of screens have primarily been concerned with improving 
pathways downstream of IPP; however increasing flux towards IPP is of outmost importance in 
construction of microbial cell factories for production of isoprenoids. IPP is biosynthesized 
through two alternative pathways, namely the mevalonate pathway and the 2-C-methyl-D-
erythritol 4-phosphate (MEP) pathway. Random and combinatorial approaches where 
colorimetric screens have been applied have primarily been performed in E. coli, which naturally 
utilizes the MEP pathway. Gallagher et al. (2003) screened a cDNA library constructed from 
poly(A)
+
 maize endosperm RNA in E. coli strains heterologously producing lycopene and β-
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carotene, respectively. They hereby identified an IPP isomerase encoded by a novel gene which 
could improve carotenoid production. The isomerization of IPP to DMAPP can therefore be 
concluded to be a limiting step in isoprenoid synthesis in E. coli. A similar approach was utilized 
by Kajiwara et al. (1997), who isolated IPP isomerase genes from Xanthophyllomyces 
dendrorhous and Haematococcus cDNA libraries, using a screen based on a β-carotene 
producing E. coli strain. Kang et al. (2005) constructed a gDNA library from E. coli and used it 
to transform a lycopene producing E. coli strain. The plasmid used to transform E. coli making it 
carotenogenic contained in addition to the lycopene biosynthetic genes also the ipi gene from H. 
pluvialis, which encodes a bacterial IPP isomerase, in order to alleviate this limiting step hereby 
allowing identification of the next limiting step in isoprenoid biosynthesis. They found that 
plasmids from their library harboring the following genes improved lycopene production: crl, 
rpoS, appY, and dxs. Of these genes, dxs which encode the first enzyme of the MEP pathway, 
could be directly linked to isoprenoid production, whereas the others encode proteins with more 
global functions such as RNA polymerase and regulatory proteins. By applying a combinatorial 
expression approach the authors found that the combination of dxs and appY resulted in the 
highest production of lycopene (4.7 mg/gDCW) which corresponds to an approximate 8 fold 
increase compared to the parental strain. The finding that the overexpression of idi and dxs can 
improve isoprenoid production corresponds well with previous studies by Matthews and Wurtzel 
(2000) and Kim and Keasling (2001). Jin and Stephanopoulos (2007) utilized an approach 
similar to that of Kang et al. (2005), but instead of only screening the library in a single strain 
they screened their gDNA library in three strains with different genetic backgrounds. These 
strains where DH5α, WS140 (dxs, idi, ispFD chromosomal overexpression – Yuan et al. 2006) 
and WS140ΔgdhΔaceΔfdhF (triple knockout strain constructed by Alper et al., 2005a from 
knockout targets identified through stoichiometric flux balance analysis, FBA). In the plasmids 
isolated from the gDNA library screened in DH5α the most frequently identified genes were the 
dxs and idi, in accordance with prior findings. In strain WS140, where the dxs and idi genes were 
overexpressed, the rpoS gene was the one that most frequently came up in the screen. rpoS was 
also identified in a single plasmid isolated from the DH5α screen. In the triple knockout 
background, rpoS was also the gene identified most frequently. These articles demonstrate how 
the combination of DNA libraries and colorimetric screening can be applied in an iterative 
manner to find novel targets one by one, hereby gradually alleviating limiting steps and 
improving isoprenoid production.  
Not only overexpression targets are of interest in the effort towards construction of microbial cell 
factories; also deletion targets have been a preferred approach. Knockout targets can be 
identified through the utilization of random transposon mutagenesis. Tao et al. (2005) initially 
aimed at using lycopene as a screen-able reporter for copy number of a ColE1-type plasmid 
carrying the lycopene biosynthetic genes. Besides identifying gene knockouts affecting plasmid 
copy number, they also identified targets that by other mechanisms altered lycopene production. 
None of these were however linkable to isoprenoid production in any obvious way. However, 
one of the mutants with increased lycopene production had a transposon insert within the hscB 
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gene, which encodes a chaperone involved in iron-sulfur cluster biogenesis. This is opposed to 
what might have been expected, since the enzymes catalyzing the last two steps of the MEP 
pathway (IspG and IspH) are iron sulfur cluster proteins. Alper et al. (2005b) also used 
transposon mutagenesis but with the aim to create isoprenoid overproducing knockout mutants. 
The mutagenesis was performed on a strain with modifications similar to those of WS140. From 
this search three transposon inserts were obtained, whereof two were inserted in ORFs (rssB and 
yjfP) and therefore can be considered knockouts. The third was inserted between the yjiD and its 
promoter. All combinations of the three mutations were constructed and combined with the 
targets identified by FBA [Alper et al., 2005a]. Interestingly two global maxima for lycopene 
production were identified; the first being a combination identified solely through FBA and the 
other being the combination of the transposon modified yjiD gene and ΔgdhA and ΔaceE. yjiD 
was also identified in a single plasmid isolated from the gDNA library screen by Jin et al. (2007) 
in the WS140ΔgdhΔaceΔfdhF background strain. This corroborates the beneficial effect of the 
combination of these three mutations and suggests that insertion of the transposon between the 
yjiD gene and its promoter resulted in overexpression of this gene. 
Deletions and overexpression constructs represent metabolic extremes, and it is unlikely that 
these will constitute the genotypic basis leading to an optimal production phenotype. However, 
the simultaneous modulation of multiple genes is troublesome and hampered by the lack of 
sufficient molecular biology techniques. To remedy this limitation Alper et al. (2007) invented a 
technique which they coined global transcription machinery engineering (gTME). gTME 
allowed them to simultaneously modulate all genes for which transcription was mediated through 
global transcription factors, hereby altering the transcription profile of the cell. However, a large 
number of cells harboring different transcription factor mutants have to be screened since an 
enormous number of combinations can be achieved already within each of the genes. As a proof 
of concept they utilized the improvement of lycopene production in E. coli, since this phenotype 
had been found to be very well suited for high-throughput screening. Using gTME in 
conjunction with colorimetric screening they could further improve upon their best deletion 
mutants described above.  
Although carotenoids have also been synthesized in Saccharomyces cerevisiae [Yamano et al. 
1994]; we have not found any example in the literature describing colorimetric screening based 
on heterologously production of carotenoids in this organism. Engineering of S. cerevisiae for 
improved isoprenoid production has rather relied on rational strategies. However, improvement 
of carotenoid production within the natural carotenoid producing yeast Xanthophyllomyces 
dendrorhous has been achieved through colorimetric screening. These screens required the 
addition of inhibitors of carotenoid biosynthesis to allow for discrimination between wild-type 
and mutant colonies [Lewis et al. 1990; Chumpolkulwong et al. 1997]. Comparable carotenoid 
yields have been achieved in S. cerevisiae and X. dendrorhous, but colorimetric saturation and 
the requirement for inhibitory compounds could perhaps be a reason that colorimetric screens 
have not been applied for S. cerevisiae. Also other yeasts, such as Candida utilis, have been 
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engineered for production of carotenoids [Miura et al. 1998], and with the development of robust 
carotenoid based colorimetric screens designed for yeasts the potential of these organisms as 
hosts for heterologous isoprenoid production could be greatly improved and developed into a 
good alternative to E. coli. Figure 1.1 shows S. cerevisiae producing lycopene, β-carotene, and 
astaxanthin, respectively. 
 
Figure 1.1: S. cerevisiae strains engineered for production of different carotenoids. The food source 
primarily associated with the carotenoid being produced by each engineered yeast is presented next 
to the strain producing it. Prevalent carotenoid being produced is A: lycopene, B: β-carotene, and 
C: astaxanthin.  
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1.4 Polyketides and flavonoids 
Colorimetric screening of surrogate molecules has also been applied for these two groups of 
metabolites, but less extensively than for the isoprenoids. Malonyl-CoA is a precursor molecule 
applied in biosynthesis of both polyketides and flavonoids, and its abundance within microbial 
cells is important for their high level production. Several rational engineering strategies have 
increased malonyl-CoA availability [Leonard et al. 2008], but no combinatorial approach has to 
our knowledge been applied. However, Zha et al. (2008) utilized directed evolution to optimize 
Psedomonas fluorescens phloroglucionol synthase heterologously expressed in E. coli by 
screening for colonies exhibiting purple halos when grown on agar plates containing Gibb’s 
reagent (N,2,6-trichloro-p-benzoquinoneimide). Color formation was a result of the reaction of 
the polyketide phloroglucinol synthesized from three molecules of malonyl-CoA and Gibb’s 
reagent. Colonies selected from the initial screen were further tested in 96-well plates by the 
reaction between the phloroglucinol in a cell-free supernatant and cinnamaldehyde. This method 
allowed the authors to isolate several genes encoding mutated phloroglucionol synthases with 
improved catalytic properties. This screening method in conjunction with one of the mutated 
phloroglucionol synthases has the potential to be converted into a more general screen for 
malonyl-CoA precursor availability and hereby to be applied towards improving heterologous 
production of polyketides and flavonoids. 
Another key precursor metabolite for synthesis of flavonoids is L-tyrosine, and screening 
methods for detecting microbes with improved L-tyrosine production has been developed. The 
first one was as proof of concept demonstrated using E. coli; Lütke-Eversloh and 
Stephanopoulos (2007) demonstrated that L-tyrosine secreted to the fermentation broth of micro-
titer plate cultures could be quantified by derivatization with 1-nitroso-2-naphthol. This method 
had previously been demonstrated to permit colorimetric and fluorometric determination of L-
tyrosine [Udenfriend and Cooper 1952; Waalkes and Udenfriend 1957] but was adapted for 
high-throughput assessment of L-tyrosine production. By using fluorescence measurements 
Lütke-Eversloh and Stephanopoulos circumvented the tedious work of removing the cells from 
the supernatant in many samples prior to L-tyrosine quantification and simplified the procedure 
from ten steps to four steps, even further improving its applicability for high-throughput 
screening. Santos and Stephanopoulos (2008) invented another colorimetric method for 
screening E. coli mutants for improved L-tyrosine production. By expression of a tyrosinase 
encoded by the melA gene from Rhizobium etli they converted the L-tyrosine into 3,4-dihydroxy-
L-phenylalanine (L-DOPA) and further by oxidation into dopachrome, which can undergo non-
enzymatic polymerization to form the black pigment melanin. After optimizing the composition 
of the growth medium to maximize melanin production they could use the black melanin 
phenotype to screen a transposon mutagenesis library for E. coli colonies on agar plates for L-
tyrosine overproducers. This method is simpler than the aforementioned method since less 
pipetting and handling is involved, and pseudo-high-throughput can be achieved without the aid 
of robotics. 
Heterologous microbial production of natural products: colorimetric surrogate metabolite screens 
 
 
28 
These examples show how microbes may be optimized for production of some of the key 
precursors for flavonoid biosynthesis, but the pathway downstream thereof also deserves 
optimization to obtain efficient production strains. Whereas most heterologous flavonoid 
production strategies had relied on phenylpropanoic precursor supplementation, Santos et al. 
(2011) demonstrated the synthesis of the main flavonoid precursor naringenin from glucose. 
Their engineered strain permits investigations towards identifying both local and global targets 
that can further improve flavonoid precursor production. However, an efficient screen is 
required, which could be performed if naringenin could be converted to a metabolite resulting in 
a quantifiable colored phenotype. Fortunately several flavonoid compounds have been found to 
exhibit properties making them ideal as colorants [Winkel-Shirley 2001]. One sub-group of these 
metabolites is the anthocyanins, which have red or blue colors. Anthocyanin has been applied to 
assess the heterogeneity of cultured strawberry cells. This was done by image analysis which 
was used to analyze microscope pictures for red coloration by comparing the RGB-color 
parameters of the images [Miyanaga et al. 2000]. Anthocyanins have been heterologously 
produced in E. coli by Yan et al. (2005). This was done by expressing four genes encoding the 
following enzymes: 3β-hydroxylase from Malus domestica, dihydroflavonol 4-reductase from 
Anthurium andraeanum, anthocyanidin synthase also from M. domestica, and UDP-
glucose:flavonoid 3-O-glucosyltransferase from Petunia. If the genes encoding these four 
enzymes were expressed in the strain created by Santos et al. (2011) it should convert the 
colorless naringenin into the colored anthocyanins which in a manner similar to the application 
of lycopene described above could be used for optimizing E. coli for heterologous production of 
flavonoids. Since all the genes encoding the pathway to anthocyanins are known it should further 
be possible to use this approach to identify novel targets for improving flavonoid production in 
other microbes. 
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1.5 Tools for improving throughput 
Even though visual inspection of microbial colonies grown on agar plates is an established and 
efficient screening method, it has drawbacks. Humans have a good visual perception, but details 
such as color intensities relative to other objects is not clearly imbedded in the memory, a fact 
that often forces the investigator to refer back and forth between the individual objects in order to 
dissociate objects with certain traits, making this approach time consuming [Yang and Youvan 
1988]. Furthermore, different persons may have different color perception. To remedy these 
drawbacks Digital Imaging Spectroscopy (DIS) was invented. DIS enables the researcher to 
perform multiple parallel spectroscopic assessments of 2D images. The main components of DIS 
are a digital camera, light source, and an array of light filters. With DIS the wavelength of the 
light source and the wavelength of the light recorded by the digital camera can be controlled, 
allowing for the generation of multiple spectra. DIS can be used to obtain both reflectance and 
absorption spectra for the target. Spectra can be obtained in the range 400-900 nm (visible to 
near infrared), to hereby include the assessment of features not visible to the human eye. 
Furthermore, DIS can be applied to obtain fluorescence spectra. With DIS, up to 25 agar plates 
can be processed simultaneously containing up to 500 colonies each. For an introduction to DIS 
the reader is referred to Youvan et al. (1995). DIS has, e.g. been used for directed evolution of 
galactose oxidase [Delagrave et al. 2001], investigation of the effects of mutations on light-
harvesting complexes of the photosynthetic bacterium Rhodobacter capsulatus [Arkin et al. 
1990], and the assessment of the reflectance spectrum of a red yeast [Yang 1994]. DIS could be 
applied to chromogenic screens to improve the throughput but has not become a widespread 
method. 
Digital cameras, scanners and personal computers are common items found in most laboratories. 
This allows for less expensive and more readily available methods for automating the 
colorimetric screening of microbial populations on solid surfaces as compared to DIS. Gallagher 
et al. (2003) applied a Hewlett Packard Scan Jet 6100C scanner to obtain images of their 
colonies of carotenogenic E. coli cells transformed with a maize endosperm cDNA library. The 
Images were processed using Adobe Photoshop 4.0.1. This is an example of application of 
“everyday” lab equipment to evaluate colony coloration caused by production of a heterologous 
compound. 
We followed a similar approach when we developed a method for quantifying colony coloration 
of S. cerevisiae engineered to produce lycopene. The method was based on the acquirement of 
digital images of carotenogenic yeast cells and processing of these images using the image 
analysis software ImageJ. By constructing a S. cerevisiae strain with the lycopene biosynthetic 
pathway under control of the copper inducible CUP1 promoter we could correlate the processed 
colony coloration intensities for yeast cells grown on a certain copper concentration with the 
measured lycopene production in liquid cultures at the same copper concentrations [Carlsen et al. 
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201Xa]. This method offers a simple approach to improving colorimetric screening of microbial 
populations expressing red pigment molecules.  
Dr. K.R. Patil and Dr. A.E. Lantz have constructed a setup which allows for measuring growth 
rates and pigment production of microbial cultures grown in micro-titer plates hereby allowing 
for the selection of mutants with the highest productivity [personal communication]. The system 
has as proof-of-concept been tested on heterologous lycopene production by S. cerevisiae and 
actinorhodin production by Streptomyces coelicolor. The setup is composed of two flat-bed 
scanners placed under an orbital shaker located within an incubator that offers control of 
temperature and humidity combined with the blockage of any interfering light sources. The 
entire setup is controlled by a computer which at set time points stops the orbital shaker and 
acquires scans of the bottom of each micro-titer plate in which microbes are growing. The micro-
titer plate images are analyzed using a custom designed software that calculates product 
formation and growth measurements. 
Although the aforementioned methods greatly improve colorimetric screening, they can only be 
considered as a step towards the setup of real high-throughput methods. Handling and picking of 
individual colonies are so far still performed manually. If the colorimetric screening methods 
were to be interfaced with robotic colony pickers for transferring the mutants identified to exhibit 
a desired trait into micro-titer plates, combined with micro-titer-plate handling and automation 
for further analysis, they would represent true high-throughput methods [Youvan et al. 1995]. 
The technologies for doing this are definitely available. For further descriptions of screening 
automation the reader is referred to Hamilton (2002). 
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1.6 Conclusions and future perspectives 
A wealth of colored metabolites is produced in nature. They represent a great potential since they 
can be heterologously biosynthesized and hereby be utilized as surrogate molecules in the 
development of novel colorimetric screens for improving microbial production. Ideal surrogate 
molecules and their biosynthetic pathways should meet as many of the following criteria as 
possible: 
 A short pathway from precursor metabolite to reporter metabolite 
 Proportional response in reporter metabolite concentration to changes in precursor 
metabolite concentration 
 Balanced pathway to avoid buildup of intermediates between precursor and reporter 
metabolite 
 Easily quantifiable compound to ensure high throughput 
 High stability and molecular integrity 
 Similar physical and chemical properties to the metabolite for which it is used as a 
surrogate 
 No or low toxicity to the chosen production organism 
 Impose small metabolic burden 
 High signal to noise ratio 
 
Most groups of metabolites span a wide range within properties such as hydrophobicity and 
volatility. This can create problems in the use of surrogate compounds. E.g. since lycopene is 
very hydrophobic and accumulated inside cells when heterologously produced in 
microorganisms [Yamano et al., 1994], its application as surrogate compound could result in the 
isolation of mutants that influence intracellular storage capacity and would thus not benefit the 
production of excreted isoprenoid metabolites. Another issue in the application of heterologous 
metabolites in surrogate screens is the host response to these. Verwaal et al. (2010) found that 
heterologous production of carotenoids in S. cerevisiae triggers the pleiotropic drug resistance 
genes, suggesting that these compounds have a detrimental effect on the yeast cells. When 
carotenoid molecules are applied in a S. cerevisiae screening endeavor, there is therefore a 
possibility that some of the recovered genotypes are involved in increasing the tolerance towards 
them. If the same is valid for E. coli, this could be the reason that some of the recovered 
genotypes in the lycopene based screens are not directly linked to improving precursor 
availability. Indeed, when we improved heterologous production of squalene, which has a 
molecular structure very similar to lycopene, in E. coli, we observed that it had a negative effect 
on the growth of the cells [Carlsen et al. 201Xb]. This supports the case of E. coli being affected 
by the expression of hydrophobic isoprenoids. Even though surrogate compounds have to be 
selected with care, their application in microbial screens have helped enormously in the effort 
towards isolation of novel genotypes for improving microbes for production of natural products.  
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Due to current sub-optimal cost-effectiveness of microbial natural product production, only high 
value natural products or molecules that cannot be obtained by other means than microbial 
production can so far be cost-competitively biosynthesized. With more culturable 
microorganisms exhibiting novel properties being identified and genetic and molecular biology 
techniques being developed to engineer these, the strategy of applying microbial production 
platforms for production of less costly natural products is not far from being realizable; the host 
organism for the production of each individual group of metabolites just has to be carefully 
selected based on the properties of the metabolites [Zhang et al. 2011]. After choosing a 
microorganism as starting point, one needs to optimize it for production of the given compound. 
In this endeavor, colorimetric screening will play an important role with a development of novel 
screens concurrently with automation of already established screens, since most of these screens 
are applicable for multiple species of microbes. Metabolites for which screening methods exist 
are still greatly exceeded by the methods available to manipulate microorganisms, so the 
development of screening methods based on surrogate compounds is definitely an area that will 
gain increased attention in the future. 
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2.1 Abstract 
Transfer of a biosynthetic pathway between evolutionary distant organisms can create a 
metabolic shunt capable of bypassing the native regulation of the host organism, hereby 
improving the production of secondary metabolite precursor molecules of important natural 
products. In most cases transfer of the genes encoding the pathway enzymes followed by 
balancing of the individual steps is sufficient to achieve expression of a fully functional 
heterologous pathway. In this study we integrated the Escherichia coli genes encoding the 2-C-
methyl-D-erythritol 4-phosphate (MEP)-pathway into the genome of Saccharomyces cerevisiae 
with the aim of bypassing regulation of the mevalonate (MVA)-pathway and create an improved 
microbial platform for production of isoprenoids. We found that most of the pathway is active, 
synthesizing 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEC) but appears to lack 
functionality of the last two steps of the MEP-pathway, catalyzed by the [4Fe-4S] iron sulfur 
cluster proteins encoded by ispG and ispH. We detected production of not only MEC but also 
deoxyxylulose 5-phosphate in S. cerevisiae, which has never before been reported. To try to 
functionalize the last two steps of the MEP-pathway we co-expressed the genes for the E. coli 
iron sulfur cluster (ISC)-assembly machinery. By deleting ERG13, thereby incapacitating the 
MVA-pathway, in conjunction with labeling experiments with U-
13
C6 glucose and growth 
experiments, we found that the ISC-assembly machinery was unable to functionalize ispG and 
ispH. However, we have found that leuC and leuD, encoding the hetero-dimeric iron sulfur 
cluster protein isopropylmalate isomerase, can complement the S. cerevisiae leu1 auxotrophy. 
This is to our knowledge the first time a bacterial iron-sulfur cluster protein has been 
functionally expressed in the cytosol of S. cerevisiae and shows that S. cerevisiae has the 
capability to functionally express at least some bacterial iron sulfur cluster proteins in its cytosol. 
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2.2 Introduction 
Isoprenoids, comprising more than 55,000 compounds, holds a great potential for the discovery 
of novel pharmaceuticals, flavors, fragrances, and in general high-value chemicals. The 
complexity of these compounds and their scarce availability in nature however render their 
production highly costly and difficult via chemical synthesis or extraction, hereby leaving 
heterologous biosynthesis in organisms amenable to genetic engineering the most obvious 
strategy of production. However, biosynthesis is not straightforward and requires optimization to 
establish an effective downstream pathway for obtaining the product of interest, avoid byproduct 
formation, and improve precursor supply. In cases where it is impossible to establish a total 
biosynthetic scheme due to, e.g., the genes encoding the required enzymatic steps being 
unknown, the cells being unable to functionally express the required genes, or the intermediates 
of the pathway being toxic to the host cell, it is advantageous to use a combinatorial approach 
comprising a fermentation step providing the isoprenoid backbone followed by a chemical step 
converting the backbone to the product of interest. Nevertheless, for any of the aforementioned 
approaches to be viable a high flux through the upstream pathway is required to ensure a high 
isoprenoid precursor supply [Maimone and Baran, 2007; Ajikumar et al. 2008]. 
All isoprenoids are biosynthesized from the C-5 precursor isopentenyl diphosphate (IPP), which 
can be produced through two distinct pathways, namely the mevalonate (MVA) pathway from 
acetyl-CoA and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway from pyruvate and 
glyceraldehyde-3-phosphate (G3P) (Figure 2.1). Some organisms like plants utilize both 
pathways, but most organisms utilize only one of the two, hereby opening an approach to bypass 
the native regulation of the production organism of choice by expression of the heterologous 
pathway [Martin et al., 2003; Maury et al., 2008]. The first example by Martin et al. (2003) 
showed this strategy to be an effective way of improving the production of isoprenoids. The 
MVA-pathway was engineered into Escherichia coli, which naturally only possesses the MEP-
pathway. In order to do this, two operons were created based on 4 codon-optimized genes each, 
encompassing upstream and downstream parts of the mevalonate pathway, respectively. By co-
expressing the two plasmids in an E. coli strain harboring an ispC deletion, which causes a 
requirement for deoxyxylulose 5-phosphate (DXP), Martin et al. [2003] were able to obtain 
DXP-non-requiring cells, hereby demonstrating that the heterologous MVA-pathway can provide 
an amount of IPP sufficient to sustain growth. They further showed that the engineered E. coli 
strain could be utilized to produce high amounts of the artimisinin precursor amorpha-4,11-
diene, and they hereby also demonstrated proof-of-concept of generating a microbial platform 
engineered to produce high amounts of IPP which can be converted into an isoprenoid of interest 
for which the synthase gene(s) are known. 
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Figure 2.1: Overview of isoprenoids biosynthetic pathways. Green gene names are mevalonate 
pathway genes and red gene names are 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway 
genes. Gene / protein: ERG10 / acetoacetyl-CoA thiolase, ERG13 / 3-hydroxy-3-methyl-glutaryl-
CoA synthase, HMG1 and HMG2 / 3-hydroxy-3-methyl-glutaryl-CoA reductase, ERG12 / 
mevalonate kinase, ERG8 / phosphomevalonate kinase, ERG19 / mevalonate-5-diphosphate 
decarboxylase, IDI and idi / isopentenyl diphosphate isomerase, ERG20 / Farnesyl diphosphate 
synthase, dxs / 1-deoxy-D-xylulose-5-phosphate synthase, dxr / 1-deoxy-D-xylulose-5-phosphate 
reductase, ispD / 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase, ispE / 4-diphosphocytidyl-2-
C-methyl-D-erythritol kinase, ispF / 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase, ispG / 
1-hydroxy-2-methyl-2-(E)-butenyl-4-phosphate synthase, ispH / 1-hydroxy-2-methyl-2-(E)-butenyl-
4-phosphate reductase. Pathway intermediates: FBP – fructose bisphosphate, DHAP - 
dihydroxyacetone phosphate, G3P – glyceraldehyde 3-phosphate, PEP – phosphoenolpyruvate, 
PYR – pyruvate, ACCoA – acetyl-CoA, AcACCoA – acetoacetyl-CoA, HMG-CoA – 3-hydroxy-3-
methyl-glutaryl-CoA, MEV – mevalonate, MEV-P – mevalonate-5-phosphate, MEV-PP – 
mevalonate diphosphate, IPP – isopentenyl diphosphate, DMAPP – dimethylallyl diphosphate, FPP 
– farnesyl diphosphate, DXP – 1-deoxy-D-xylulose-5-phosphate, MEP – 2-C-methyl-D-erythritol-4-
phosphate, CDP-ME – 4-diphosphocytidyl-2-C-methyl-D-erythritol, CDP-MEP – 2-phospho-4-
diphosphocytidyl-2-C-methyl-D-erythritol, MEC – 2-C-methyl-D-erythritol-2,4-cyclodiphosphate, 
HMBP – 1-hydroxy-2-methyl-2-(E)-butenyl-4-phosphate. 
Expression of a non-native, multi-step pathway yields a deregulation of the flux, which thus 
increases desirably, but this also implies that the pathway cannot self-regulate and therefore in 
most cases has to be additionally engineered to avoid bottlenecks which would otherwise cause 
suboptimal pathway performance. This was indeed the case for the strain engineered by Martin 
et al. [2003]. When the authors analyzed their strain by liquid chromatography – mass 
spectrometry (LC-MS), they found a buildup of the MVA-pathway intermediate 3-hydroxy-3-
methylglutaryl-CoA (HMG-CoA), which inhibited cell growth. The buildup was attributed to 
HMG-CoA reductase being inefficient at converting HMG-CoA to MVA. The problem was 
alleviated by modulation of the expression level of the tHMGR gene, encoding a truncated 
HMG-CoA reductase, hereby demonstrating the importance of balancing the carbon flux of a 
heterologously expressed multi-step pathway [Pitera et al. 2007]. 
Saccharomyces cerevisiae, on the other hand, naturally utilizes the MVA-pathway for production 
of isoprenoids, so in order to engineer a S. cerevisiae platform for production of isoprenoids 
[Maury et al. 2008] expressed the seven genes encompassing the mevalonate pathway on two 2μ 
self-replicating plasmids together with a valencene synthase gene. The MEP-pathway has been 
found to be stoichiometrically superior to the MVA-pathway [Dugar and Stephanopoulos, 2011], 
making it obvious to try this pathway for heterologous expression. Maury and coworkers 
amplified the seven MEP-pathway genes by PCR from E. coli genomic DNA and expressed 
them using a dual galactose inducible promoter system based on the GAL1-promoter and the 
GAL10-promoter. To verify that the MEP-pathway was active they inhibited the MVA-pathway 
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with the hypocholesterolemic drug lovastatin, which specifically inhibits the HMG-CoA 
reductase [Alberts et al., 1980], and since the MVA pathway supplies precursors for ergosterol 
and other essential compounds, this drug inhibits growth of wild type yeast. The MEP pathway 
appeared to support growth, thwarting the lovastatin mediated inhibition, hereby indicating that 
the heterologous expressed MEP-pathway is active. This work led to the patenting of MEP-
pathway transformed microorganism for production of isoprenoids [Maury et al., 2008]. 
So far the aforementioned examples are the only two examples of transferring the 
complementary IPP biosynthetic pathway into an organism devoid of either the MVA-pathway 
or the MEP-pathway. Transferring an entire pathway is a tedious and challenging task, which is 
probably why it have only been done in the model organisms E. coli and S. cerevisiae, for which 
well-developed genetic engineering tools and expression systems are available. In this study we 
likewise decided to engineer the MEP-pathway into S. cerevisiae, but to create a stable strain 
amenable for further genetic modification we chose to chromosomally integrate the seven MEP-
pathway genes from E. coli with the addition of the Idi gene, which encodes the E. coli 
IPP/dimethylallyl diphosphate (DMAPP) isomerase. These eight genes where obtained 
synthetically and codon optimized to improve their expression in S. cerevisiae to compensate for 
the lower expression level caused by having a single copy of the gene in the chromosome 
compared to the 2μ-based multi-copy plasmids. To test whether the chromosomally integrated 
pathway were functional expressed we decided to delete the ERG13 gene, which encodes the 
HMG-CoA synthase of the MVA-pathway. Contrarily to what was presented by Maury et al. 
[2008], the E. coli MEP-pathway chromosomally expressed in S. cerevisiae was unable to 
support growth in the absence of IPP supplied by the MVA-pathway. To investigate what caused 
the MEP-pathway to be inactive, and where in the pathway the problem occurred, we analyzed 
the strain for MEP-pathway metabolites using liquid chromatography – mass spectrometry. We 
detected both DXP and 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEC). The results 
indicate that the MEP pathway is active until MEC, and the problem thus originates from lack of 
sufficient expression of either of the two genes (ispG and ispH) downstream of MEC or both. 
We hereafter searched the literature to elucidate whether S. cerevisiae meets the co-factor 
requirements for the entire MEP-pathway, cf. Table 2.1. From Table 2.1 it can be seen that all 
co-factor requirements for the first five pathway steps are fulfilled. However, step 6 and 7 
requires ferredoxin or flavodoxin and ferredoxin (flavodoxin) NADP
+
 reductase to couple the 
reaction to NADPH for electron transfer. Furthermore, both ispG and ispH are iron-sulfur cluster 
proteins which need to be loaded with a [4Fe-4S]-iron-sulfur cluster (ISC) to be functional 
[Seemann and Rohmer, 2007]. Ferredoxin is also an [2Fe-2S] ISC-protein [Blaschkowski et al. 
1981]. 
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Table 2.1: MEP-pathway reactions and cofactors 
Protein 
name/ gene 
name(s) 
Substrate(s)/product(s) Cofactor(s) Reference EcoCyc 
accession 
number 
Dxs/ dxs  pyruvate + D-
glyceraldehyde-3-phosphate 
+ H
+
/ CO2 + 1-deoxy-D-
xylulose 5-phosphate  
Thiamine 
diphosphate; 
Mg
2+
; Mn
2+
  
Xiang et al., 
2007 
G6237  
Dxr/ dxr  1-deoxy-D-xylulose 5-
phosphate + NADPH + H
+
/ 
2-C-methyl-D-erythritol-4-
phosphate + NADP
+
  
Co
2+
; Mg
2+
; 
Mn
2+
  
Takahashi et 
al., 1998  
EG12715  
IspD/ ispD  2-C-methyl-D-erythritol-4-
phosphate + CTP + H
+
 / 4-
(cytidine 5'-diphospho)-2-
C-methyl-D-erythritol + 
diphosphate  
CTP; Co
2+
; 
Mg
2+
; Mn
2+
  
Rohdich et al., 
1999  
G7423  
IspE/ ispE  4-(cytidine 5'-diphospho)-2-
C-methyl-D-erythritol + 
ATP / 2-phospho-4-
(cytidine 5'-diphospho)-2-
C-methyl-D-erythritol + 
ADP + 2 H
+
  
ATP;  Lüttgen et al., 
2000; Lange 
& Croteau 
1999  
EG11294  
IspF/ ispF  2-phospho-4-(cytidine 5'-
diphospho)-2-C-methyl-D-
erythritol / CMP + 2-C-
methyl-D-erythritol-2,4-
cyclodiphosphate  
Mn
2+
 Herz et al. 
2000  
EG11816  
IspG/ ispG 
(gcpE)  
2-C-methyl-D-erythritol-
2,4-cyclodiphosphate + 
[reduced ferredoxin]2 / 1-
hydroxy-2-methyl-2-(E)-
butenyl 4-diphosphate + 
[oxidized ferredoxin]2 + 
Mn
2+
; 
flavodoxin or 
ferredoxin; 
NAD(P)H; 
[4Fe-4S] 
cluster  
Altincicek et 
al., 2001;  
Seemann et 
al., 2002; 
Zepeck et al., 
EG10370  
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H2O 2005  
IspH/ ispH 
(lytB)  
NADPH + 1-hydroxy-2-
methyl-2-(E)-butenyl 4-
diphosphate + H
+
/ NAD(P)
+
 
+ dimethylallyl diphosphate 
+ isopentenyl diphosphate + 
H2O  
Co
2+
 ; 
flavodoxin or 
ferredoxin; 
NAD(P)H; 
[4Fe-4S] 
cluster  
Rohdich et al., 
2002; 
Seemann and 
Rohmer, 2007 
EG11081  
 
ISC proteins are ubiquitously found throughout nature, but the approach of assembling these 
varies from species to species. Three different ISC-assembly pathways have so far been 
discovered in bacteria, namely the NIF (nitrogen fixation), ISC (iron-sulfur cluster) and SUF 
(sulfur mobilization) [Tokumoto et al. 2004], whereas a conserved ISC assembly machinery 
located in the mitochondria is present in eukaryotes. This machinery has been inherited from a 
bacterial ancestor of the mitochondria and therefore has high similarity to the ISC-assembly 
machinery found in bacteria [Mühlenhoff and Lill, 2000]. However, located in the mitochondria, 
the eukaryotic ISC-assembly machinery has to supply ISCs to apo-proteins throughout the cell. 
This is done by the cytosolic iron-sulfur cluster assembly machinery (CIA) [Lill and Mühlenhoff, 
2008]. The CIA machinery is not very well characterized, and the exact mechanisms responsible 
for targeting cytosolic and nuclear apo-proteins to be loaded with ISCs exported from 
mitochondria are unknown. This obviously complicates engineering of the ispG and ispH to 
functionalize them within the cytosol of S. cerevisiae; in order to remedy this situation we 
decided to co-express the E. coli ISC-assembly machinery with the heterologous MEP-pathway. 
The core functions in ISC biogenesis in E. coli are encoded by a single gene cluster composed of 
the following genes: iscR – transcriptional regulator, iscS – cysteine desulferase (sulfur donor), 
iscU – scaffold, iscA – A-type protein, HscB – DnaJ-like co-chaperone, HscB – DnaK-like 
chaperone, fdx – ferredoxin and iscX – unknown function, found to interact with iscS [Py and 
Barras, 2010; Tokumoto et al., 2002]. Besides these 10 genes, the ErpA gene, encoding another 
A-type protein, is essential in E. coli for converting ispG from its apo form to its holo form 
[Loiseau et al., 2007]. Furthermore, the E. coli CyaY gene, encoding frataxin, takes part in ISC-
assembly, probably as an iron-donor [Yoon and Cowan, 2003]. Bedekoviks et al. [2007] showed 
that a mitochondrially targeted version of the E. coli CyaY gene could functionally complement 
the yfh1 deletion in S. cerevisiae. YFH1 has previously been found to be important for ISC-
biogenesis in yeast, hereby further strengthening the evidence that frataxin is required for ISC-
assembly [Duby et al., 2002]. Finally, Justino et al. [2007] showed that the E. coli YtfE-encoded 
protein acts as a repair protein to mend ISC-proteins that have been damaged due to nitrosative 
stress. 
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Iron storage and sequestration in biological system is of outmost importance to ensure that the 
iron is soluble and thereby accessible where necessitated and to avoid the formation of reactive 
oxygen species, e.g. through the Haber-Weiss-Fenton reaction, which generates hydroxyl 
radicals [Aisen et al., 2001]. Most organisms use the polymeric protein ferritin to store iron. 
Even though S. cerevisiae contains ferritin, the majority of the iron stored within the cell is 
located in the vacuole [Raguzzi et al., 1988]. Little is known about how iron is transported within 
the yeast cell, and it is unknown whether the iron stored in the vacuole will be available for a 
heterologous ISC-machinery. It has previously been found that iron storage in S. cerevisiae, and 
thereby tolerance towards stress induced by high extracellular iron concentrations, can be 
improved by heterologous expression of human hetero-polymeric ferritin [Kim et al., 2003]. We 
therefore decided to additionally express the E. coli Bfr, FtnA, and Bfd genes, encoding the 
bacterioferritin, ferritin and bacterioferritin-associated ferredoxin, respectively. These iron 
storage genes together with the ISC-machinery genes, the ISC repair gene and the Fdx, Fpr, and 
FldA, encoding the ferredoxin, ferredoxin (flavodoxin) NADP
+
 reductase, and flavodoxin 1 
[Nakamura et al., 1999; Bianchi et al., 1993; Puan et al., 2005], make up the supporting system 
that we hypothesized to be required to functionalize the MEP-pathway expressed in S. 
cerevisiae. Here we report the cloning and expression of these 16 genes combined with the 8 
MEP-pathway genes (including Idi), together with the testing of this complex system. We finally 
show that S. cerevisiae is capable of functional expression of bacterial ISC-proteins within the 
cytosol.  
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2.3 Materials and Methods 
2.3.1 Chemicals, enzymes and growth media 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich®, St. Louis, MO, 
and all enzymes from New England Biolabs Inc., Ipswich, MA. 
E. coli cells were grown in BD Difco
TM
 LB broth from BD Diagnostic Systems, Sparks, MD. For 
selection and maintenance of plasmids, ampicillin was added to a final concentration of 100 
mg/l. S. cerevisiae cultures that required no auxotrophic selection were grown on YPD, 
composed of: 10 g/l Bacto
TM
 yeast extract, BD Diagnostic Systems; 20 g/l Bacto
TM
 peptone, BD 
Diagnostic Systems; and 20 g/l dextrose. For auxotrophic selection, S. cerevisiae was grown on 
SC-medium with the appropriate nutrient(s) omitted or SD for prototrophic strains. SC medium 
was composed of 6.7 g/l Yeast Nitrogen Base (YNB) without amino acids, BD Diagnostic 
Systems; CSM – amino acid dropout mixture (amount according to manufacturer’s 
recommendation), Sunrise Science Products, Inc., San Diego, CA; and 20 g/l dextrose or 
galactose. SD was made the same way as SC with the difference of omitting the CSM amino acid 
dropout mixture. All media components and media besides YNB were sterilized by autoclaving. 
YNB was sterilized by filtration. 
 
2.3.2 Plasmids and strains 
The strains and plasmids acquired for this study can be seen from Table 2.2. Every cloning for 
the construction of the plasmids described below was carried out by treating the recipient 
plasmids with endonuclease(s), purification by gel-electrophoresis and recovery by gel extraction 
using the PureLink™ Quick Gel Extraction Kit, Life Technologies, Grand Island, NY, followed 
by ligation to the insert using T4 DNA ligase. Each insert was either prepared by removing it 
from the plasmid harboring it by endonuclease digestion followed by gel-electrophoresis and 
purification in the same way as the plasmid recipient, or amplified by PCR, purified using the 
QIAquick PCR Purification Kit, Valencia, CA, treated with endonucleases and purified again 
using the QIAquick PCR Purification Kit. All constructs were verified by sequencing. The DNA 
ladder used as size reference was the Quick-Load® 1 kb DNA Ladder from New England 
Biolabs Inc., Ipswich, MA (bands corresponds to the following DNA lengths: 0.5, 1.0, 1.5, 2.0, 
3.0, 4.0, 5.0, 6.0, 8.0, 10.0 kb). 
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Table 2.2: Strains and plasmids acquired for this study. 
Strain Genotype Source 
Saccharomyces cerevisiae  
F1702 MATa ade1 arg4 his2 leu2 trp1 ura3 Dr. G. Fink, Whitehead Institute, 
Cambridge, MA 
CEN.PK 113-
7D 
MATα MAL2-8c SUC2 Dr. P. Kötter, Frankfurt, 
Germany. 
JAY20 MATα leu1 ura3-52 (derived from FY2, 
Winston et al. 1995) 
Dr. J. Avalos and Dr. G. Fink, 
Whitehead Institute, Cambridge, 
MA 
Escherichia coli  
MAX 
Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 
Life Technologies, Grand Island, 
NY 
K-12, 
MG1655 
F- lambda- ilvG- rfb-50 rph-1 Ajikumar et al., 2010 
   
Plasmid name Origin/reference 
pKT127 Sheff and Thorn, 2004. 
pRS414TEF Mumberg et al., 1995 
pRS415GPD Mumberg et al., 1995 
PUCAR1 Dr. Hang Zhou 
pUC19 Life Technologies, Grand Island, 
NY 
PUG72 Güldener et. al., 2002 
pESC-URA Stratagene, Agilent Technologies, 
Inc., Santa Clara, CA 
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2.3.3 Construction of expression cassettes 
For expression of the genes of interest, four expression cassettes were created and tested for their 
ability to mediate transcription by verifying that they could express the yeast enhanced green 
fluorescent protein (yeGFP). This was done on the basis of the pRS414TEF and pRS415GPD in 
which the yeGFP from pKT127 was inserted by SpeI/XhoI digestion. The pRS414TEF with the 
insert yeGFP was modified by exchanging the CYC1t with the ADH1t, ACT1t and ENO2t by 
XhoI/KpnI digestion. The TEF1p was substituted with the PGK1p in the plasmid with the 
ACT1t, and with the TEF2p in the plasmid with the ENO2t, by SacI/SpeI digestion. The 
replacement promoters and terminators were obtained by PCR from CEN.PK 113-7D genomic 
DNA (gDNA) using the primers containing adaptamers with the respective restriction sites (see 
Table 2.3). This resulted in the construction of 4 expression cassettes harboring yeGFP, namely 
the TEF1p-yeGFP-ADH1t, TDH3p (GPDp)-yeGFP-CYC1t, PGK1p-yeGFP-ACT1t and TEF2p-
yeGFP-ENO2t in the pSCX001, pSCX002, pSCX003 and pSCX004 plasmids, respectively. 
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Table 2.3: Primers. 
Feature Forward
1
 primer (5’ - 3’) Reverse1 Primer (5’ - 3’) Amplicon 
size (bp)
2 
Restriction 
sites
3
 
yeGFP GACTTAACTAGTATGT
CTAAAGGTGAAGAATT
ATTCACTGG 
TATGACCTCGAGTT
ATTTGTACAATTCAT
CCATACCATGGG 
717 SpeI/XhoI 
ADH1t GACTTACTCGAGGCGA
ATTTCTTATGATTTAT
GATTTTTATTATTAAA
TAAGT 
TATGACGGTACCGA
GCGACCTCATGCTA
TACCTG 
166 XhoI/KpnI 
PGK1p GACTTAGAGCTCAGAC
GCGAATTTTTCGAAGA
AGTACC 
TATGACACTAGTTG
TTTTATATTTGTTGT
AAAAAGTAGATAAT
TACTTCC 
1000 SacI/SpeI 
ACT1t GACTTACTCGAGTCTC
TGCTTTTGTGCGCGTA
TGT 
TATGACGGTACCAT
ATGATACACGGTCC
AATGGATAAAC 
293 XhoI/KpnI 
TEF2p GACTTAGAGCTCGGGC
GCCATAACCAAGGTAT
C 
TATGACACTAGTGT
TTAGTTAATTATAGT
TCGTTGACCGTATA 
500 SacI/SpeI 
ENO2t GACTTACTCGAGAGTG
CTTTTAACTAAGAATT
ATTAGTCTTTTCTG 
TATGACGGTACCAG
GTATCATCTCCATCT
CCCATATG 
400 XhoI/KpnI 
HIS2 GACTTAAAGCTTTCAA
TCTTGCCGGTTTCATA
CATGTTG 
TATGACAAGCTTAA
AGGTTTCCCAGCCA
AACCCG 
1750 HindIII 
ADE1 GACTTAAAGCTTATTC
ACGAGTCAGTCTGACT
CTTG 
TATGACAAGCTTGA
ATACGAAAGAGAAC
TGAGTCAGTTG 
1427 HindIII 
YPRCδ15-
UP 
GACTTAGACGTCTTAA
TTAAGCCAGGCGCCTT
TATATCAT 
TATGACGTCGACGC
GGCCGCTGACCTAG
ACCTAGGTTTGCGA
690 AatII-
PacI/SalI-
NotI-AvrII 
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AACCCTATGCTCT 
YPRCδ15-
DOWN 
GACTTAGCTAGCAATG
GAAGGTCGGGATGAG 
TATGACGCGGCCGC
TGACCTAGACCTAG
GATAAAGCAGCCGC
TACCAAA 
651 NheI/NotI-
AvrII 
YPRCτ3-
UP 
GACTTAGACGTCTTAA
TTAAAAAGGAGGTGC
ACGCATTAT 
TATGACGTCGACGC
GGCCGCTGACCTAG
ACCTAGGTTCCAAG
GAGGTGAAGAACG 
598 AatII-
PacI/SalI-
NotI-AvrII 
YPRCτ3-
DOWN 
GACTTAGCTAGCGATG
GGACGTCAGCACTGTA 
TATGACGCGGCCGC
TGACCTAGACCTAG
GCGGTATTACTCGA
GCCCGTA 
638 NheI/NotI-
AvrII 
Expression 
cassettes 
GACTTAGCTAGCCCTC
ACTAAAGGGAACAAA
AGCTG 
TATGACGCGGCCGC
TGACCTAGACCTAG
GAATACGACTCACT
ATAGGGCGAATTG 
Variable NheI/NotI-
AvrII 
TRP1 GACTTAGCTAGCGTAC
AATCTTGATCCGGAGC
TTTTC 
TATGACGCGGCCGC
TGACCTAGACCTAG
GAGGCAAGTGCACA
AACAATACTTAAAT
AAATA 
870 NheI/NotI-
AvrII 
LEU2 GACTTAGCTAGCTCGA
CGGTCGAGGAGAACTT
C 
TATGACGCGGCCGC
TGACCTAGACCTAG
GTCGACTACGTCGT
AAGGCCG 
2235 NheI/NotI-
AvrII 
ERG13-UP CGGAATAAGCTTCGTA
TATACAATAGAAAAAT
TTTC 
TATGACCTGCAGGC
TGCACCTTTTATAGT
AATTTGGCTAC 
213 HindIII/ 
PstI 
ERG13-
DOWN 
GACTTAACTAGTCCCG
GGTCTTCCCCCATCGA
TTGCATCTTG 
TATGACCCGCGGCG
GCCGGGAAAACACG
TCGGGGTTATGAAT
G 
272 SpeI/SacII 
ERG13- CACTATCCATCCGACA ACCAAGGGGATTAT 1000  
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Delta(1) GATGGAC TGATGCTTGCT 
ERG13-
Delta(2) 
TTGAGATGAGCTTAAT
CATGTCAAAGC 
GATGTTTCTAAAGT
GGCCTGTACG 
900  
ERG13 ATGAAACTCTCAACTA
AACTTTGTTGGTG 
TTTTTTAACATCGTA
AGATCTTCTAAATTT
GTCATC 
1473  
leuC GACTTAGGATCCATGG
CTAAGACGTTATACGA
AAAATTGTTC 
TATGACAAGCTTTT
ATTTAATGTTGCGA
ATGTCGGCGAAATG 
1401 BamHI/ 
HindIII 
leuD GACTTAGAATTCATGG
CAGAGAAATTTATCAA
ACACACAG 
TATGACGAGCTCTT
AATTCATAAACGCA
GGTTGTTTTGCTTC 
606 EcoRI/SacI 
LEU1 GACTTAGGATCCATGG
TTTACACTCCATCCAA
GGG 
TATGACCTCGAGCT
ACCAATCCTGGTGG
ACTTTATC 
2340 BamHI/ 
XhoI 
TEF1p-dxs-
ADH1t 
CGAGGGGCCCGCTGG
AGCTCATAGCTTC 
CCAGCGACGTCTAC
CGAGCGACCTC 
2483 ApaI/AatII 
PGK1p-
ispF-ACT1t 
CCCAGCATGCAGACGC
GAATTTTTCG 
CTAGACCTAGGGCG
AATTGGGTACCGGC
CGC 
1806 SphI/AflII 
TDH3p-
ispE-CYC1t 
CGGTAGACGTCGCTGG
AGCTCAGTTTATC 
CTAGACCTAGGGCG
AATTGGGTACCGG 
1823 AatII/AvrII 
TEF1p-
ispD-
CYC1t 
GCTAGGCGCCGGGAA
CAAAAGCTGGAGCTC
ATAGC 
GTACCATATGCGAC
TCACTATAGGGCGA
ATTGGG 
1450 KasI/NdeI 
TEF1p-
ispG-
CYC1t 
CTGCAGGCATGCAAGC
TTGAATACGAAAGAG 
GACCGTGTATCATA
TCGGCCGGTACCCA
CTTAAGGGC 
1879 SphI/AflII 
TDH3p-
ispH-
CYC1t 
GGTAGACGTCGCTGGA
GCTCAGTTTATCATTA
TC 
GCTCCTAGGGCGAA
TTGGGTACCGGCCG
C 
1919 AatII/AvrII 
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PGK1p-
ispC-ACT1t 
CGCCCTAGGAGCTGGA
GCTCAGACGCGAATTT
TTC 
GCCCTTAAGTGGGT
ACCGGCCGATATGA
TACAC 
2544 AvrII/AflII 
TEF1p-idi-
ADH1t 
GAGGGGCCCGCTGGA
GCTCATAGCTTC 
CAGCGACGTCTACC
GAGCGACCTCATGC 
1167 ApaI/AatII 
TDH3p-
YtfE-CYC1t 
CTAGAGGATCCCCGGG
TACCGCTGGAGCTCAG
TTTATCATTATC 
CACTTAAGGGCCGC
AAATTAAAGCCTTC
GAGCGTCCC 
1626 BamHI/ 
AflII 
TEF1p-bfr-
ADH1t 
CGAGGGGCCCGCTGG
AGCTCATAGCTTC 
CCAGCGACGTCTAC
CGAGCGACCTCATG
CTATAC 
1511 ApaI/AatII 
PGK1p-
bfd-ACT1t 
CGCCCTAGGAGCTGGA
GCTCAGACGCGA 
GGCCCTTAAGTGGG
TACCGGCCGATATG
ATACACGGTCCAAT
G 
1546 AvrII/AflII 
TDH3p-
FtnA-
CYC1t 
CGGTAGACGTCGCTGG
AGCTCAGTTTATCATT
ATC 
GCTCCTAGGGCGAA
TTGGGTACCCGGCC
GCAAATTAAAGCCT
TCG 
1468 AatII/AvrII 
ARG4 CGCCAAGCTTCACTGT
CAGAGACTGTTTCC 
GAGGATCCAGAGTC
GACAACGACTTTGG
GAGG 
2320 HindIII/ 
BamHI 
1
 Primer direction defined according to the direction of translation of the ORF. 
2
 Amplicon size does not include adaptamers containing the restriction sites. 
3
 Restriction site(s) in the adaptamer of the forward primer / restriction site(s) in the adaptamer of 
the reverse primer. 
 
The 8 MEP-pathway genes were purchased codon optimized for S. cerevisiae from DNA 2.0, 
Menlo Park, CA, flanked by SpeI (5’) and XhoI (3’) restriction sites. Using these restriction sites 
the genes were cloned into expression cassettes (see Table 2.4). The 16 ISC-assembly machinery 
genes were amplified from E. coli K12, MG1655 gDNA using Phusion® High-Fidelity DNA 
Polymerase (applied for all PCR reactions described in section 2.2.) and primers listed in Table 
2.4. The forward and reverse primers were designed with adaptamers containing SpeI and XhoI 
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restriction sites respectively. These restriction sites were used to clone the genes into their 
designated expression cassettes.  
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Table 2.4: ORFs and primers. 
ORF 
name 
Forward
1
 primer (5’ - 3’) Reverse1 Primer (5’ - 3’) EcoCyc 
accession 
number 
Expression 
cassette 
dxs
2 
ATGTCATTTGATATTG
CCAAGTACCC 
 
CTATGCCAACCAAGCC
TTAATTTTC 
 
G6237 TEF1p/ADH1t 
dxr
2
 ATGAAACAATTAACG
ATTCTTGGCTCAAC 
 
TCAGGATGCTAACCTC
ATTACTTCTTT 
EG12715 PGK1p/ACT1t 
ispD
2
 ATGGCAACAACGCACT
TGGATG 
TTACGTGTTTTCTTGGT
GAATTGTTCTTG 
G7423 TEF1p/ADH1t 
ispE
2
 ATGAGAACTCAGTGGC
CTAGTC 
TTAAAGCATGGCTCTAT
GAAGTGGG 
EG11294 TDH3p/CYC1t 
ispF
2
 ATGAGAATTGGTCACG
GCTTCG 
CTATTTCGTTGCCTTGA
TCAACAAG 
EG11816 PGK1p/ACT1t 
ispG
2
 ATGCATAACCAAGCAC
CCATCC 
TCATTTTTCAACTTGCT
GTACATCTATCC 
EG10370 TEF1p/ADH1t 
ispH
2
 ATGCAAATATTGTTGG
CTAATCCCAG 
TCAGTCGACTTCTCTAA
TATCAACAC 
EG11081 TDH3p/CYC1t 
idi
2
 ATGCAAACTGAGCAC
GTAATTCTG 
CTACTTTAACTGGGTGA
ATGCAGAT 
G7508 TEF1p/ADH1t 
iscX GACTTAACTAGTATGG
GACTTAAGTGGACCGA
TAG 
TATGACCTCGAGTTATT
CGGCCTCGTCCAGCC 
EG12311 TEF2p/ENO2t 
iscR GACTTAACTAGTATGA
GACTGACATCTAAAGG
GCG 
TATGACCTCGAGTTATT
AAGCGCGTAACTTAAC
GTCGATC 
G7326 TEF1p/ADH1t 
iscS GACTTAACTAGTATGA
AATTACCGATTTATCT
CGACTACTC 
TATGACCTCGAGTTAAT
GATGAGCCCATTCGAT
GCTG 
G7325 PGK1p/ACT1t 
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iscA GACTTAACTAGTATGT
CGATTACACTGAGCGA
CAGT 
TATGACCTCGAGTCAA
ACGTGGAAGCTTTCGC
CG 
EG12132 PGK1p/ACT1t 
iscU GACTTAACTAGTATGG
CTTACAGCGAAAAAGT
TATCGAC 
TATGACCTCGAGTTATT
TTGCTTCACGTTTGCTT
TTATAGTCC 
G7324 PGK1p/ACT1t 
HscA GACTTAACTAGTATGG
CCTTATTACAAATTAG
TGAACCTG 
TATGACCTCGAGTTAA
ACCTCGTCCACGGAAT
GGC 
EG12130 TEF1p/ADH1t 
HscB GACTTAACTAGTATGG
ATTACTTCACCCTCTTT
GGC 
TATGACCTCGAGTTAA
AAATCGAGCAGTTTTTC
TTCGAGTTG 
EG12131 TEF1p/ADH1t 
CyaY GACTTAACTAGTATGA
ACGACAGTGAATTTCA
TCGCC 
TATGACCTCGAGTTAG
CGGAAACTGACTGTTT
CACC 
EG11653 TEF2p/ENO2t 
ErpA GACTTAACTAGTATGA
GTGATGACGTAGCACT
GC 
TATGACCTCGAGTTAG
ATACTAAAGGAAGAAC
CGCAAC 
EG12332 TEF2p/ENO2t 
bfr GACTTAACTAGTATGA
AAGGTGATACTAAAGT
TATAAATTATCTCAAC 
TATGACCTCGAGTCAA
CCTTCTTCGCGGATCTG
TG 
EG10113 TEF1p/ADH1t 
FtnA GACTTAACTAGTATGC
TGAAACCAGAAATGA
TTGAAAAACTTAAT 
TATGACCTCGAGTTAGT
TTTGTGTGTCGAGGGTA
GAG 
EG10921 TDH3p/CYC1t 
bfd GACTTAACTAGTATGT
ACGTTTGTCTTTGTAA
TGGTATCAG 
TATGACCTCGAGTTATG
CGGACTCCTTAAACTCC
G 
EG11181 PGK1p/ACT1t 
fdx GACTTAACTAGTATGC
CAAAGATTGTTATTTT
GCCTCATC 
TATGACCTCGAGTTAAT
GCTCACGCGCATGGTT
GAT 
EG11328 TDH3p/CYC1t 
fpr GACTTAACTAGTATGG
CTGATTGGGTAACAGG
TATGACCTCGAGTTACC
AGTAATGCTCCGCTGTC
EG10628 TDH3p/CYC1t 
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CAAA ATA 
FldA GACTTAACTAGTATGG
CTATCACTGGCATCTT
TTTCG 
TATGACCTCGAGTCAG
GCATTGAGAATTTCGTC
GAGA 
EG10318 TDH3p/CYC1t 
YtfE GACTTAACTAGTATGG
CTTATCGCGACCAACC
TTTA 
TATGACCTCGAGTCACT
CACCCGCCAGCGCGC 
G7866 TDH3p/CYC1t 
1
 Primer direction defined according to the direction of translation of the ORF. 
2
 These genes were purchased codon optimized with flanking restriction sites and sub-cloned so no 
primers were required to clone these genes into their individual expression cassettes. The primers 
listed here are therefore the primers used for verification of genomic inserts and RT-PCR. 
 
2.3.4 Construction of plasmids for integration of multiple expression cassettes 
To integrate the 8 MEP-pathway genes in the genome of S. cerevisiae, two plasmids with 4 
expression cassettes each were constructed based on the pUC19 plasmid. A 1750 bp fragment 
containing the HIS2 ORF with 352 bp upstream of the start codon and 390 bp downstream of the 
stop codon, and a 1427 bp fragment containing the ADE1 ORF with 332 bp upstream of the start 
codon and 274 bp downstream of the stop codon, were amplified from CEN.PK113-7D derived 
gDNA by PCR with primers containing HindIII adaptamers (see Table 2.3) and separately 
cloned into pUC19 digested with HindIII. The direction of the insert was determined by 
sequencing. The AatII sites in the backbone of the constructed vectors and in the HIS2 ORF were 
removed by introducing silent point mutations, using the QuikChange® Multi Site-Directed 
Mutagenesis Kit, Stratagene, La Jolla, CA. A new multiple cloning site (MCS) comprised of two 
complementary primers (5’-
GCGCGAGCTCCTCGAGGGGCCCAAGCTTGACGTCGTCGACCCTAGGCTGCAGCTTA
AGTCTAGAGGTACCGCGC-3’, which were annealed and subsequently digested with SacI and 
KpnI, were inserted in the plasmids treated with SacI and KpnI to create pSC600 (with the HIS2 
marker) and pSC700 (with the ADE1 marker). 
dxs, ispF, ispE, and ispD were treated with SpeI and XhoI restriction endonucleases and inserted 
in the pSCX001, pSCX003, pSCX002 and pRS414TEF, respectively, hereby creating the 
following expression cassettes: TEF1p-dxs-ADH1t, PGK1p-ispF-ACT1t, TDH3p-ispE-CYC1t, 
and TEF1p-ispD-CYC1t. ispG, ispH, ispC, and idi were treated with SpeI and XhoI restriction 
endonucleases and inserted in the pRS414TEF, pSCX002, pSCX003, and pSCX001 respectively, 
hereby creating the following expression cassettes: TEF1p-ispG-CYC1t, TDH3p-ispH-CYC1t, 
PGK1p-ispC-ACT1t, and TEF1p-idi-ADH1t. The cassettes were amplified by PCR with the 
primers listed in Table 2.3, purified, and digested with the sets of restriction endonucleases also 
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stated in Table 2.3. The dxs, ispF, ispE, and ispD expression cassettes were in the order listed 
here sequentially inserted in pSC600 to create pSC604. The ispG, ispH, ispC, and idi expression 
cassettes were in the order listed here sequentially inserted in pSC700 to create pSC704. 
For chromosomal integration of the expression cassettes containing the bfr, FtnA, bfd and YftE 
genes, a plasmid based on the pUC19 derived pSC700 plasmid was applied. The genes were 
amplified from E. coli K-12, MG1655 gDNA by PCR with primers listed in Table 2.4, digested 
with SpeI and XhoI and purified. YtfE and FtnA were inserted into the pSCX002 plasmid treated 
with SpeI and XhoI by ligation; and bfr and bfd in the same way into pSCX001 and pSCX002, 
respectively. The following expression cassettes were hereby constructed: TDH3p-YtfE-CYC1t, 
TEF1p-bfr-ADH1t, PGK1p-bfd-ACT1, and TDH3p-FtnA-CYC1t. The expression cassettes were 
amplified by PCR using the primers listed in Table 2.3, and digested with the sets of restriction 
endonucleases specified in Table 2.3. The YtfE, bfr, bfd, and FtnA expression cassettes were in 
the order listed here sequentially inserted into pSC600, whereafter the ARG4 marker was inserted 
between the HindIII and BamHI sites to construct pSC804. The ARG4 marker was prior to the 
insertion amplified from CEN.PK113-7D derived gDNA with primers designed to amplify a 
DNA sequence from 546 bp upstream of the start codon to 364 bp downstream of the stop codon 
(primers listed in Table 2.3), digested with HindIII and BamHI, and purified. 
To ensure high expression of the 12 remaining ISC-assembly machinery genes, we created two 
plasmids with 6 of the expression cassettes each targeting them into the YPRCδ15 and YPRCτ3 
loci respectively, since integration of two different lacZ expression cassettes into these Ty 
remnants has given high expression [Flagfeldt et al., 2009]. We first separately introduced DNA 
sequences homologous to the upstream parts of the YPRCδ15 and YPRCτ3 loci into pUC19. The 
DNA was amplified from F1702 derived gDNA using reverse primers containing adaptamers 
which introduced the AvrII and NotI restriction sites. These two sites were used to digest the two 
plasmids, and the two first expression cassettes were amplified with primers introducing a NheI 
restriction site in front of the promoter and an AvrII and a NotI restriction site following the 
terminator; since AvrII and NheI are compatible, this allowed the insert treated with NheI and 
NotI to be inserted into the two plasmids, leaving behind a new set of AvrII and NotI restriction 
sites. This approach was iteratively used (see Supplementary Figure 2.1) to insert the expression 
cassettes into the two plasmids, finally creating the plasmid pSCFeS107TRP, containing the 
iscX, iscR, iscS, fdx, TRP1, cyaY, and iscU expression cassettes; and pSCFeS207LEU, containing 
the hscB, fpr, iscA, erpA, LEU2, hscA and fldA. The last insert in each of the two plasmids was 
the DNA sequences homologous to the downstream of the YPRCδ15 and YPRCτ3 loci 
respectively. All primers used for the construction of pSCFeS107TRP and pSCFeS207LEU are 
listed in Table 2.3. 
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2.3.5 Construction of other plasmids 
ERG13 was deleted by a cassette constructed by introducing a 213 bp sequence identical to the 
gDNA sequence upstream of the ERG13 start codon in the HindIII and PstI restriction sites and a 
272 bp sequence identical to the gDNA sequence downstream of the ERG13 stop codon in the 
SpeI and SacI restriction sites of pUG72, hereby creating plasmid pSCΔ001. The sequences were 
amplified from F1702 derived gDNA using the primers listed in Table 2.3. 
To test whether leuC and leuD can complement the leu1 auxotrophy, three plasmids were 
constructed, namely pESC-leuC, pESC-leuC/D and pESC-LEU1. pESC-leuC was constructed 
from pESC-URA by inserting leuC between the BamHI and HindIII restriction sites. pESC-
leuC-D was constructed by inserting leuD between the EcoRI and SacI of pESC-leuC. The 
pESC-LEU1 plasmid was constructed by inserting LEU1 between the BamHI and XhoI 
restriction sites of pESC-URA. LeuC and leuD were amplified from E. coli gDNA and LEU1 
from F1702 gDNA using the primers listed in Table 2.3. 
All final plasmids constructed in this study are listed in Table 2.5, and their maps can be seen 
from Figure 2.2 in the Supplementary material. 
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Table 2.5: Plasmids constructed in this study. 
Plasmid name Origin Auxotrophic 
marker 
Description 
pSCX001 pRS414TEF TRP1 Plasmid for test of expression cassette 
with GFP 
pSCX002 pRS414TEF TRP1 Plasmid for test of expression cassette 
with GFP 
pSCX003 pRS415GPD LEU2 Plasmid for test of expression cassette 
with GFP 
pSCX004 pRS414TEF TRP1 Plasmid for test of expression cassette 
with GFP 
pSC604 pUC19 HIS2 Plasmid for genomic integration of dxs, 
ispD, ispE and ispF expression cassettes 
pSC704 pUC19 ADE1 Plasmid for genomic integration of dxr, 
ispG, ispH and idi expression cassettes 
pSC804 pUCAR1 ARG4 Plasmid for genomic integration of bfr, 
FtnA, bfd and YtfE expression cassettes 
pSCFeS107TRP pUC19 TRP1 Plasmid for genomic integration of iscX, 
iscR, iscS, fdx, CyaY and iscU expression 
cassettes 
pSCFeS207LEU pUC19 LEU2 Plasmid for genomic integration of HscB, 
fpr, iscA, ErpA, HscA and FldA 
expression cassettes 
pSCΔ001 pUG72 URA3 Plasmid for deletion of ERG13 
pESC-leuC pESC-URA URA3 2μ plasmid for expression of leuC 
pESC-leuC-D pESC-leuC URA3 2μ plasmid for expression of leuC and 
leuD 
pESC-LEU1 pESC-LEU1 URA3 2μ plasmid for expression of leu1 
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2.3.6 Construction of yeast strains 
All transformations of S. cerevisiae were carried out using the lithium acetate/polyethylene 
glycol method according to Gietz and Woods [2002]. Transformants were selected on SC with 
the appropriate nutrient(s) omitted. The constructed strains were verified by extraction of gDNA 
using the Wizard® Genomic DNA Purification Kit, Promega, Madison, WI, followed by PCR 
amplification of all the integrated ORFs. Self-replicating plasmids were used directly to 
transform S. cerevisiae, whereas the plasmid destined for genomic integration was linearized. 
Prior to the transformation of S. cerevisiae the plasmids pSC604, pSC704 and pSC804 were 
linearized by digestion with MscI, HpaI and AgeI endonucleases respectively to facilitate their 
integration into the non-functional markers present in the yeast genome. The pSCFeS107TRP 
and pSCFeS207LEU integration cassettes were removed from their respective plasmids by 
digestion with PacI and NotI endonucleases, and the ERG13 deletion cassette was removed from 
the pSCΔ001 plasmid by NotI and SacII digestion. The order in which the strains were 
constructed by transformation with the individual plasmids or cassettes can be seen from Table 
2.6. 
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Table 2.6: S. cerevisiae strains constructed in this study 
Strain Parental 
strain 
Auxotrophic 
markers 
Integrated plasmid or 
cassette 
Integration locus or S. 
cerevisiae origin of 
replication 
SCX001 F1702 ade1, arg4 his2 
leu2 ura3 
pSCX001 CEN6-ARSH4 
SCX002 F1702 ade1 arg4 his2 
leu2 ura3 
pSCX002 CEN6-ARSH4 
SCX003 F1702 ade1 arg4 his2 
trp1 ura3 
pSCX003 CEN6-ARSH4 
SCX004 F1702 ade1 arg4 his2 
leu2 ura3 
pSCX004 CEN6-ARSH4 
SC704 F1702 arg4 his2 leu2 
trp1 ura3 
pSC704 YAR015W 
SCMEP SC704 arg4 leu2 trp1 
ura3 
pSC604 YFR025C 
SCMEP-
FeS1 
SCMEP arg4 trp1 ura3 pSCFeS207LEU YPRCτ3 
SCMEP-
FeS2 
SCMEP-
FeS1 
arg4 ura3 pSCFeS107TRP YPRCδ15 
SCMEP-
FeS2-IS 
SCMEP-
FeS2 
ura3 pSC804 YHR018C 
SCMEP-
FeS2-IS-
ΔERG13 
SCMEP-
FeS2-IS 
Prototrophic pSCΔ001 YML126C 
SC-pESC JAY20 leu1 pESC-URA 2μ 
SC-leuC JAY20 leu1 pESC-leuC 2μ 
SC-leuC-D JAY20 Prototrophic pESC-leuC-D 2μ 
SC-LEU1 JAY20 Prototrophic pESC-LEU1 2μ 
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2.3.7 Test of expression cassette functionality using yeGFP 
The SCX001, SCX002 and SCX004 were grown on SC-TRP and SCX003 on SC-LEU plates at 
30 °C until colonies had formed. To test the expression of yeGFP the colonies were visually 
inspected using the Safe Imager™ 2.0 Blue-Light Transilluminator, Life Technologies, Grand 
Island, NY, with corresponding filter. 
 
2.3.8 Liquid chromatography – Mass spectrometry analysis of MEP-pathway metabolites 
SCMEP and SCMEP-FeS2-IS were grown in 5 ml SC-ADE-HIS and SC-ADE-ARG-HIS-LEU-
TRP respectively at 30 °C at 250 rpm orbital shaking until the OD600 reached 1. Two ml of each 
culture were harvested by centrifugation followed by extraction and analysis according to [Zhou 
et al., in press]. 
 
2.3.9 Verification of pathway functionality using U-13C6 glucose 
Strain SCMEP-FeS2-IS-ΔERG13 was inoculated at OD600 = 0.05 in 5 ml SD medium made with 
U-13C6 glucose, Cambridge Isotope Laboratories, Andover, MA and grown aerobically for 2 
days at 30 °C with 250 rpm orbital shaking. The cells were spun down at 3,000 rpm for 10 min, 
re-suspended in 2 ml 20% w/v sodium hydroxide in 50% ethanol, transferred to an 8 ml glass 
tube, and extracted according to Madsen et al. [2011]. The extract was dried, re-dissolved in 50 
μl pyridine, derivatized by addition of 50 μl N,O-bis(trimethylsilyl) trifluoroacetamide (BSTFA) 
+ 1 % trimethylchlorosilane (TMCS) according to Nielsen and Madsen [2000], and analyzed 
using GC-MS. A 1-μl sample was analyzed using splitless injection on a DB-35ms, 30 m, 0.25 
mm, 0.25 µm column, Agilent Technologies, Santa Clara, CA, with helium as carrier gas. The 
temperature of the oven was initially held a 160 °C for 30 sec, then increased to 320 °C at 10 
°C/min, and finally held at 320 °C for 3 min. Ergosterol and squalene standards were subjected 
to the same procedure for authentication. 
 
2.3.10 Verification of gene expression by reverse transcriptase polymerase chain reaction 
(RT-PCR) 
Five ml. S. cerevisiae cultures were grown at 30 °C until OD600 = 1, where after the cells were 
harvested by centrifugation at 3000 g for 10 min and washed with TE-buffer. They were 
transferred to a 2-ml FastPrep® tube, MP Biomedicals LLC, Solon, OH, and re-suspended in 
500 μl TE-buffer. Two hundred μl acid washed glass beads (425-600 μm), Sigma-Aldrich® and 
500 μl acidic phenol-chloroform-isoamyl alcohol (125:24:1), pH 4.5, Life Technologies, Grand 
Island, NY, were added. The cells were disrupted using a Savant FastPrep® FP120 Cell 
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Disrupter, MP Biomedicals LLC. The phases were separated by centrifugation at 18,000 g for 10 
min, and 450 ml of the aqueous phase were transferred to a micro-centrifuge tube. Total RNA 
was precipitated by addition of 45 μl 3 M sodium acetate, pH 5.2 and 450 μl isopropanol, rinsed 
twice with 500 μl 80 % ethanol and re-dissolved in 90 μl nuclease-free water, Qiagen, Valencia, 
CA. The RNA was treated with DNase I, extracted with 400 μl acidic phenol-chloroform-
isoamyl alcohol (125:24:1), pH 4.5 and 400 μl TE-buffer pH 8.0, then precipitated by sodium 
acetate and isopropanol and finally re-dissolved in 100 μl nuclease free water. This RNA served 
as template for RT-PCR using the Illustra
TM
, Ready-To-Go
TM
, RT-PCR Beads from GE 
Healthcare Biosciences, Pittsburgh, PA. The RNA solution was checked for DNA contamination 
by PCR using the Taq DNA polymerase. The PCR products were visualized by gel 
electrophoresis (0.75 % agarose in TAE) and staining by Sybr® Safe, Life Technologies, Grand 
Island, NY. 
 
2.3.11 Evolution of S. cerevisiae by serial sub-culturing 
Strain SCMEP-FeS2-IS-ΔERG13 was inoculated from glycerol stock in 5 ml SC-ADE-ARG-
HIS-LEU-TRP-URA supplemented with 10 g/l mevalonolactone. The strain was incubated at 30 
°C for 5 days with 250 rpm orbital shaking. Hereafter the OD600 was measured, and 5 ml SC-
ADE-ARG-HIS-LEU-TRP-URA with 5 g/l mevalonolactone was inoculated at OD600 = 0.1. This 
periodical re-inoculation was continued, reducing the mevalonolactone concentration with every 
re-inoculation. The mevalonolactone was prepared as a 500 g/l stock-solution according to 
Dimster-Denk et al. [1994] by dissolving it in dH2O at 65 °C for 1 h followed by filter 
sterilization. 
 
2.3.12 Microscopy 
The morphology of cells from the serial sub-culturing was investigated using a Nikon Eclipse 
TE200-S microscope, Nikon Instruments Inc. Melville, NY. The bright field images were 
obtained at 1000x magnification. 
 
2.3.13 Functional complementation of leu1 auxotrophy 
Strains SC-pESC, SC-leuC, SC-leuC-D and SC-LEU1 were streaked out on SC (galactose)-
LEU-URA plates from glycerol stock and incubated at 30 °C for 4 days, and the growth was 
assessed and documented by photography of the plates.   
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2.4 Results and discussion 
Based on the pRS-series of S. cerevisiae/E. coli shuttle plasmids constructed by Mumberg et al. 
[1995], we constructed 4 plasmids, each containing an expression cassette harboring the gene 
encoding yeGFP. S. cerevisiae F1702 was transformed with these plasmids, and their ability to 
mediate expression was verified by visual inspection of the resulting colonies, result not shown. 
The 4 expression cassettes then served as starting point for creating 24 individual expression 
cassettes harboring the genes listed in Table 2.4. After systematic assembly of the 24 expression 
cassettes into 5 plasmids designed for chromosomal integration, the plasmids were one by one 
integrated in the genome of F1702. The first two plasmids to be integrated were pSC604 and 
pSC704, harboring the codon optimized genes encoding the MEP-pathway enzymes to construct 
the strain designated SCMEP. gDNA from SCMEP was isolated and used as template for PCR 
reactions confirming that all the genes were indeed integrated, result not shown. To test whether 
the heterologous MEP-pathway could supply the IPP required to sustain growth, we tried to 
delete the ERG13 gene using a deletion cassette. We were unable to obtain viable colonies from 
which the ERG13 gene had been knocked out. Several false positive colonies were obtained, 
probably due to integration of the deletion cassette at a non-specific locus. The SCMEP strain 
was then subjected to analysis using LC-MS, by which we detected 3.2 ± 0.5 mg DXP per g dry 
cell weight (DCW) and 5.0 ± 3.1 mg MEC per g DCW (the number following the ± is the 
standard deviation based on biological triplicates). These results prove that the MEP-pathway is 
active until MEC, but whether the last two steps are active is impossible to determine based on 
these results since no HMBPP (detection limit = 0.2 mg/l) could be detected and it is impossible 
to discriminate between the IPP originating from the MVA-pathway and the MEP-pathway. 
What can be concluded is that the MEP-pathway is insufficient at supplying precursors in 
quantities that can support growth. However, this is the first time that DXP and MEC have been 
produced and detected in a S. cerevisiae strain. 
The last two steps of the MEP-pathway are catalyzed by ISC-proteins, which require an 
elaborate support machinery to load the apo-proteins with ISC and couple these to NAD(P)H 
cofactor metabolism for supplying reducing equivalents. To remedy this potential problem we 
delineated the proteins that we, based on the literature, hypothesized could be sufficient to 
decouple the ISC assembly system from E. coli and graft it into the cytosol of S. cerevisiae. The 
16 genes encoding these proteins were by the plasmids pSCFeS107TRP, pSCFeS207LEU and 
pSC804 integrated in the genome of SCMEP to construct SCMEP-FeS2-IS. gDNA was isolated 
from SCMEP-FeS2-IS, and all 24 genes were verified by PCR to be inserted within its genome. 
The results of the PCR can be seen from Figure 2.2. 
Expression of chromosomally integrated genes for the bacterial 2-C-methyl-D-erythritol 4-phosphate 
pathway in Saccharomyces cerevisiae: challenges of heterologous expression of bacterial iron-sulfur cluster 
genes in yeast 
 
 
68 
 
 
Figure 2.2: Verification of genomic integrated genes by PCR with SCMEP-FeS2-IS gDNA as 
template. To verify that all the genes had been inserted into the genome of SCMEP-FeS2-IS, gDNA 
was purified and used as template for amplification of the individual ORFs using primer pairs 
listed in Table 2.4. The amplification product was visualized by gel-electrophoresis on 0.75% 
agarose gel in TAE–buffer. Numbering of lanes corresponds to the following ORFs: 1: iscX (0.20 
kb), 2: iscR (0.49 kb), 3: iscS (1.22 kb), 4: fdx (0.34 kb), 5: CyaY (0.32 kb), 6: iscU (0.39 kb), 7: hscB 
(0.52 kb), 8: fpr (0.75 kb), 9: iscA (0.32 kb), 10: erpA (0.35 kb), 11: hscA (1.85 kb), 12: fldA (0.53 kb), 
13: bfr (0.48 kb), 14: FtnA (0.50 kb), 15: bfd (0.20 kb), 16: YtfE (0.66 kb), 17: dxs (1.86 kb), 18: ispE 
(0.85 kb), 19: ispF (0.48 kb), 20: ispD (0.71 kb), 21: idi (0.55 kb), 22: ispH (0.95 kb), 23: dxr (1.19 
kb), 24: ispG (1.12 kb). 
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After verifying that all the genes had been inserted into the chromosome, we once more tried to 
delete the ERG13 gene, but no viable colonies were obtained. This result does as aforementioned 
not prove that the MEP-pathway is inactive but only that the activity is too low to support 
growth, so we once again tested the strain using LC-MS, but we saw no significant change in 
MEC compared to the SCMEP strain. However the DXP concentration had increased to 7.9 ± 2.5 
mg/gDCW; we do not know the reason for this increase. To be able to delete ERG13 we had to 
supplement the medium with 10 g/L mevalonolactone, which serves as a source for mevalonate. 
Thirty colonies were screened by extraction of gDNA followed by PCR. Three colonies (colony 
13, 25 and 29) were identified by PCR to have the deletion cassette integrated in the correct 
locus and no duplication of ERG13 prior to the deletion, see Figure 2.3. These strains were 
named SCMEP-FeS-IS-ΔERG13-strain13, SCMEP-FeS-IS-ΔERG13-strain25 and SCMEP-FeS-
IS-ΔERG13-strain29. 
 
Figure 2.3: Verification of deletion of ERG13. gDNA purified from the following strains; 1: 
SCMEP-FeS2-IS-ΔERG13-colony13, 2: SCMEP-FeS2-IS-ΔERG13-colony25, 3: SCMEP-FeS2-IS-
ΔERG13-colony29 and 4: F1702 was used as templates for PCR reactions using the primers shown 
in Table 2.3. The PCR reactions of the ERG13UP (1.00 kb) and ERG13DOWN (0.90 kb) fragments 
verify that the deletion cassette has been inserted in the correct locus, and the inability to amplify 
the ERG13ORF (1.47 kb) from templates 1, 2 and 3 verifies that ERG13 has not been duplicated 
prior to the knockout. 
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In order to find out if the MEP-pathway is active in the SCMEP-FeS2-IS-ΔERG13 strains 
isolated, they were grown on SD-medium made with uniformly C
13
-labelled glucose and 
unlabeled mevalonolactone as carbon sources. Since ERG13 was deleted, the only way labeled 
carbon can end up in IPP is if the MEP-pathway is active. IPP is the first isoprenoid precursor of 
ergosterol, which is made from 2 FPP units (equivalent to 6 IPP units) forming squalene, which 
then undergoes several modifications to form ergosterol. During these modifications, 3 carbon 
atoms are lost due to the C14-demethylase and C4-decarboxylase activities encoded by ERG11 
and ERG26, respectively. Furthermore, a carbon is gained through the activity of the C24-methyl 
transferase, encoded by ERG6 [Veen and Lang, 2004]. This means that if the MEP-pathway is 
active one would expect to see a shift in the molecular weight of ergosterol of 3 Daltons or 
higher, whereas a shift of 1 Dalton just indicates the labeled carbon gained from the C-24 methyl 
transferase. The ergosterol extracts from the 3 strains grown on medium with either uniformly 
C
13
-labelled glucose or regular glucose were analyzed on GC-MS and the peaks corresponding to 
squalene and ergosterol identified by comparisons of squalene and ergosterol standards. An 
example of the results obtained from this analysis can be seen from Supplementary Figure 2.3. 
The peak for the molecular weight of un-fragmented ergosterol derivatized with BSTFA is 
located at approximately 468 Daltons (corresponding to the M0 peak), and its eight mass-
isotopomers peaks M1, M2, M3, M4, M5, M6, M7 and M8 (corresponding to M0 + increments 
of 1 Dalton respectively) were integrated for ergosterol isolated from the SCMEP-FeS2-IS-
ΔERG13 strain grown on either uniformly C13-labelled glucose or regular glucose in triplicate. 
The results from all the strains were almost identical. The result from SCMEP-FeS-IS-ΔERG13-
strain13 can be seen from Figure 2.4. The species that are heavier than M0 and M1 for the 
unlabeled and labeled, respectively, are due to natural occurrence of C
13
.These results show a 
shift of 1 Dalton from the unlabeled to the labeled, which indicates that the MEP-pathway has a 
very limited flux if any at all. 
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Figure 2.4: Ergosterol Mass isotopomer distribution. Integration of the peak areas of the ergosterol 
468 Dalton (corresponding to M0) and 27 of its mass isotopomers (only the first 8 are shown since 
the area of every mass isotopomer peak above 5 is close to 0) at increments of 1 Dalton normalized 
to the total abundance. The labeled results are from ergosterol extracted from SCMEP-FeS-IS-
ΔERG13 grown on U-13C6 glucose whereas the unlabeled results are from SCMEP-FeS-IS-
ΔERG13 grown on regular glucose. The experiment was done in biological triplicates. 
To test if all 24 genes were expressed, total RNA was isolated from SCMEP-FeS2-IS and tested 
for residual DNA by PCR. No DNA was found (results not shown). The RNA was used as 
template in RT-PCR reactions with primers pairs (Table 2.4) designed to amplify the entire ORF 
of the individual genes. The result of the RT-PCR reactions (Figure 2.5) showed that, except for 
bfd, fldA and hscA, all the genes are expressed. The experiment was therefore repeated, and bfd 
and fldA was also shown to be expressed (data not shown). However, it was not possible to 
detect any band for hscA. Since the same 4 promoters were used to express the genes, and as all 
other genes expressed by the same promoter as hscA, were expressed, the failure to detect 
transcription could be due to low mRNA stability, either in vivo or post cell breakage. However, 
lack of hscA expression is presumably not detrimental for functionality of the ISC-assembly 
machinery, since it has been found in vitro to be stimulatory rather than absolutely required for 
the transfer of ISC from the assembly machinery to the apo-proteins [Mansy et al., 2002]. 
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Figure 2.5: Verification of gene expression by Reverse Transcription PCR. To find out if the genes 
inserted in the genome of SCMEP-FeS2-IS are transcribed, total RNA was purified and used as 
template for amplification of the individual ORFs by RT-PCR using the primer pairs listed in 
Table 2.4. The amplification product was visualized by gel electrophoresis on 0.75% agarose gel in 
TAE–buffer. Numbering of lanes corresponds to the following ORFs: 1: iscX (0.20 kb), 2: iscR (0.49 
kb), 3: iscS (1.22 kb), 4: fdx (0.34 kb), 5: CyaY (0.32 kb), 6: iscU (0.39 kb), 7: hscB (0.52 kb), 8: fpr 
(0.75 kb), 9: iscA (0.32 kb), 10: erpA (0.35 kb), 11: hscA (1.85 kb), 12: fldA (0.53 kb), 13: bfr (0.48 
kb), 14: FtnA (0.50 kb), 15: bfd (0.20 kb), 16: YtfE (0.66 kb), 17: dxs (1.86 kb), 18: ispE (0.85 kb), 19: 
ispF (0.48 kb), 20: ispD (0.71 kb), 21: idi (0.55 kb), 22: ispH (0.95 kb), 23: dxr (1.19 kb), 24: ispG 
(1.12 kb).  
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To investigate the possibility that the SCMEP-FeS2-IS-ΔERG13 strains have a finite, albeit low, 
flux through the MEP-pathway that could be increased, we set out to adapt the cultures to grow 
with IPP being solely supplied by the MEP-pathway by serial sub-culturing with decreasing 
amounts of mevalonolactone. Adaptive evolution has previously been found efficient for growth 
of engineered S. cerevisiae strains on xylose [Zhou et al., 2012]. The result of the evolution can 
be seen from Figure 2.6. 
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Figure 2.6: OD600 measured during serial sub-culturing. Three strains of SCMEP-FeS-IS-ΔERG13 were grown on SC-ADE-ARG-HIS-
LEU-TRP-URA supplemented with mevalonolactone. The cultures were inoculated at OD600 = 0.1 at each sub-culturing and the 
mevalonolactone concentration gradually reduced. The OD600 was measured after each sub-culturing which lasted for 5 days. 
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The newly created SCMEP-FeS2-IS-ΔERG13 strains needed 5 g/l mevalonolactone to grow 
(results not shown), which corresponds with the value reported by [Umebayashi and Nakano, 
2003]. However, serial sub-culturing for more than a half year resulted in two of the strains being 
able to grow to a similar OD600 in medium with 5 mg/L mevalonolactone, i.e. 1000-fold less. 
Despite this strong adaptation no mevalonate independent cells could be isolated. In other words, 
the heterologous MEP-pathway was still unable to support growth. [Zhou et al., 2012] strain 
grew on xylose albeit slowly whereas the SCMEP-FeS2-IS-ΔERG13 strains did not grow at all 
without mevalonolactone. This indicates that the MEP-pathway is probably inactive since it 
should be possible to evolve a pathway directly linked to growth with low activity to higher 
activity, whereas evolving a pathway with no activity to become active is less likely. During the 
directed evolution the morphology of the cells was observed using light microscopy. Figure 2.7 
shows the morphology of the three SCMEP-FeS2-IS-ΔERG13 strains grown in SC-ADE-ARG-
HIS-LEU-TRP-URA + 0.25 g/l mevalonolactone. It can be seen that strain 25 and 29 exhibit 
abnormal morphology, probably due to the stress of low mevalonate availability. 
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Figure 2.7: Microscope pictures of evolved SCMEP-FeS-IS-ΔERG13 strains. The strains were 
grown in SC-ADE-ARG-HIS-LEU-TRP-URA + 0.25 g/l mevalonolactone for 5 days before the 
morphology was assessed by light-microscopy. A: SCMEP-FeS-IS-ΔERG13-strain13, B: SCMEP-
FeS-IS-ΔERG13-strain25, and C: SCMEP-FeS-IS-ΔERG13-strain29. 
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In order to test whether S. cerevisiae can functionally express other heterologous ISC-proteins 
from E. coli within its cytosol we decided to test if the S. cerevisiae strain JAY20 auxotrophic 
for leucine due to a deletion of the LEU1 gene, encoding the second step in the biosynthesis of 
leucine, catalyzed by the isopropylmalate isomerase, could be complemented by the E. coli 
heterodimeric isopropylmalate isomerase, encoded by leuC and leuD [Skala et al., 1991 and 
Jardine et al., 2002]. The leuC gene was inserted in the pESC-URA plasmid followed by leuD, 
hereby constructing plasmids pESC-leuC and pESC-leuC-D, respectively. As a positive control, 
LEU1 from F1702 was inserted in pESC-URA as well. These 3 plasmids together with the 
pESC-URA plasmid, which served as negative control, were used to transform JAY20. 
Expression of the genes integrated in pESC-URA was under control of the GAL1/GAL10 
inducible promoter system. The four strains were plated on SC-LEU-URA with galactose as 
carbon source. The result can be seen from Figure 2.8 and shows that pESC-leuC-D can 
complement the LEU1 auxotrophy. This is to our knowledge the first example of a bacterial ISC-
protein being functionally expressed in the cytosol of S. cerevisiae. leuC and leuD do however 
have a high degree of homology with LEU1, which could explain why they can be loaded with 
ISC. The mechanism of targeting apo-ISC-proteins to be loaded with ISC and hereby converted 
to their active holo-form has not yet been elucidated, but this result demonstrates that bacterial 
ISC-proteins heterologously expressed in S. cerevisiae can be converted to their functional holo-
form. 
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Figure 2.8: Complementation of the leu1 auxotrophy in the JAY20 S. cerevisiae strain. JAY20 
transformed with pESC-URA, pESC-leuC-D, pESC-LEU1 and pESC-leuC was plated on SC-LEU-
URA and incubated at 30 °C for 3 days. 
The fact that S. cerevisiae is capable of loading cytosolic heterodimeric isopropylmalate 
isomerase encoded by leuC and leuD with ISCs does not imply that all bacterial ISC-proteins 
heterologously expressed within yeast cytosol can be loaded with ISCs.  
ispG and ispH are not the only two ISC-proteins among the proteins required for MEP-
functionality. Ferredoxin is also an [2Fe-2S] ISC-protein [Ta and Vickery, 1992], which is 
involved in the transfer of electrons to ispG and ispH, as well as electron transfer to ISC-
biogenesis. To be functional, ferredoxin therefore needs to be loaded with an ISC, which have to 
originate from the yeast CIA-machinery, since it cannot originate from the heterologous ISC-
assembly machinery because no ISC can be generated through the heterologous expressed ISC-
assembly machinery before ferredoxin is converted to its active holo-form. With ferredoxin as a 
pivotal point for MEP-pathway functionality, emphasis on research to assess whether this protein 
can be converted to its holo-form is required. If ferredoxin is found only in its apo-form, research 
should focus on adapting it to be loaded with ISC via the CIA-machinery, since this will be key 
to functionally express the MEP-pathway in the cytosol of S. cerevisiae. 
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The requirements for an elaborate ISC-assembly machinery for ispG and ispH function, 
combined with the finding that MEC can be detected in cell extract, suggest that the MEP-
pathway is only active until MEC. This is further supported by the lack of labeled carbon ending 
up in ergosterol through the MEP pathway, as well as the mevalonolactone requirement of the 
erg13Δ strains. This view contradicts the view expressed by Maury et al. [2008], who used 
lovastatin in an attempt to find out if the MEP-pathway was active. However, the growth in the 
presence of lovastatin could have been caused by other circumstances, e.g., a mutation 
conferring resistance towards the drug. To circumvent the use of lovastatin, Maury et al. [2008] 
furthermore suggested deleting a gene encoding one of the early steps of the MVA-pathway such 
as ERG10, ERG13 or HMG1 and HMG2. We deleted ERG13 in strain SCMEP, which only 
expresses the MEP-pathway genes, as well as in the SCMEP-FeS2-IS, expressing the MEP-
pathway together with all the support genes hypothesized to be required. In neither case were we 
able to obtain transformants that had lost ERG13 and could grow without mevalonolactone 
supplementation. Furthermore Maury et al. (2008) did not express any additional genes for 
coupling the ispG and ispH to NAD(P)H such as ferredoxin, flavodoxin and ferredoxin 
(flavodoxin) oxidoreductase. S. cerevisiae natively possesses ferredoxin, but it is located within 
the mitochondria and found to be required for the assembly of ISC-proteins [Lange et al., 2000]. 
No evidence of ferredoxin present in the cytosol of S. cerevisiae has been reported, and it is 
therefore probably not available for ispG and ispH. This is an additional reason to doubt that the 
MEP-pathway was functional in the S. cerevisiae system presented by Maury et al. [2008]. 
S. cerevisiae have several advantageous characteristics making it an ideal host for microbial 
production of isoprenoids such as well-established large scale fermentation, enabling easy scale-
up, GRAS classification by the FDA, which eases the approval of novel products, 
compartmentalization for co-localization of enzymes, and strains pre-engineered to express 
cytochrome P450 which is important for the downstream decoration of the isoprenoid backbones 
have been demonstrated [Huang et al., 2008 and Truan et al., 1993]. The combination of S. 
cerevisiae with the stoichiometrical superior MEP-pathway holds great potential for bypassing 
native regulation, hereby constructing an excellent platform for isoprenoid production. Our 
results show that ISC-proteins can be expressed in the cytosol of yeast and that the MEP-
pathway is active until MEC, which is encouraging for the further quest for functionalizing the 
MEP-pathway in its entirety. Further research into the requirements for targeting heterologous 
ISC-apo-proteins to be converted to their holo-form through the CIA machinery could help 
functionalize the MEP-pathway, whereas the approach of expressing the heterologous ISC-
machinery in S. cerevisiae could not only help functionalize the MEP-pathway but also help us 
understand which parts of the E. coli ISC-machinery are essential and how this system should be 
delineated. Alone from E. coli, 100 ISC-proteins have been isolated [Fontecave, M. 2006], and 
being able to functionally express this group of ubiquitous proteins in S. cerevisiae encompasses 
great prospects for biosynthetic production of novel compounds, as well as obtaining a greater 
understanding of the complex processes involved in ISC-assembly. A S. cerevisiae strain pre-
engineered to express the machinery required for cytosolic expression of heterologous ISC-
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proteins would therefore be a great tool in many areas within biotechnological and 
pharmaceutical research. Our work has showed the initial steps towards obtaining such strains 
and highlighted the obstacles on the way towards reaching this goal. This will hopefully spark 
further interest within the area of heterologous expression of ISC-proteins.  
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2.7 Supplementary material 
2.7.1 Supplementary figure legends 
Supplementary Figure 2.1: Restriction endonucleases AvrII (A) and NheI (C) create compatible 
sticky ends, which upon ligation with each other cannot be redigested with either of the two 
enzymes. A cleavage site for restriction endonuclease NotI is indicated by B. DNA is amplified 
with primers containing the appropriate cleavage sites, treated with C and B, and ligated into a 
plasmid opened by A and B. This creates a plasmid with a new unique site A, maintaining site B 
and thus enabling insertion of another PCR product treated with C and B. This method can be 
iteratively used to assembly DNA as long as the restriction sites remain unique. 
Supplementary Figure 2.2: Maps of plasmids applied in this study. 
Supplementary Figure 2.3: GC-MS data. A: Total ion-count chromatogram of S. cerevisiae cell 
extract. B: MS-spectrum of ergosterol extracted from SCMEP-FeS-IS-ΔERG13 grown on 
unlabeled glucose. C: MS-spectrum of ergosterol extracted from SCMEP-FeS-IS-ΔERG13 
grown on U-13C6 glucose. 
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2.7.2 Supplementary figures 
Supplementary Figure 2.1 
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Supplementary Figure 2.2: Plasmid maps 
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Supplementary Figure 2.3: GC-MS data. 
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3.1 Abstract  
Heterologous production of isoprenoids in microbes through fermentation is a promising 
alternative to isolation of the isoprenoid molecules from their native hosts since their scarce 
availability therein makes their purification both laborious and costly. Microbes are not naturally 
optimized for production of isoprenoids and therefore have to be optimized to improve their 
isoprenoid production capabilities. Instead of having to separately engineer a production system 
for each individual isoprenoid it would be beneficial to establish a microorganism as an 
isoprenoid production platform producing high amounts of the universal isoprenoid precursor 
isopentenyl pyrophosphate (IPP). In such a microbial production platform one would simply 
have to insert the genes encoding the downstream pathway converting IPP to the isoprenoid of 
interest followed by minor adjustments to obtain an optimized production system. 
The methodology of metabolic engineering has been developed to enable the construction of 
microorganisms with desired phenotypes through direct genetic engineering. However, prior 
knowledge of the microbial system chosen for heterologous isoprenoid production is a 
prerequisite for the success of any direct metabolic engineering approaches. Saccharomyces 
cerevisiae holds great promise as a starting point for developing a microbial isoprenoid 
production platform due to all the available knowledge of its physiology, genetics and 
fermentation characteristics. Even though this great amount of knowledge is available for S. 
cerevisiae, very few genetic targets for increasing the flux towards IPP have been identified. To 
remedy this, we decided to employ inverse metabolic engineering in an effort to identify novel 
targets that could improve the isoprenoid precursor availability and thereby establish S. 
cerevisiae as a superior microbial isoprenoid production platform. 
In this study, we sought potential overexpression targets from S. cerevisiae itself and pursued 
these through creation of a constitutive overexpression gDNA library from CEN.PK113-9D 
gDNA based on the pRS415TDH3 plasmid. We were able to create a gDNA library where 1/10 
of the total library, when transformed into E. coli, resulted in 100,000 CFU of which 80% 
contained an insert. The library was screened for its ability to improve the heterologous 
production in S. cerevisiae of lycopene, an isoprenoid surrogate compound whose production 
correlates with increased flux through the isoprenoid biosynthetic pathway. As a red pigment 
lycopene allowed us to visually screen the library through the selection of colonies with 
increased red coloration. 200 colonies were picked for a second round of screening, and from 
these 200, 27 colonies were selected for testing in liquid culture. Plasmids from the 10 cultures 
producing the highest biomass yield of lycopene were isolated and transformed back into a clean 
background strain. Of the 10 plasmids only a single one could recover the lycopene production 
level found in the initial test, and when this plasmid was sequenced, it was found not to contain 
an open reading frame. The results highlight the feasibility of our approach but also that a greater 
number of colonies have to be analyzed in order to successfully identify plasmid-based lycopene 
overproducing mutants.  
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3.2 Introduction 
With more than 55,000 identified compounds, isoprenoids constitute the largest group of 
secondary metabolites to date. This ubiquitous group of compounds holds great potential for 
identification of novel bioactive molecules. Several isoprenoids such as paclitaxel and 
artemisinin have already been demonstrated to be applicable as anticancer and antimalarial 
drugs, respectively. An inherent problem in production of isoprenoids is the limited availability 
of the molecules within their natural organism of production, which renders their production 
costly and labor intensive [Ajikumar et al., 2008; Muntendam et al., 2009]. 
As an alternative to isolating isoprenoids from their natural sources, heterologous microbial 
production holds great potential. By applying direct metabolic engineering, the gene(s) involved 
in the biosynthesis of a given molecule can be transferred to a well-characterized microbial host. 
The advantages of a microbial host, compared to natural isoprenoid-producing plants or higher 
eukaryotes, include higher productivity due to rapid cell growth and independence of seasonal 
variations caused by environmental stimuli e.g. weather conditions and nutrient availability. 
Furthermore microorganisms can be grown on relative cheap substrates in large fermenters 
where rigid process control allows for product quality consistency [Chemler and Koffas, 2008; 
Lee et al., 2009]. The advantage of applying well characterized model organism such as 
Escherichia coli and S. cerevisiae over microbes naturally producing isoprenoids of interest is 
the ease of which the model organisms can be genetically engineered to further improve 
production and the well-established fermentation protocols allowing for easy scale up and 
production. 
S. cerevisiae has been applied in fermentative production for centuries, which has resulted in the 
vast accumulation of knowledge about its genetics, physiology, and genetic engineering. Its 
applicability is further supported by having a fully-sequenced genome and by the existence of 
molecular biology tools such as selectable markers, expression vectors, affinity tags and reporter 
genes. Most of this information is made readily accessible in databases such as Saccharomyces 
Genome Database (http://www.yeastgenome.org) and Comprehensive Yeast Genome Database 
(http://mips.gsf.de/genre/proj/yeast/) [Nevoigt, 2009]. Even though E. coli has only been applied 
in biotechnological production for a very short time relative to S. cerevisiae, the knowledge and 
tools available for this systems rivals that of S. cerevisiae. E. coli has a higher growth rate, which 
results in higher turnover rates, whereas S. cerevisiae has greater tolerance towards high sugar 
concentrations and low pH, minimizing the risk of contamination [Porro et al., 2011]. Of great 
importance for production of several isoprenoid molecules is the oxidative decoration catalyzed 
by cytochrome P450. For functional expression of cytochrome P450, it needs to be linked to a 
reductase, either transcriptionally or by co-localization. The disadvantage of transcriptional 
linking is that it has to be done individually in each case, whereas co-localization allows for a 
single reductase to link with multiple cytochrome P450s. In the latter case, a strain 
overexpressing a reductase targeted to a specific compartment in the cell, such as an organelle, 
Chapter 3 
 
 
101 
 
can be constructed thereby serving as a platform for heterologous cytochrome P450 expression. 
As a eukaryotic organism, S. cerevisiae possesses organelles, making it superior to E. coli for 
production of isoprenoids that require cytochrome P450s [Kirby and Keasling, 2009]. In the end 
the best choice of production platform depends on the specific product. However, we have 
selected S. cerevisiae in which to identify novel genetic targets for improving isoprenoid 
production since an inferior number of targets for this organism have been identified so far 
compared to the other major organism applied for isoprenoid production, namely E. coli. This 
limited knowledge hampers the application of direct metabolic engineering of S. cerevisiae for 
isoprenoid production, which in turn hinders the construction of a strain capable of producing 
isoprenoids at levels that are cost-competitive with organic synthesis. We are convinced that S. 
cerevisiae holds great potential and given that novel targets are identified it will be possible 
through metabolic engineering to establish it as an isoprenoid production platform. For a short 
review on the engineering efforts to increase the isoprenoid production within the two organisms 
see the tables in [Ajikumar et al., 2008]. 
One of the main contributions to strain improvement has come from creating diversity within a 
microbial population through mutagenesis followed by selection or screening. Prior to the advent 
of modern genetic engineering, the method known today as classical strain improvement was 
conducted through global random approaches such as chemical, UV-light, or X-ray induced 
mutagenesis [Adrio and Demain, 2006]. Classical strain improvement has several drawbacks 
such as accumulation of non-beneficial mutations and it is inherently difficult to identify the 
causative genotype of a desired phenotype. Today diversity within a microbial production can be 
created via introduction of DNA libraries e.g. gDNA and cDNA libraries. Using this approach, 
the genotype causing the phenotype for which the library has been screened can easily be traced 
back to the DNA originating from the library initially used to transform the population. This 
approach can be considered as a subsidiary of inverse metabolic engineering. Inverse metabolic 
engineering is defined as: “first, identifying, constructing, or calculating a desired phenotype; 
second, determining the genetic or the particular environmental factors conferring that 
phenotype; and third, endowing that phenotype on another strain or organism by directed genetic 
or environmental manipulation” [Bailey et al., 1996]. In general inverse metabolic engineering 
relies on two organisms with discrete phenotypes and can be seen as the search for the genetic 
element which can impose the desired phenotype of one organism on the other. In special cases 
within inverse metabolic engineering, the application of two distinct phenotypes can be 
neglected, e.g. DNA from the same organism can be inserted back into itself with altered copy 
number, expression level or other modification to identify overexpression targets and/or copy 
number effects [Ramer et al., 1992].  
Imperative for the success of an inverse metabolic engineering approach relying on DNA 
libraries to create diversity is a high-throughput screen to identify the colonies with the desired 
phenotype. Several methods for screening libraries have been developed. The most effective 
screening method is known as selection. Selection relies on the desired phenotype exhibiting a 
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higher growth rate than the undesired. In the best case selection will be discrete, and only the 
mutants with a desired phenotype will survive (“cloning by complementation” can be seen as a 
sub-group of this selection strategy). In cases where the growth rates exist over a continuous 
range, the important parameter is the selection ratio, which is defined as 
   
       
       
 
If the selection ration is higher than 1.2, the selection can be carried out on solid media, whereas 
if it is lower than 1.2, selection in continuous cultures such as chemostat cultures is required 
[Zhang et al., 2006]. This type of inverse metabolic engineering strategy, among others, has been 
applied in order to identify a gene from a Pichia stipites gDNA library which could improve 
xylose assimilation in S. cerevisiae. The diversified population was enriched by serial sub-
culturing, thereby exploiting the favorable selection ratio for the mutants with an improved 
xylose assimilation phenotype. From the enriched population 16 mutants were analyzed, and it 
was found that 10 of them harbored the P. stipites XYL3 gene [Jin et al., 2005].  
However, it is not always possible to identify a selection pressure for which the desired 
phenotype confers an advantage, especially not for secondary metabolites produced 
heterologously. Secondary metabolites are defined as metabolites non-essential for growth but 
assumed to confer an advantage to their natural production organism since they would otherwise 
have been lost during the course of evolution [Williams et al., 1989]. This advantage is seldom 
transferred to a heterologous production host since the external environment of the heterologous 
organism does not apply similar selection pressures. On the contrary, heterologous production of 
secondary metabolites confers a growth disadvantage since precursor metabolites otherwise used 
for biomass generation is re-directed to produce the secondary metabolite. So unless a growth 
strategy imposing a selection pressure on the heterologous host similar to the one giving the 
natural producer an advantage conferred by the specific secondary metabolite, a mean other than 
selection is required for obtaining mutants with the desired phenotype. 
Screening can also be conducted through a quantifiable phenotype, and as with selection, two 
cases exist, namely screening for discrete or continuous phenotypes. Discrete phenotypes are 
preferred over the continuous since the mutants exhibiting the desired phenotype can be picked 
in an either/or manner. With the continuous phenotypes it can be difficult to assess subtle 
changes, and if the screening is done for a phenotype which is difficult to manually quantify, the 
screening process easily becomes subjective, e.g. individual color perception. Screening has 
traditionally been performed manually by visual inspections of mutants on solid medium, but has 
recently been improved by automation with the advent of micro titer technology and robotics. An 
example of the screening for a discrete phenotype was published by Weinstock et al. (1983), who 
constructed a special vector allowing them to screen a gDNA library for open reading frames 
(ORF) with the application of the lacZ gene. Only colonies harboring an ORF would result in 
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blue colony coloration. Similar approaches were applied by Gray et al. (1982) and Ruby et al. 
(1983). An example of a continuous case is the identification of mutants with improved 
antibiotics or growth-inhibitory compound production. These mutants can be screened by the 
area of the clearing zone which corresponds to the potency of the produced compound and its 
production level [Lin et al. 2001].  
No selection strategy or method for isolating isoprenoid overproducing mutants of S. cerevisiae 
has, to our knowledge, been identified so far. However, the naturally occurring pigment 
lycopene, belonging to the isoprenoid subgroup called carotenoids, has been extensively applied 
in both direct and inverse metabolic engineering schemes. Lycopene, as all other isoprenoids, is 
biosynthesized from IPP, which through a polymerization reaction with 2 molecules of 
dimethylallyl pyrophosphate (DMAPP) is converted to farnesyl pyrophosphate (FPP). This 
reaction in S. cerevisiae is catalyzed by the FPP synthase encoded by the ERG20 gene. FPP is 
reacted with another molecule of DMAPP to form geranylgeranyl pyrophosphate (GGPP) 
catalyzed by GGPP synthase, encoded by the BTS1 gene in S. cerevisiae and by the crtE gene in 
bacteria. The last two steps of the pathway are not endogenously present in S. cerevisiae but can 
be introduced into yeast by genetic engineering of the bacterial crtB and crtI genes, encoding 
phytoene synthase and phytoene dehydrogenase, respectively. The biosynthetic scheme for 
lycopene can be seen in Figure 3.1. 
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Figure 3.1: Lycopene biosynthetic pathway. Modified from Sedkova et al. (2005). IPP and two 
molecules of DMAPP are converted into FPP, catalyzed by the FPP synthase, and subsequently 
FPP is condensed with another molecule of DMAPP to form GGPP, catalyzed by GGPP synthase. 
Two molecules of GGPP are condensed head to head to form phytoene, catalyzed by the phytoene 
synthase. Phytoene is desaturated to form lycopene by the phytoene dehydrogenase. The enzymes 
catalyzing the four steps in our S. cerevisiae strain engineered to heterologously produce lycopene 
are encoded by the ERG20, crtE, crtB and crtI genes, respectively. 
 
Lycopene has been applied as a surrogate or reporter metabolite in studies spanning from random 
mutagenesis of single protein targets [Leonard et al., 2010], over the effect of chromosomal 
mutations on plasmid copy number [Tao et al. 2005], stoichiometric modeling [Alper et al., 
2005(a)], combinatorial effects of deletions and overexpression targets [Jin and Stephanopoulos, 
2007], to the screening of gDNA- [Kang et al., 2005], cDNA- [Gallagher et al., 2003] and 
transposon mutagenesis- [Alper et al., 2005(b)], to global transcription factor engineering-
libraries [Alper et al., 2007]. 
As mentioned above, lycopene has been especially successful as a surrogate metabolite applied 
in identifying novel genetic targets in E. coli for improving isoprenoid production. The method 
relied on cloning partially digested E. coli gDNA into the high copy number vector pBluescript 
to create a shot-gun library. This library was then transformed into E. coli, and the best strains 
were picked based on their colony coloration [Kang et al., 2005]. pBluescript is a very high copy 
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number vector in E. coli, present in 500-700 copies per chromosome [Mayer, 1995]. The 
improved lycopene production was therefore probably a result of the increased copy number of 
the identified genes. The application of a high copy vector in such an endeavor has several 
drawbacks: the effect of increased copy number will only have a marginal effect on tightly 
controlled genes, genes encoding products which are toxic at elevated levels cannot be identified, 
and the resultant phenotype can be the result of multiple genotypes if more than one plasmid 
have transformed (and can be co-maintained within) a single cell [Ramer et al., 1992]. To 
circumvent this, a low copy vector can be used in combination with an inducible promoter. This 
was done by Ramer et al. (1992), who applied an YCp plasmid and the GAL1 promoter to 
construct an inducible expression library from S. cerevisiae gDNA. For improvement of a 
secondary metabolite production phenotype, toxic genes are not of interest since they are non-
applicable in most metabolic engineering strategies for industrial scale production. So to 
eliminate these, a strong constitutive promoter could be applied instead of the inducible. This 
approach could be a great way of identifying within S. cerevisiae’s genome novel targets that 
could be engineered to increase its ability to produce isoprenoids. If novel targets can be 
identified by this approach, they can subsequently serve as starting points in a metabolic 
engineering effort to establish S. cerevisiae as an isoprenoid production platform through a 
combinatorial gene expression approach. The approach could also be applied to other organisms 
to identify gDNA fragments which upon expression in S. cerevisiae will improve isoprenoid 
production.  
We here demonstrate the construction of a constitutive expression library based on S. cerevisiae 
gDNA cloned into an YCp plasmid and the subsequent application of the library to create 
diversity within a S. cerevisiae population pre-engineered to produce lycopene. The resultant 
transformants are screened for isoprenoid over-producing mutants by visual selection of mutants 
exhibiting increased red colony coloration due to increased production of lycopene. The general 
strategy for our approach can be seen in Figure 3.2. 
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Figure 3.2: Strategy for construction and screening of gDNA libraries for lycopene overproducing 
mutants.   
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3.3 Materials and methods 
3.3.1 Enzymes, chemicals and media 
Unless otherwise stated, all enzymes applied in the construction of plasmids were purchased 
from New England Biolabs Inc., Ipswich, MA, and all chemicals from Sigma-Aldrich®, St. 
Louis, MO. For auxotrophic selection S. cerevisiae were grown on SC medium with the 
appropriate nutrient(s) omitted. This medium was composed of 6.7 g/l Yeast Nitrogen Base 
(YNB) without amino acids, Sunrise Science Products, Inc., San Diego; CSM – amino acid 
dropout mixture (amount according to manufacturer’s recommendation), Sunrise Science 
Products, Inc., and 20 g/l dextrose. Growth of S. cerevisiae where no selection was required was 
conducted on YPD medium composed of: 10 g/l BactoTM yeast extract, BD Diagnostic 
Systems, Sparks, MD; 20 g/l Bacto
TM
 peptone, BD Diagnostic Systems; and 20 g/l dextrose. E. 
coli cells were grown in BD Difco
TM
 LB broth from BD Diagnostic Systems. For selection and 
maintenance of plasmids, ampicillin was added to a final concentration of 100 mg/l. Solid media 
was made by addition of 20 g/l BD Bacto™ Agar, BD Diagnostic Systems. 
 
3.3.2 Plasmid and strain construction 
Construction of the plasmids described below was done by treating the recipient plasmids with 
endonuclease(s), purification by gel-electrophoresis and recovery by gel extraction using the 
PureLink™ Quick Gel Extraction Kit, Life Technologies, Grand Island, NY, followed by 
ligation to the insert using T4 DNA ligase. The inserts were either prepared by removing it from 
the plasmid harboring it by endonuclease digestion followed by gel-electrophoresis and 
purification in the same way as the plasmid recipient or amplified by PCR, purified using the 
QIAquick PCR Purification Kit, Qiagen, Valencia, CA, treated with endonucleases and purified 
again using the QIAquick PCR Purification Kit, Qiagen. PCR amplifications were performed 
using the Phusion® High-Fidelity DNA Polymerase. All constructs were verified by sequencing. 
The DNA ladder used as size reference was the 1 kb DNA ladder from New England Biolabs 
Inc. (bands corresponds to the following DNA lengths: 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, 
10.0 kb). All the plasmids and strains acquired for this study can be seen in Table 3.1. For 
expression of the genes of interest, three expression cassettes were created and tested for their 
ability to mediate transcription by verifying that they could express the yeast enhanced green 
fluorescent protein (yeGFP). This was done on the basis of the pRS414TEF and pRS415TDH3 
plasmids in which the yeGFP amplified by PCR from pKT127 was inserted by SpeI/XhoI 
digestion followed by ligation. The pRS414TEF plasmid with the inserted yeGFP was modified 
by exchanging the CYC1t with the ADH1t and ACT1t by XhoI/KpnI digestion. The TEF1p was 
substituted with the PGK1p in the plasmid with the ACT1t by SacI/SpeI digestion. The 
replacement promoters and terminators were obtained by PCR from CEN.PK113-7D genomic 
DNA. This resulted in the construction of 3 expression cassettes harboring yeGFP, namely 
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TEF1p-yeGFP-ADH1t, TDH3p (GPDp)-yeGFP-CYC1t and PGK1p-yeGFP-ACT1t in the 
pSC011, pSC012, and pSC013 plasmids, respectively. The carotenogenic genes CrtE, CrtB and 
CrtI were purchased codon optimized from Entelechon GmbH, Regensburg, Germany, based on 
the following protein sequences from Pantoea agglomerans, CrtE (GGPP synthase) - GenBank: 
AAA24819.1, CrtB (phytoene synthase) - GenBank: AAA24821.1 and CrtI (phytoene 
dehydrogenase) - GenBank: AAA24820.1. To construct individual expression cassettes the CrtE, 
CrtB, and CrtI were amplified by PCR and inserted in the SpeI/XhoI treated pSC011, pSC013, 
and pSC012 respectively. The three expression cassette were then sequentially inserted into the 
pRS306 plasmid which was previously modified to harbor a new multiple cloning site (MCS) 
and to have its AatII and ApaI restriction sites removed by silent point mutations, yielding the 
pSC203 plasmid. The new MCS was comprised of two complementary primers which were 
annealed followed by digestion with SacI and KpnI and inserted in pRS306. The new MCS 
contained 9 restriction enzyme recognition sites, whereof the ApaI, AatII, AvrII and AflII were 
used to insert the expression cassettes. The point mutations were performed using the 
QuickChange® Multi Site-directed Mutagenesis kit, Stratagene, La Jolla, CA. 
All transformations of S. cerevisiae were performed using the lithium acetate and polyethylene 
glycol method according to [Gietz and Woods, 2002]. Auxotrophic selection of the transformants 
was done on SC medium with the appropriate nutrient(s) omitted. Verification of the constructed 
strains was done by extraction of gDNA using the Wizard® Genomic DNA Purification Kit, 
Promega, Madison, WI, followed by PCR amplification of all the integrated ORFs. CEN.PK113-
9D was transformed with the pSC203 plasmid to construct strain SimC002. Prior to the 
transformation, the plasmid was linearized with the StuI endonuclease. SimC002 was 
transformed with the pRS414TDH3 to construct the SimC008. The constructed strains can be 
seen in Table 3.1. 
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Table 3.1 - Strains and plasmids. The table shows the acquired and constructed, strains and 
plasmids applied in this study. 
Strain Genotype Source 
Saccharomyces cerevisiae  
CEN.PK113-7D MATa MAL2-8
c
 SUC2 Dr. P. Kötter, Frankfurt, Germany. 
CEN.PK113-9D MATa MAL2-8
c
 SUC2 trp1 ura3 Dr. P. Kötter, Frankfurt, Germany. 
SimC002 MATa MAL2-8
c
 SUC2 trp1 
ura3::pSC203(TEF1p-CrtE-ADH1t 
PGK1p-CrtB-ACT1t TDH3p-CrtI-
CYC1t URA3) 
This study. 
SimC008 MATa MAL2-8
c
 SUC2 ura3::pSC203 
(TEF1p-CrtE-ADH1t PGK1p-CrtB-
ACT1t TDH3p-CrtI-CYC1t URA3) – 
pRS415TDH3 (TRP1) 
This study. 
   
Escherichia coli  
MAX 
Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rk
-
, mk
+
) 
phoA supE44 λ- thi-1 gyrA96 relA1 
Life Technologies, Grand Island, 
NY. 
ElectroMAX™ 
DH10B™ T1 
Phage-Resistant 
Competent 
Cells 
F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZ ΔM15 ΔlacX74 recA1 endA1 
araD139 Δ(ara, leu)7697 galU galK λ- 
rpsL nupG tonA 
Life Technologies, Grand Island, 
NY. 
   
Plasmid name Origin/reference 
pSC203 Center for Microbial 
Biotechnology plasmid collection, 
DTU†. 
pSC011 Center for Microbial 
Biotechnology plasmid collection, 
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DTU†. 
pSC012 Center for Microbial 
Biotechnology plasmid collection, 
DTU†. 
pSC013 Center for Microbial 
Biotechnology plasmid collection, 
DTU†. 
pRS306 [Sikorski and Hieter, 1989] 
pKT127 [Sheff and Thorn, 2004] 
pRS414TEF [Mumberg et al., 1995] 
pRS415TDH3 [Mumberg et al., 1995] 
pRS414TDH3 [Mumberg et al., 1995] 
† Constructed by Simon Carlsen as part of his Ph.D. thesis work. 
 
3.3.3 Library construction 
The gDNA library was created by inserting gDNA fragments in the SalI restriction site which, in 
the YCp plasmid pRS414TDH3, is located between the TDH3 promoter and the CYC1 
terminator. The gDNA was isolated from CEN.PK113-9D using the Wizard® Genomic DNA 
Purification Kit, Promega and fragmented by partial digestion with Sau3AI endonuclease. Prior 
to the digestion the Sau3AI was diluted 10 fold in diluent buffer A, New England Biolabs Inc. A 
dilution series of the endonuclease concentration was set up with each reaction having a final 
volume of 100 μl. Each digestion reaction was stopped by addition of a 30 μl of a 1:2 mix of 0.5 
M EDTA, pH 8, and gel loading buffer, New England Biolabs Inc. Following fragmentation, the 
gDNA was selected for the desired size distribution by gel-electrophoresis on a 0.75 % agarose 
gel. Fragments from 1.5-10 kb were purified using the PureLink™ Quick Gel Extraction Kit. 
The purified fragmented gDNA was then treated with Klenow Fragment (3´→5´ exo–) with the 
addition of dATP and dGTP (nucleotides were acquired from Life Technologies), converting the 
4 bp overhang to a 2 bp overhang, followed by purification with the QIAquick PCR Purification 
Kit, Qiagen. The pRS414TDH3 plasmid was treated with SalI-HF endonuclease for 8 h, purified 
by gel-electrophoresis, and recovered using the PureLink™ Quick Gel Extraction Kit, Life 
Technologies. The linearized plasmid was treated with Klenow (-exo) fragment with addition of 
dCTP and dTTP (nucleotides were acquired from Life Technologies) to avoid self-ligation. 
Subsequently, the plasmid was purified with the QIAquick PCR Purification Kit, Qiagen and 
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ligated in an estimated 1:1 molar ratio (total DNA concentration = 30 ng/μl, total volume 50 μl) 
to the fragmented gDNA with the T4 DNA ligase by incubation at 16 °C overnight. The ligation 
mix was precipitated with the addition of 5 μl 3 M sodium acetate, pH 5.2 and 50 μl isopropanol, 
washed twice with 50 μl ice cold 80 % ethanol and re-dissolved in 5 μl nuclease free water, 
Qiagen. A half microliter of the library was transformed into ElectroMAX™ DH10B™ T1 
Phage-Resistant Competent Cells and plated on large (150 mm in diameter) LB + ampicillin 
plates and incubated overnight at 37 °C. Sixteen colonies were picked onto new LB + ampicillin 
plates for analysis of the library quality. The rest of the colonies were scraped of the plates using 
1 ml ice cold LB medium per plate and a Drigalski spatula. Plasmids from the collected cells 
were purified using the Plasmid Midi Kit, Qiagen and hereafter constituted the working subset of 
the library while the remainder of the concentrated ligation mix was stored at -20 °C as a master 
library in case more working library has to be generated. The quality of the library was tested by 
colony PCR to verify how many of the 16 colonies harbored a pRS414TDH3 plasmid with an 
inserted gDNA fragment. The protocol was inspired by Rose and Broach (1991). 
 
3.3.4 Library screening 
SimC002 was transformed with 5 μg of the working subset of the library using the lithium 
acetate and polyethylene glycol method according to Gietz and Woods (2002) and plated on 50 
large (150 mm diameter) SC-TRP-URA plates. The plates were incubated at 30 °C for three 
days, and based on the intensity of the red colony coloration, 200 mutants were picked onto new 
SC-TRP-URA plates and incubated for 2 days at 30 °C. Out of the 200 colonies, 27 colonies 
were picked for further testing. The strains were tested in triplicate, each in 5 ml SC-TRP-URA, 
for their lycopene production levels. The procedure for quantification of lycopene production is 
described in the following section. 
 
3.3.5 Lycopene extraction, verification and quantification 
The CEN.PK113-7D (negative control) and SimC002 strains were tested for the ability to 
produce lycopene by growing them on 5 ml SC-TRP-URA in 14 ml Falcon 2059 tubes, BD 
Biosciences. The cultures were inoculated at OD600 = 0.1 from pre-cultures and incubated at 30 
°C with 250 rpm orbital shaking for 2 days. The OD600 were measured spectrophotometrically, 
followed by harvesting of the cells from 1 ml of culture. The cultures were harvested by 
centrifugation at 3000 g for 10 min, washed with 1 ml phosphate-buffered saline (Cellgro®, 
Mediateach, Inc., Manassas, VA) and transferred to a 2 ml FastPrep® tube (MP Biomedicals 
LLC., Solon, OH). The cells were spun down at 18,000 g for 1 min, and the phosphate-buffered 
saline removed. Two hundred μl acid washed glass beads (425-600 μm, Sigma-Aldrich®) and 1 
ml of acetone containing 100 mg/l 2,6-di-tert-butyl-4-methylphenol (BHT) was added to each 
FastPrep® tube. The cells were disrupted using a Savant FastPrep® FP120 Cell Disrupter (MP 
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Biomedicals LLC.), and the extracts were filtered using a 13 mm syringe filter (w/ 0.2 μm PTFE 
filter, VWR, Radnor, PA). Finally the lycopene concentration was determined 
spectrophotometrically by measuring the absorbance of the extract at 474 nm. The absorbance 
values were converted to concentration using a standard curve made in triplicate from genuine 
lycopene. To verify that the red pigment was lycopene, the absorption spectra from the extract 
and lycopene standard in acetone with 100 mg/l BHT were recorded from 350-900 nm and 
compared. The same approach was applied to quantify the lycopene production levels of the 
isolated mutants.  
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3.4 Results and discussion 
3.4.1 Strain construction and verification 
The pSC203 plasmid harboring the carotenogenic genes encoding the lycopene biosynthesis 
pathway was used to transform the S. cerevisiae CEN.PK113-9D strain. The resultant 
transformant was picked and tested by PCR to verify that the genes had been inserted in the 
genome. The results confirmed that the genes were inserted (result not shown), and the strain 
was named SimC002. To construct the control strain, SimC002 was transformed with the 
pRS414TDH3 plasmid, which likewise was confirmed by PCR (results not shown). The resultant 
strain was named SimC008. SimC002 and SimC008 were tested for their ability to produce 
lycopene by extracting biomass into acetone and spectrophotometrically verifying that the 
absorption spectra recorded from 350-900 nm match the reference spectrum found in the 
Carotenoid Handbook [Britton et al., 2004] (result not shown). 
3.4.2 Library construction 
In order to construct a S. cerevisiae gDNA library, gDNA was purified from CEN.PK113-9D. 
The gDNA size and quality was tested by gel-electrophoresis. The result can be seen in Figure 
3.3, lane 1, which shows that the obtained gDNA has a high concentration and integrity. To 
fragment the gDNA, the endonuclease Sau3AI was applied, and a dilution series of the Sau3AI 
was set up to determine the concentration of the enzyme which would give the best size range of 
partially digested gDNA. The results can be seen in Figure 3.3, lanes 4-14. The desired size 
range of partially digested gDNA was selected as that obtained in between the 4
th
 and 6
th
 
dilutions, corresponding to lanes 8-10 in Figure 3.3. It is important to notice that the amount of 
endonuclease required to obtain the desired size distribution of fragmented gDNA depends both 
on the initial gDNA concentration and size, which means that the required endonuclease amount 
has to be determined experimentally for each batch of purified gDNA. 
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Figure 3.3: Partial digests of S. cerevisiae gDNA. The DNA was separated and visualized by gel 
electrophoresis in a 1 % agarose gel. The first lane to the left 1 kb ladder (bands corresponds to 0.5, 
1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, and 10.0 kb) from New England Biolabs Inc.. Lane 1: gDNA 
preparation, lane 2: gDNA preparation incubated at 37 ˚C for 0.5 h, lane 3: gDNA mixed with BSA 
and buffer 4 followed by incubation in 37 ˚C for 0.5 h, and lane 4-14: 1:1 dilution series of Sau3AI 
with constant concentration of gDNA after incubation at 37 ˚C for 0.5 h. 
 
The three digestion reactions exhibiting the desired size distribution were pooled and size-
selected on a 0.75 % agarose gel, and the fragments in the size ranging from 1.5 to 10 kb were 
recovered. The recovered fragments were treated with Klenow (-exo) fragment and ligated into 
the pRS414TDH3 plasmid which prior to the ligation was digested with SalI-HF and treated with 
Klenow (-exo). The ligation mix was concentrated approximately 10-fold by precipitation and 
used to transform electro-competent E. coli cells (ElectroMAX™ DH10B™ T1 Phage-Resistant 
Competent Cells, >1·10
10
 CFU/μg DNA). The resultant transformants were plated on 10 large 
LB+amp plates and incubated overnight at 37 °C. It was estimated that each plate contained at 
least 10,000 colony forming units (CFU), and the total size of the working subset of the library is 
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hereby estimated to be approximately 100,000 CFU. Since only one tenth of the ligation mix was 
transformed into E. coli, the total library size is around 1·10
6
 CFU. Sixteen colonies were picked 
and analyzed by colony PCR to determine if they had inserts. The result of the colony PCR can 
be seen in Figure 3.4. A band of around 600 bp indicates that the plasmid harbored by the tested 
cells is empty, whereas a larger band indicates that a DNA fragment has been inserted in the 
plasmid. From Figure 3.4 it can be seen that 13 out of 16 tested colonies contained an insert, 
corresponding to an insert percentage of 81.25 %. 
 
Figure 3.4: Visualization of colony PCR. Colonies were tested by PCR to determine the percentage 
of colonies harboring a plasmid which have had a gDNA fragment inserted. The primers were 
designed to anneal approximately 300 bp on each side of the insertion site. Bands at sizes larger 
than 600 bp indicate that a gDNA fragment has been inserted, whereas a band at around 600 bp 
indicates that no fragments have been inserted. The PCR was separated and visualized on a 1 % 
agarose gel. The first lane to the left in each tier is the 1 kb ladder (bands corresponds to 0.5, 1.0, 
1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0, and 10.0 kb) from New England Biolabs Inc., and the remaining 16 
lanes each represent an individual colony tested by colony PCR. 
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Some of the lanes in Figure 3.4 can be seen to have multiple bands which can be caused by two 
things, either by erroneous primer annealing or by the picking of multiple colonies into the 
colony PCR reaction. The latter is the more probable cause since 10,000 colonies on a single 
agar plate, even though they are evenly distributed, only allows for a limited area of growth for 
each colony and thereby increases the probability of joined-colonies forming from 2 or more 
transformants. Thus the insert percentage of 81.25 % is only approximating the actual insert 
percentage, but since this is always the case when a subset of a population is analyzed in order to 
characterize the entire population, this was not investigated more thoroughly. For further 
calculations the insert percentage will be rounded to 80 %. The colonies from the 10 plates were 
scraped off and purified, resulting in 0.5 μg/μl library pooled in a total volume of 0.5 ml. 
3.4.3 Library quality considerations 
High molecular weight DNA is prone to physical shearing which means that the purified DNA 
has to be handled very carefully. If the DNA is physically sheared rather than digested, the 
fragments can act as competitive inhibitors of the subsequent ligation reaction, so to ensure a 
favorable ratio between sheared and digested DNA, it is important that the size of the purified 
gDNA is at least 3- to 4- fold larger than the average size of the insert [Wu et al., 2004]. From 
Figure 3.4 the average insert size of our library can be estimated to be around 2 kb, and with an 
average size of purified gDNA > 10 kb (cf. Figure 3.3) the ratio requirement is met. 
When fragmenting gDNA with restriction endonuclease, the distribution will be biased due to the 
uneven distribution of cleavage sites throughout the genome. This bias can be lessened by using 
endonucleases with short recognition sequences [Wu et al., 2004]. We applied the Sau3AI which 
has a 4 bp recognition sequence. In a completely random DNA sequence, it would cleave every 
256 bp; however, restriction endonucleases with 4 bp recognition sequences would cleave within 
most ORFs if they were to fully digest the gDNA, which is the main reason for limiting the 
digestion time to ensure a partial digest. Furthermore, it is important to apply multiple 
concentrations of the endonuclease to avoid bias at individual cleavage sites and to obtain a more 
even concentration distribution over fragment sizes [Jauert et al., 2005]. 
To take GC-content of the gDNA into consideration, different endonucleases with 4 bp 
recognition sequences could be applied. Methods for completely avoiding the bias caused by 
cleavage site distribution such as random fragmentation of the gDNA by physical shearing or 
DNase I digestion have been developed [Ramer et al., 1992; Santangelo et al., 1986]. The 
drawback of these methods is that they generate random ends which have to be blunt-ended 
before they can be ligated into a plasmid, and thereby the ligation efficiency is decreased 
compared to 4 bp overhangs. It is possible to create 4 bp overhangs on the blunt-ended fragments 
by ligating adapters to each end of the fragments. However, this would require an additional 
ligation reaction, hereby lowering the overall yield. We chose to use the restriction endonuclease 
approach since we were more concerned with having a high ligation efficiency combined with 
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the subsequent possibilities that it creates for avoiding plasmid self-ligation, having plasmids 
with multiple inserts and DNA self-ligation. 
The standard way of preventing plasmids from self-ligating is to treat the digested plasmid with 
phosphatase [Rodrigues et al. 2001]. This does only prevent the plasmid from self-ligating and 
thus does not prevent multiple inserts or fragment self-ligation. Furthermore, the efficiency of 
the phosphatase is crucial to obtaining a good library since linearized plasmids with only one of 
the two phosphate groups will be able to self-ligate albeit with a gap. Our initial library 
construction was performed with phosphatase-mediated dephosphorylation, and our best library 
constructed in this manner had an insert percentage around 20 % (result not shown), which is 
unacceptably low. To circumvent all of the three issues, the large Klenow fragment engineered to 
have no exonuclease activity can be used to partly fill in the 4 bp overhangs. This results in 2 bp 
overhangs which are unable to mediate any self-ligation and integration of multiple DNA 
fragments. However, this will lower the ligation efficiency but not to the same level as for the 
blunt-end case. For the case of plasmid self-ligation, which is the biggest problem of the three 
since it results in transformants harboring empty plasmids, the phosphatase treatment can create 
four possible outcomes: no dephosphorylation, dephosphorylation of either of the two ends of the 
plasmid, or dephosphorylation of both ends. Three of these four possibilities will be able to self-
ligate, whereas the treatment with Klenow fragment will prevent plasmid self-ligation if a single 
nucleotide is filled in at either of the two ends. Actually the only plasmids capable of self-
ligating would be linearized plasmids completely unaffected by the Klenow treatment, so if 
enzyme activity is disregarded, these considerations illustrate why Klenow treatment would be 
more efficient in preventing plasmid self-ligation, which is also supported by our results. 
The average ORF size in S. cerevisiae was found to be 1,385 bp [Hurowitz and Brown, 2003] 
which is less than the average fragment size found for our gDNA library. Furthermore the 
probability of a given DNA sequence being present in a gDNA library can be estimated from the 
following formula: 
 
      (
   
 
)
 
 
where N is the total number of clones containing an insert, I is the average insert size and G is 
the target genome size (the combined exponent is the calculation of genome equivalents). The 
formula is based on a Poisson distribution [Moore, 1998] and shows that a greater number of 
clones obtained and/or a longer average insert size results in a greater probability of a given 
DNA sequence being present in the library. For the working subset of the library this probability 
was calculated as follows: 
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In order for the potential ORFs inserted in the expression vector to be deregulated, they not only 
need to be present but also to be inserted in the correct direction according to the promoter (in 
this case the TDH3 promoter), and the digestion site upstream of the start codon has to be in 
close enough proximity to the start codon so the native regulatory elements which could affect 
transcription are replaced with the ones present in the plasmid-based promoter sequence. Ramer 
et al. (1992) constructed a gDNA library using the inducible GAL1 promoter. To test their 
library, they plated it on selective media with galactose and auxotrophic selection for histidine 
prototrophic transformants. They obtained 42 clones which were subsequently plated on similar 
medium with glucose as the carbon source instead of galactose to limit transcription initiation 
from the GAL1 promoter. Of the 42 mutants, 4 were unable to grow on histidine-deficient 
medium thereby proving that these had indeed been deregulated. They fragmented their gDNA 
by physical shearing which of course means that there is an equal probability for each ORF to be 
deregulated. This example shows that this strategy of constructing overexpression libraries is 
feasible, be it with an inducible, repressible, constitutive or any other type of promoter. We 
applied random digestion, and there will therefore be some ORFs that we will be unable to 
deregulate due to the absence of a Sau3AI cleavage site between their start codons and their 
regulatory element(s). We applied a constitutive promoter and were hereby unable to perform a 
similar test since it is very difficult to set up an auxotrophic selection pressure which can 
discriminate between the native and the constitutive promoter. However, based on the results 
from Ramer et al. (1992) we are confident that we will be able to obtain deregulated versions of 
most of the ORFs present in the library. Nevertheless there will always be some genetic elements 
which cannot be obtained from a gDNA library due to their lethality or their poor maintenance 
and/or propagation in a heterologous host [Wu et al., 2004]. 
cDNA libraries would in many cases be a better choice of library compared to gDNA libraries 
since only genetic elements encoding proteins would be obtained, and the elements can be 
inserted in the correct direction into the expression plasmid. However, not all organisms perform 
poly-adenylation as part of their post transcriptional modifications, making the purification of 
their mRNA and subsequent cDNA library construction troublesome. Many of the organisms 
that do not poly-adenylate their mRNA also do not have introns. In these casas gDNA libraries 
would be the library type of choice, whereas for organisms with a high percentage of genes 
containing introns, cDNA libraries would be the best solution. In our case the donor organism 
and host organism are the same, thereby negating the need to construct a cDNA library. In the 
end, the best suited library type primarily depends on the organism from where the genetic 
element is sought. 
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3.4.4 Library screening and strain testing 
The constructed library was transformed into the lycopene producing S. cerevisiae strain 
SimC002. Of the resultant transformants 200 colonies were picked based on their individual red 
color intensity by visual inspection and transferred onto new SC-TRP-URA plates. After 
incubation at 30 °C the new colonies, each corresponding to one of the initial 200, were screened 
a second time by visual inspection. Twenty seven colonies were selected for further testing to 
identify the ones capable of producing the most lycopene in liquid medium. Each colony was 
inoculated into 5 ml SC-TRP-URA medium and tested in technical triplicate, as was the 
SimC008 control strain. The mean values for the technical triplicates can be seen in Figure 3.5 
where each mean has been normalized with respect to the SimC008 mean. 
 
 
Figure 3.5: Relative isoprenoid production level. 27 of the 200 isolated mutants were tested for their 
ability to produce lycopene in 5 ml cultures together with the non-carotenogenic strain 
CEN.PK.113-9D and the positive control SimC008. The lycopene level were quantified in technical 
triplicate as a biomass yield (mg/l/OD600) and normalized to the value of the positive control strain. 
The ten mutants with the highest biomass yield of lycopene are marked with an asterisk. 
 
Eighteen of the 27 tested strains were shown to have higher lycopene producing capabilities 
compared to the SimC008 strain. Of these 18 strains the 10 best were selected for further 
evaluation (marked with an asterisk in Figure 3.5). Plasmids from the 10 strains were isolated 
and used to transform SimC002. From the resultant colonies three colonies were picked 
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randomly from each transformation and tested in liquid SC-TRP-URA medium for their 
lycopene production levels. The results can be seen in Figure 3.6 (blue columns). 
 
Figure 3.6: Lycopene biomass yield determination. The red columns are the initial non-normalized 
values determined for the ten best mutants shown in Figure 3.5, and the blue columns are the 
values determined for 3 randomly picked colonies of the retransformation of the clean background 
strain SimC002 with the plasmids isolated from the aforementioned ten mutants. The experiment 
was performed in 5 ml cultures and compared to the positive control strain SimC008. The error 
bars represent the standard deviation calculated for n=3 (technical triplicates for the initial values 
and biological triplicates for the reconstitution experiment). 
 
For comparison the values for the initial test can be seen as the red columns in Figure 3.6. The 
only plasmid capable of re-constituting the lycopene overproducing phenotype is the plasmid 
isolated from colony 119 of the original transformation. Furthermore, it can be seen from the two 
tests that for the control strain there is a difference in the lycopene production level which is 
outside the limits delineated by the standard deviations. This could probably be caused by small 
differences in the media composition since a new batch was prepared for each of the two 
experiments, and it emphasizes how important it is to always include the control strain to identify 
the base lycopene production level for each individual batch of medium. The plasmid isolated 
from colony 119 was sequenced but found not to contain an open reading frame (results not 
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shown). Since the initial increase in lycopene production level could not be attributed to the 
genetic element harbored within the individual plasmids, the cause remains unidentified but 
could be caused by mutations or other genetic alterations that the individual cells had undergone 
during the transformation. These results demonstrate that even though mutants with increased 
lycopene production levels are isolated, there is no guarantee that the increase is caused by the 
transformed plasmid. In order to increase the probability of isolating such plasmids, the number 
of mutants analyzed in liquid cultures has to be increased. 
Since one can only perform a given number of lycopene extractions in a given time frame, there 
will always be a tradeoff between how many individual transformants one can test and how 
many replicates it will be possible to include. From Figure 3.6 it can be seen that the standard 
deviations are relatively small, indicating that it could be possible to lower the number of 
replicates and still retain a certain degree of confidence in the results. This means that a higher 
number of tranformants can be analyzed in the same time, and the probability of identifying 
lycopene overproducing mutants caused by the genetic element harbored within the transformed 
plasmid thereby could be increased as well. 
Another possibility to increase the probability of identifying mutants with increased lycopene 
production could be to improve the screening method. Visual inspection of large numbers of 
colonies is very labor-intensive and also biased due to the individual color perception of the 
person performing the screen. If a high-throughput screening method independent of personal 
color perception could be set up, it would greatly aid in this endeavor. 
3.4.5 Alternative screens 
The increment in colony coloration as a function of carotenoid produced by the individual yeast 
colonies changes only slightly as carotenoid concentration increases, especially at higher 
carotenoid concentrations [Lewis et al., 1990]. This saturation effect can be mitigated by the 
addition of carotenoid biosynthetic inhibitors to the media. On this basis the carotenoid 
biosynthetic inhibitors diphenylamine [Chumpolkulwong et al., 1997] and β-ionone [Lewis et al., 
1990] have been applied in chemical mutagenesis studies with subsequent screens for 
astaxanthin overproducers by visual inspection of Xanthophyllomyces dendrorhous mutants. The 
main problems with applying these inhibitors to identify mutants with increased isoprenoid 
production capabilities are that the inhibitors are specific to the carotenoid biosynthetic pathway, 
which would mean that most positive mutants isolated would probably be due to a mutation 
within the genes encoding this pathway, and that the inhibitors inhibit enzymes downstream of 
the lycopene synthase, which means that the heterologous pathway would have to be extended 
for them to be applied. Such genetic targets would of course be beneficial if the aim were to 
optimize S. cerevisiae for production of xanthophylls, but since the aim is to create an isoprenoid 
production platform with increased flux towards IPP, they would be useless. Other inhibitors 
such as statins have been shown to inhibit enzymes upstream of IPP and could therefore be used 
in the search for a general production host. However, this would mean that the search mainly 
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would aim at obtaining mutations within the gene encoding the protein targeted by the inhibitor. 
This “one step at a time”-approach would be very laborious, and it would therefore be 
preferential if the screen could identify mutations within multiple target at once. Subsequently, 
the identified targets could be engineered in a combinatorial approach to identify synergistic 
effects and by this mean identify the best candidate strain for a S. cerevisiae-based isoprenoid 
production platform. 
The throughput of the screen could also be improved by applying a non-subjective standardized 
screening method capable of analyzing multiple mutants in shorter time than the manual 
inspection of agar plates. Digital Image Spectroscopy (DIS) has been demonstrated as a medium 
throughput method able to acquire and analyze absorption spectra in the region from 400-900 nm 
from up to 500 individual colonies [Arkin et al., 1990]. This method enables the researcher to 
analyze microbial populations for any property resulting in a change in absorption spectra such 
as the production of a pigment [Yang, 1994]. However, this method is, as mentioned above, only 
medium throughput since the colonies still have to be manually picked for further analysis. If this 
method were combined with a colony picker or another automatic method for separating the 
positive mutants from the remainder of the population, it would increase the throughput 
drastically, but a setup of this type must be considered very specialized; to our knowledge there 
have not been published any scientific paper for a method or setup like this. DIS could be 
combined with the inhibitor approach. 
Fluorescence-activated cell sorting (FACS) would be the obvious choice if a very high-
throughput screen is required. By FACS each individual cell can be analyzed and sorted at very 
high rates circumventing the need to plate the entire library of transformants to obtain colonies 
that can be analyzed. However, this approach relies on fluorescence, so a fluorescent surrogate 
isoprenoid metabolite needs to be produced heterologously as a reporter metabolite. The 
xanthophyll molecule astaxanthin has been found to be fluorescent and has been applied in a 
screen for X. dendrorhous mutants exhibiting increased astaxanthin production. The reported 
FACS methods can at best be considered as an enrichment step, which when applied to a library 
screen, has to be followed by a manual screen by visual inspection [An et al., 1991 and Ukibe et 
al., 2008]. This enrichment step will lower the number of colonies that have to be inspected and 
thereby also the work load, but in order for it to be applied in S. cerevisiae, the lycopene pathway 
has to be extended to convert lycopene into astaxanthin. 
It is difficult to speculate which of the aforementioned methods for improving the screening 
effort is the most robust, but from a throughput point of view the FACS method seems to be the 
best choice, followed by the DIS method. If this is the case, in practice remains to be 
demonstrated. 
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4.1 Abstract 
Multiple techniques have been developed for generation of diversity within microbial 
populations and have greatly aided in the identification of novel genetic targets for obtaining 
microorganisms with desired phenotypes. As a result, very large mutant libraries can readily be 
created, but when searching these libraries for traits which cannot be actively selected for, the 
existence of an efficient screen is imperative for success. The screening method has to have 
sufficiently high throughput to be able to process the large number of mutants, which can readily 
be created. One of the screening methods with the highest throughput developed to date is the 
fluorescence-activated cell sorting (FACS). This method can be used to sort out microbial cells 
overproducing a fluorescent reporter molecule. We here demonstrate the engineering of 
Saccharomyces cerevisiae for the production of lycopene, β-carotene, and astaxanthin. The three 
constructed strains produced 1.05, 0.815, and 1.06 mg/gDCW lycopene, β-carotene, and 
astaxanthin, respectively. The obtained astaxanthin production is 9-fold higher than what has 
previously been achieved in S. cerevisiae. β-carotene and astaxanthin have previously been 
demonstrated to exhibit fluorescence when excited at 488 nm. The constructed strains served as 
the basis for testing if any of the three carotenoids as part of a sub-group of the isoprenoids can 
be applied as surrogate molecules for screening microbial libraries for increased isoprenoid 
production using FACS. The results show that the change in in vivo fluorescence due to 
production of carotenoids was too weak to enable us to efficiently apply these compounds as 
surrogate molecules in the endeavor of screening populations of S. cerevisiae for isoprenoid 
overproducers by FACS. 
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4.2 Introduction 
Within the realm of metabolic engineering, there are two main approaches to engineering 
organisms for obtaining mutants exhibiting desired phenotypes, namely rational and 
combinatorial metabolic engineering. The rational approach relies on prior knowledge of the 
system to identify key targets which when perturbed will result in the desired phenotype 
improvements. Whereas, the combinatorial approach does not rely on prior knowledge but 
instead relies on the large number of techniques, from random mutagenesis to molecular 
biological methods such as gDNA, cDNA, and transposon libraries for generating diversity 
which can subsequently be screened to identify mutants with desired phenotypes [Tyo et al., 
2006]. However, biological systems are highly regulated and intertwined creating an enormous 
search space which needs to be efficiently probed in order to improve the probability of 
identifying mutants with beneficial traits, which in turn means that mutant libraries need to be 
sufficiently large and diverse. The large number of mutants that needs to be screened in order for 
this approach to be effective necessitates the existence of a high-throughput screen. 
One of the most effective screening methods developed is fluorescence-activated cell sorting 
(FACS), which allows for the characterization of individual cells by flow cytometry in 
conjunction with cell sorting, isolating the cells identified by the flow cytometer as exhibiting a 
desired trait. FACS was originally used in the study of mammalian cells but has been adapted to 
enable the characterization and sorting of microbial populations [Katsuragi and Tani, 2000]. The 
main objectives for FACS when applied for identification of cells with over-producing 
phenotypes are: reduce the required workload, reduce the required time, and identify the cells 
with the highest production rate [Mattanovich and Borth, 2006], which is ideal when screening 
large mutant libraries in the search of improved production phenotypes. A prerequisite for the 
application of FACS is that the target molecule fluoresces upon excitation or that a specific 
fluorescent probe for the molecule of interest exists. For a review on FACS see [Ibrahim and van 
den Engh, 2007]. 
The obvious target for screening for S. cerevisiae isoprenoid hyper-producers would be the two 
universal isoprenoid precursors, isopentenyl pyrophosphate (IPP) and dimethylallyl 
pyrophosphate (DMAPP). However, neither of these two molecules exhibits fluorescence, nor 
has any fluorescent probe for the two been identified. To bypass this problem a fluorescent 
surrogate isoprenoid molecule could be exploited. It has previously been shown that Dunalella 
salina and Xanthophyllomyces dendrorhous (formerly Phaffia rhodozyma) mutant hyper-
producers of β-carotene and astaxanthin, respectively, could be isolated using FACS [Nonomura 
and Coder, 1988; An et al., 1991; Ukibe et al., 2008]. Besides FACS, laser confocal microscopy 
has been used to correlate the cellular auto-fluorescence with the carotenoid content of single X. 
dendrorhous cells [An et al., 2000]. All the aforementioned studies on carotenoid fluorescence 
applied a 488 nm argon ion laser. 
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Both β-carotene and astaxanthin belong to the group of secondary metabolites known as 
carotenoids, with astaxanthin belonging to the carotenoid sub-group known as xanthophylls, 
which encompasses oxygen decorated carotenoids. The main feature of carotenoids is their 9-11 
conjugated C=C double bonds which creates a large π-electron system absorbing light within the 
gap of chlorophyll absorption making them ideal as accessory light-harvesting molecules in 
photosynthesis. This light absorption is also the cause for the carotenoids colorfulness and their 
application as pigments [Vershinin, 1999]. The absorption spectra of β-carotene and astaxanthin, 
together with their fluorescent excitation and emission spectra can be seen in Figure 4.1. 
 
 
Figure 4.1: Absorption and fluorescence spectra of β-carotene (left panel) and astaxanthin (right 
panel) in chloroform at 25 °C. a: absorption spectra, b: fluorescence excitation spectra, c and d: 
emission spectra. The emission spectra for β-carotene were recorded at 430 nm (c) and 350 nm (d) 
excitation wavelengths; the excitation spectrum was recorded for an emission wavelength of 570 nm 
and normalized to the absorption maximum at 464 nm. The astaxanthin emission spectrum was 
recorded at 435 nm excitation wavelength; the excitation spectrum was recorded for an emission 
wavelength of 600 nm and normalized to the absorption maximum at 490 nm. The figure is adapted 
from [Jørgensen et al., 1992]. 
 
The structures of β-carotene and astaxanthin are very similar with the only differences being the 
hydroxyl moieties at the 3/3’ positions and the keto moieties at the 4/4’ positions. The structures 
of the molecules can be seen in Figure 4.2. The hydroxyl groups do not affect the optical 
properties of astaxanthin. However, the keto groups are conjugated with the polyene backbone 
and are responsible for the change in both the absorption and fluorescence spectra. The β-
carotene absorption spectrum has the characteristic absorption maxima at 425, 450 and 475 nm 
whereas the astaxanthin absorption spectrum has a single absorption maximum at 460 nm. 
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Furthermore, the keto groups create a shift in the fluorescence spectra towards higher excitation 
and emission wavelengths. It should be noted that the excitation maxima coincide with the 
absorption maxima [Jørgensen et al., 1992; Visser et al., 2005]. The large number of double 
bonds allows for a great number of cis/trans isomers which have slightly different optical 
properties, but carotenoids in nature are predominately found in all-trans conformation, since this 
conformation is more thermodynamically favorable. The existence of two chiral centers at 3 and 
3’ positions give rise to three isomeric forms, namely the 3R/3’R, 3S/3’S and 3S/3’R. These 
optical isomeric forms do not exhibit differences in optical absorbance [Visser et al., 2005]. 
Biosynthesis of β-carotene and astaxanthin has been found to occur in several microorganisms, 
e.g. yeasts: Sporobolomyces roseus [Davoli and Weber, 2002], X. dendrohous [Andrews et al., 
1976]; green algae: Haematococcus pluvialis [Boussiba and Vonshak, 1991]; and marine 
bacteria: Paracoccus sp. strain N81106, Paracoccus sp. strain PC1 [Berry et al., 2003] and 
Brevundimonas sp. Strain SD212 [Nishida et al., 2005]. Since β-carotene and astaxanthin are 
both isoprenoids, they are both biosynthesized from the ubiquitous isoprenoid precursor IPP 
which is polymerized with three molecules of DMAPP to form geranylgeranyl pyrophosphate 
(GGPP). Two molecules of GGPP are then condensed head to head to form phytoene which is 
then desaturated to form lycopene. Subsequently each end of lycopene is cyclized to form β-
carotene, which is finally decorated at the 3/3’-positions with hydroxyl moieties and at the 4/4’-
positions with keto moieties to form astaxanthin. The course of the pathway until β-carotene is 
identical within prokaryotes and eukaryotes; however, the synthesis of astaxanthin from β-
carotene proceeds differently in different organisms. In X. dendrorhous the reaction is catalyzed 
by a single enzyme, astaxanthin synthase encoded by the crtS gene. The crtS encodes a 
cytochrome P450 enzyme which in order to be functional has to be coupled to a reductase. The 
reductase corresponding to the crtS is encoded by the crtR gene. On the other hand, bacteria have 
been found to utilize two enzymes, namely 3,3’- β-carotene hydroxylase and 4,4’- β-carotene 
ketolase encoded by the crtZ and crtW genes, respectively [Nishida et al., 2005, Ukibe et al., 
2009]. The bacterial biosynthetic pathway for β-carotene and astaxanthin can be seen in Figure 
4.2.  
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Figure 4.2: Carotenoid biosynthetic pathway to astaxanthin. FPP is converted to GGPP with one 
molecule of DMAPP by CrtE, followed by the condensation of two molecules of GGPP, catalyzed by 
the CrtB, to form phytoene. Subsequently, catalyzed by the CrtI, phytoene is desaturated to form 
lycopene followed by the cyclization by CrtY of each end of the lycopene molecule to form β-
carotene. β-carotene undergoes a series of oxidative reactions to finally form astaxanthin. These 
reactions are catalyzed by CrtZ and CrtW. The figure is modified from [Choi et al., 2006]. 
 
Heterologous microbial production of β-carotene and astaxanthin has been achieved in 
Escherichia coli, Saccharomyces cerevisiae and Candida utilis. For reviews on heterologous 
microbial production of carotenoids see Misawa and Shimada (1998) and Das et al. (2007). For 
microbial β-carotene production in S. cerevisiae the X. dendrorhous crtE, crtYB, and crtI genes 
have been successful in yielding up to 5.9 mg/gDCW in an engineered background strain 
[Verwaal et al., 2007; Lange and Steinbüchel, 2011]. However, the bacterial crtE, crtB, crtI, and 
crtY genes have not been as effective in this endeavor. Yamano et al. (1994) were only able to 
obtain 103 μg/gDCW β-carotene in S. cerevisiae with genes from Pantoea ananatis (formerly 
called Erwinia uredovora), but codon optimized versions of these genes have been applied in C. 
utilis with greater success yielding up to 0.4 mg/gDCW β-carotene [Miura et al., 1998]. In the 
same study it was demonstrated that the produced β-carotene could be converted to astaxanthin 
by co-expressing codon optimized versions of the crtZ and crtW genes from Agrobacterium 
aurantiacum. Besides this example, only one other example of astaxanthin production in yeast 
has been published in the literature, namely the study by Ukibe et al. (2009). They expressed the 
crtE, crtYB, crtI, crtS and crtR genes from X. dendrorhous in S. cerevisiae which resulted in the 
production of 120 μg/gDCW astaxanthin. They furthermore tested the substitution of the crtS 
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and crtR genes with the crtZ gene from Pantoea ananatis and crtW from Paracoccus sp. 
NBRC101723. This substitution resulted in a production of 29 μg/gDCW astaxanthin. 
We here present the construction of two S. cerevisiae strains for production of β-carotene and 
astaxanthin, respectively. This was done on the basis of a previously constructed plasmid which 
enables S. cerevisiae to produce lycopene. To extend the pathway to β-carotene and astaxanthin, 
we created two plasmids for chromosomal integration of codon optimized versions of the crtY 
gene and the crtY, crtZ, and crtW genes, respectively. The codon optimized genes are based on 
the corresponding genes from Brevundimonas sp. SD212. Use of bacterial genes was selected 
since heterologous expression of cytochrome P450 (required for the X. dendrorhous pathway) is 
inherently troublesome. The reason that the Brevundimonas sp. SD212 genes were chosen as the 
basis for the codon optimized genes is that the crtZ and crtW from this organism has been 
demonstrated to be more effective at producing astaxanthin compared to the corresponding genes 
from Paracoccus sp. PC1, Paracoccus sp. N81106 and Pantoea ananatis when heterologously 
expressed in E. coli [Choi et al., 2005; Choi et al., 2006]. Since Miura et al. (1998) have 
demonstrated that codon optimizing the carotenoid biosynthetic genes from Pantoea ananatis 
results in higher carotenoid production we decided to only test the codon optimized versions of 
the Brevundimonas sp. SD212 genes in S. cerevisiae. We chose to integrate the genes in the 
chromosome of S. cerevisiae since it has been demonstrated that chromosomal integration of the 
carotenoid biosynthetic genes improved the production of β-carotene [Verwaal et al., 2007]. The 
constructed strains finally form the basis for testing whether FACS can be utilized to 
discriminate between S. cerevisiae strains producing lycopene, β-carotene, or astaxanthin and a 
non-carotenogenic negative control strain. 
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4.3 Material and methods 
4.3.1 Enzymes, chemicals and media 
All enzymes applied for constructing plasmids were purchased from New England Biolabs Inc., 
Ipswich, MA. The lycopene and β-carotene standards were purchased from Sigma-Aldrich®, St. 
Louis, MO, and the astaxanthin standard was purchased from Enzo Life Sciences, Inc., 
Farmingdale, NY. The HPLC grade water and acetone used for the HPLC analysis were 
purchased from Sigma-Aldrich®. S. cerevisiae were grown on SC medium with the appropriate 
nutrient(s) omitted. SC medium was composed of 6.7 g/l Yeast Nitrogen Base (YNB) without 
amino acids, Sunrise Science Products, Inc., San Diego; CSM – amino acid dropout mixture 
(amount according to manufacturer’s recommendation), Sunrise Science Products, Inc., and 20 
g/l dextrose. E. coli cells were grown in BD Difco
TM
 LB broth from BD Diagnostic Systems, 
Sparks, MD. For selection and maintenance of plasmids, ampicillin was added to a final 
concentration of 100 mg/l. 
4.3.2 Plasmid and strain construction 
The codon optimized genes encoding the CrtY (GenBank: BAD99407.1), CrtZ (GenBank: 
BAD99414.1), and CrtW (GenBank: BAD99406.1) enzymes were purchased from Bio Basic 
Inc., Markham, Ontario, Canada. The genes were synthesized to be flanked with SpeI and XhoI 
restriction sites, which were used to clone the genes into pSC011, pSC012, and pSC013 hereby 
creating the TEF1p-crtY-ADH1t, PGK1p-crtY-ACT1t, and TDH3p-crtW-CYC1t expression 
cassettes, respectively. The TEF1p-crtY-ADH1t expression cassette was amplified by PCR using 
Phusion® High-Fidelity DNA Polymerase and the following primers: 5’- 
AAGCTGGAGCTCATAGCTTCAAAATGTTTCTACTCCTTTTTTAC-3’ and 5’- 
TATGACGGATCCGCGGCCGCTGACCTAGACCTAGGGAGCGACCTCATGCTATACCTG
-3’ (restriction sites are underlined). The amplified DNA fragment was treated with SacI and 
BamHI endonucleases and ligated into pRS405 which prior to the ligation also had been treated 
with SacI and BamHI endonucleases and gel purified. This resulted in the construction of 
pSCA101 which contains the TEF1p-crtY-ADH1t expression cassette followed by the AvrII and 
NotI restriction sites. The PGK1p-crtY-ACT1t expression cassette was amplified with the 
following primers: 5’-GACTTAGCTAGCAGACGCGAATTTTTCGAAGAAGTACC-3’ and 
5’-TATGACGCGGCCGCTGACCTAGACCTAGGCCGATATGATACACGGTCCAATG-3’ 
(restriction sites are underlined). The amplified fragment was treated with NheI and NotI 
endonucleases and ligated into pSCA101 which prior to the ligation had been treated with AvrII 
and NotI endonucleases and gel purified. This resulted in the construction of pSCA102 which 
contains the TEF1p-crtY-ADH1t and PGK1p-crtY-ACT1t expression cassettes. The NheI 
endonuclease used to treat the insert generates 4 bp overhangs which are compatible with the 4 
bp overhangs generated by the AvrII endonuclease used to treat the backbone; therefore the final 
construct will neither have the NheI nor the AvrII restriction sites. However the reverse primer 
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used to amplify the expression cassette contained a new AvrII restriction site, allowing this to be 
repeated and permitting iterative plasmid construction. The TDH3p-crtW-CYC1t expression 
cassettes were amplified using the following primers: 5’- 
GACTTAGCTAGCAGTTTATCATTATCAAT-3’ and 5’- 
TATGACGCGGCCGCTGACCTAGACCTAGGAAATTGTAAACGTTAATATTTTGTTAAA
ATTCGCGTTAA-3’ (restriction sites are underlined). The amplified fragment was inserted in 
pSCA102 to create pSCA103 the same way as the previous fragment was inserted into 
pSCA101. All ligations were performed overnight at 16 °C using T4 DNA ligase. The 
constructed plasmids can be seen in Table 4.1 and the plasmid maps in Figure 4.3. 
All transformations of S. cerevisiae were done using the lithium acetate and polyethylene glycol 
method according to Gietz and Woods (2002). Auxotrophic selection of the transformants was 
done on SC medium with the appropriate nutrients(s) omitted. Verification of the constructed 
strains was done by extraction of gDNA using the Wizard® Genomic DNA Purification Kit, 
Promega, Madison, WI, followed by PCR amplification of all the integrated ORFs. The 
constructed strains can be seen in Table 4.1. 
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Table 4.1 - Strains and plasmids. The table shows the acquired and constructed, strains and 
plasmids applied in this study. 
Strain Genotype Source 
Saccharomyces cerevisiae  
CEN.PK113-7D MATa MAL2-8
c
 SUC2 Dr. P. Kötter, Frankfurt, Germany. 
CEN.PK102-3A MATa MAL2-8
c
 SUC2 leu2 ura3 Dr. P. Kötter, Frankfurt, Germany. 
SimC013 MATa MAL2-8
c
 SUC2 
leu2::pRS405(LEU2) 
ura3::pSC203(TEF1p-CrtE-ADH1t 
PGK1p-CrtB-ACT1t TDH3p-CrtI-
CYC1t URA3) 
This study. 
SimC014 MATa MAL2-8
c
 SUC2 
leu2::pSCA101(TEF1p-CrtY-ADH1t 
LEU2) ura3::pSC203(TEF1p-CrtE-
ADH1t PGK1p-CrtB-ACT1t TDH3p-
CrtI-CYC1t URA3) 
This study. 
SimC015 MATa, MAL2-8
c
, SUC2, 
leu2::pSCA103(TEF1p-CrtY-ADH1t 
PGK1p-CrtZ-ACT1t TDH3p-CrtW-
CYC1t LEU2) ura3::pSC203(TEF1p-
CrtE-ADH1t PGK1p-CrtB-ACT1t 
TDH3p-CrtI-CYC1t URA3) 
This study. 
Escherichia coli  
MAX 
Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rk
-
, mk
+
) 
phoA supE44 λ- thi-1 gyrA96 relA1 
Life Technologies, Grand Island, 
NY. 
   
Plasmid name Origin/reference 
pSC203 Center for Microbial 
Biotechnology plasmid collection, 
DTU†. 
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pRS405 [Sikorski and Hieter, 1989] 
pSC011 Biotechnology plasmid collection, 
DTU†. 
pSC012 Biotechnology plasmid collection, 
DTU†. 
pSC013 Biotechnology plasmid collection, 
DTU†. 
pSCA101 This study. 
pSCA102 This study. 
pSCA103 This study. 
† Constructed by Simon Carlsen as part of his Ph.D. thesis work. 
 
 
Figure 4.3: Plasmid maps for the plasmids utilized in this study.  
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4.3.3 Carotenoid extraction 
The yeast strains (CEN.PK113-7D, SimC013, SimC014 and SimC015) were tested for their 
ability to produce carotenoids by growing them on 6 ml SC-LEU-URA in 14 ml Falcon 2059 
tubes, BD Biosciences, Sparks, MD. The cells were inoculated at OD600 = 0.1 from pre-cultures 
and incubated at 30 °C with 250 rpm orbital shaking for 2 days. The OD600 was measured 
spectrophotometrically, followed by harvesting of the cells. For verification of the carotenoids 
produced by the cells, 5 ml of the cultures were harvested, whereas for quantification, 1 ml of the 
cultures was harvested. The cultures were harvested by centrifugation at 3000 g for 10 min, 
washed with 1 ml phosphate-buffered saline (Cellgro®, Mediateach, Inc., Manassas, VA) and 
transferred to a 2 ml FastPrep® tube (MP Biomedicals LLC, Solon, OH). The cells were spun 
down at 18,000 g for 1 min and the phosphate-buffered saline removed. Two hundred μl acid 
washed glass beads (425-600 μm, Sigma-Aldrich®) and 1 ml of acetone was added to each 
FastPrep® tube. The cells were disrupted using a Savant FastPrep® FP120 Cell Disrupter (MP 
Biomedicals LLC.), and the extracts were filtered using a 13 mm syringe filter (w/ 0.2 μm PTFE 
filter, VWR, Radnor, PA). Finally 800 μl of each of the extracts were transferred to HPLC vials 
for further analysis. 
 
4.3.4 Carotenoid analysis and quantification by HPLC 
The HPLC analysis of the carotenoids was performed according to the method described by 
Rentel et al. (1998). The method was performed on a Shimadzu UFLC-LC-20AD equipped with 
an Agilent Hypersil AA-ODS column (5 μm, 2.1 x 200 mm) and appertaining guard column. 
Chromatograms were recorded using a SPD-M20A diode array detector, detecting at 474 nm 
together with scans obtained in the interval 350-550 nm. The chromatography was performed 
with a constant flow at 0.750 ml/min with the column at room temperature. Following injection 
of the sample the mobile phase was kept at 10 % water in acetone for 1 min, after which the 
acetone concentration was increased to 100 % using a linear gradient for 4 min. The 
concentration was kept at 100 % for 2 min, and subsequently decreased in 1 min to the initial 
concentration using a linear gradient followed by 2 min hold at this concentration before the next 
sample was injected. The method was validated using authentic standards of lycopene, β-
carotene and astaxanthin which were dissolved in acetone and mixed in a single HPLC vial. A 
dilution series of the carotenoid standard mix were made in triplicates and analyzed using the 
method described above to obtain correlations between the individual areas under the peaks with 
their corresponding carotenoid concentrations enabling quantification of carotenoids. 
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4.3.5 Fluorescence microscopy 
The yeast cells were inoculated in 5 ml SC-LEU-URA medium at OD600 = 0.1 and incubated 
overnight at 250 rpm orbital shaking. The cells from 1 ml of each culture was transferred to a 
micro centrifuge tube and harvested at 18,000 g for 1 min. The cells were washed with 
phosphate-buffered saline and re-suspended in 100 μl phosphate-buffered saline. Five μl of each 
cell suspension was transferred to a microscope slide and examined using the Nikon Eclipse 
TE200-S microscope, Nikon Inc., Melville, NY equipped with 100x objective and GFP band-
pass filter (GFP-B: EX480/40, DM505, BA535/50). Fluorescent images were acquired using 10 
sec exposure time and processed using the SPOT Advance
TM
 software, SPOT
TM
, Imaging 
Solutions, a division of Diagnostic Instruments, Inc., Sterling Heights, MI. 
 
4.3.6 Flow cytometry 
The yeast cells were grown the same way as for the fluorescence microscopy. The cells were 
washed with phosphate-buffered saline and re-suspended in phosphate-buffered saline at an 
approximate concentration of 1·10
6
 cells per ml. The cells were analyzed using the FACS caliber 
cytometer, BD Biosciences equipped with a 488 nm Argon-ion blue laser and the following 
filters: FL1: 530/30, FL2: 585/42, FL3: 670LP, FL4: 660/20, SSC (side scatter): 488/10. The 
acquired data was analyzed using the Cellquest
TM
 software, BD Biosciences. 
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4.4 Results and discussion 
4.4.1 Establishing carotenoid biosynthesis in S. cerevisiae 
S. cerevisiae strain CEN.PK102-3A was transformed with pSC203 and either pRS405, 
pSCA101, or pSCA103 to create SimC013, SimC014 and SimC015, respectively; these three 
carotenoid pigmented strains with characteristic phenotypes can be seen in Figure 4.4. 
 
 
Figure 4.4: Phenotypes of carotenogenic S. cerevisiae. A: SimC013 (lycopene producer), B: 
SimC014 (β-carotene producer) and C: SimC015 (astaxanthin producer). 
 
The lycopene mediated orange-red phenotype of SimC013 closely resembles the astaxanthin 
phenotype of SimC015, whereas the β-carotene phenotype of the SimC014 stands out with its 
orange-yellow color. To confirm that the principal carotenoids causing the phenotypes of 
SimC013, SimC014, and SimC015 are indeed lycopene, β-carotene, and astaxanthin, 
respectively, the three strains were grown in SC-LEU-URA medium, and the produced 
carotenoids were extracted into acetone and analyzed by HPLC. The data was compared to 
HPLC data for authentic carotenoid standards of the three compounds. The results of the HPLC 
analysis can be seen in Figure 4.5. 
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Figure 4.5: HPLC analysis of carotenoids. I: analysis of carotenoid standards in order to determine 
their retention time and absorbance spectra from 350-550 nm. The chromatogram was recorded at 
474 nm. A: astaxanthin, B: lycopene, and C: β-carotene. II: HPLC analysis of acetone extracts from 
CEN.PK113-7D, SimC013, SimC014 and SimC015. Chromatograms were recorded at 474 nm 
shown together with the absorption spectrum from 350-550 nm of each of the dominant carotenoid 
peaks. 
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Figure 4.5 shows that the retention time of the principal carotenoids produced by SimC013, 
SimC014, and SimC015 match the retention times of lycopene, β-carotene, and astaxanthin 
standards, respectively. Furthermore, the UV-spectrum of each carotenoid matches the UV-
spectrum of the carotenoid standard, hereby verifying that the produced compounds are identical 
to the carotenoid standards. The absorption spectra were also verified by comparison to their 
respective spectra found in the Carotenoids Handbook [Britton et al., 2004]. The HPLC analysis 
of the SimC014 strain extract shows that there is residual lycopene which means that not all 
lycopene has been converted to β-carotene, and for the SimC015 strain extract both lycopene and 
β-carotene are also detected. This shows that the conversion of lycopene to β-carotene and 
further on to astaxanthin is incomplete. As expected, the extract from the negative control strain 
CEN.PK113-7D does not show any noticeable carotenoid production. 
The carotenoid concentrations in the extracts were quantified and can be seen in Table 4.2.  
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Table 4.2: Quantification of carotenoids extracted from SimC013, SimC014 and SimC015. The 
number following the (±)-sign is the standard deviations based on biological triplicates. 
 Specific titer in mg/l/OD600 
 Lycopene β-carotene Astaxanthin Total 
SimC013 0.284±0.026 ND ND 0.284 
SimC014 0.061±0.053 0.221±0.014 ND 0.282 
SimC015 0.102±0.021 0.087±0.013 0.288±0.004 0.477 
     
 Yield on biomass in mg/gDCW† (% of total) 
 Lycopene β-carotene Astaxanthin Total 
SimC013 1.05±0.096 (100) ND ND 1.05 
SimC014 0.225±0.196 (21.73) 0.815±0.052 (78.27) ND 1.04 
SimC015 0.376±0.077 (21.39) 0.321±0.048 (18.29) 1.06±0.015 (60.32) 1.76 
† Calculated based on the experimentally determined conversion factor for the spectrophotometer 
(0.271 gDCW/OD600/L). 
ND = not detectable. 
 
The presence of intermediate metabolites in SimC014 and SimC015 extracts could possibly be 
eliminated by modulating the expression level of the genes encoding the enzymes catalyzing the 
individual pathway steps. However, for this study it is sufficient that the carotenoid of interest 
constitutes the major fraction of the total carotenoid, and the fluorescent phenotype resulting 
thereof can be considered to result primarily from the principal carotenoid. The buildup of 
intermediates might create problems later on if it can be shown that one of the carotenoids can be 
used as a surrogate molecule to identify isoprenoid overproducers, since this might affect the 
response to changes in upstream metabolites by acting as a buffer system. 
The two small peaks appearing adjacent to the large main peak for astaxanthin in the SimC015 
extract are probably caused by pathway intermediates between β-carotene and astaxanthin, cf. 
Figure 4.2. It was not possible to identify the molecules eluting just after astaxanthin since no 
standards for the intermediate molecules were analyzed using our HPLC method. Even without 
adding the unidentified carotenoid peaks to the total produced carotenoids SimC015 produces 
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almost double the amount of carotenoids compared to SimC013 and SimC014. What causes this 
improvement is unknown, but it could be related to the change in hydrophobicity as a result of 
the addition of the 3/3’-hydroxyl and 4/4’-keto moieties. However, the total amount of 
astaxanthin produced by SimC015 is very similar to the total amount of lycopene produced by 
SimC013 and the total amounts of carotenoids produced by SimC014. This could suggest a 
capability of S. cerevisiae to store higher concentrations of less hydrophobic carotenoids. 
Verwaal et al. (2010) found that the production of lycopene and β-carotene in S. cerevisiae 
triggered the pleiotropic drug resistance genes, suggesting that carotenoid production confers a 
stress upon the cells. Their results additionally show that the stress might be membrane stress 
which corresponds well with the hydrophobic nature of lycopene and β-carotene; this 
observation, could be related to SimC015’s ability to produce a higher total amount of 
carotenoids. 
In a previous study, Verwaal et al. (2007) have shown that S. cerevisiae were capable of 
producing up to 5.9 mg/gDCW β-carotene demonstrating that S. cerevisiae is capable of 
producing and storing higher amounts of β-carotene than what was produced by our strain. It 
should be noted that this production level was obtained in a strain engineered to overexpress the 
truncated HMG1 gene encoding the HMG-CoA reductase and that the carotenoid pathway had 
been balanced by expression of an extra copy of the CrtI gene. Without balancing the carotenoid 
pathway they were able to produce 0.5 mg/gDCW β-carotene, and their strain without balancing 
the carotenoid pathway but with the tHMG1 gene overexpressed produced 1.6 mg/gDCW. These 
results indicate that we should be able to further increase the β-carotene production if necessary. 
Using codon optimized bacterial carotenogenic genes it has been shown that C. utilis can be 
engineered to produce 1.1, 0.4, and 0.4 mg/gDCW lycopene, β-carotene, and astaxanthin, 
respectively [Miura et al., 1998]. The lycopene amount produced is very similar to the amount 
we have obtained, whereas β-carotene and astaxanthin is approximately half of what we have 
obtained. They utilized carotenogenic genes codon optimized for C. utilis based on the crt-genes 
from P. ananatis and A. aurantiacum. This emphasizes the importance of choosing the best 
genes to base the codon optimized genes upon. We employed genes codon optimized based on 
the crtZ and crtW from Brevundimonas sp. SD212 which have previously been found to be more 
effective in heterologous production of astaxanthin in E. coli. Ukibe et al. (2009) tested non-
codon optimized genes of both yeast (X. dendrorhous) and bacterial (Paracoccus sp. 
NBRC101723 and P. ananatis) origin. They obtained the best astaxanthin production with the 
CrtS and CrtR genes from X. dendrorhous (0.12 mg/gDCW). With the bacterial genes they were 
able to obtain 0.029 mg/gDCW astaxanthin. Since this is the only other example found in 
literature, our strain is, to date, the best S. cerevisiae strain at producing astaxanthin. The best X. 
dendrorhous mutants isolated by FACS by An et al. (1991) produced between 0.39 and 1.25 
mg/gDCW total carotenoids (carotenoid distribution has not been specified) whereas the best 
mutant isolated by FACS by Ukibe et al. (2008) produced 0.50 mg/gDCW astaxanthin. The wild 
type from which this mutant originates produced 0.13 mg/gDCW astaxanthin. It has hereby been 
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shown that the SimC013, SimC014, and SimC015 strains produce principally the carotenoids 
which they were engineered to produce in amounts comparable to the astaxanthin production 
level of X. dendrorhous strains used for FACS. Therefore, these strains served as the basis for 
testing in vivo fluorescence of the three carotenoids in order to determine whether they can be 
used as surrogate metabolites in FACS screening for isoprenoid overproducing S. cerevisiae 
strains. 
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4.4.2 Fluorescence microscopy  
To test if the constructed strains exhibited fluorescence due to the production of their respective 
carotenoid, they were subjected to investigation by fluorescence microscopy using the filter 
normally applied for green fluorescent protein (GFP) and compared to the negative control 
CEN.PK113-7D. The result can be seen in Figure 4.6. 
 
 
Figure 4.6: Fluorescence microscopy of S. cerevisiae cells. A: CEN.PK113-7D, B: SimC013, C: 
SimC014 and D: SimC015. The pictures were obtained using the Nikon Eclipse TE200-S 
microscope equipped with 100x objective and GFP band-pass filter (GFP-B: EX480/40, DM505, 
BA535/50). The exposure time was set to 10 sec. 
 
The filter setup normally applied for GFP was chosen because β-carotene and astaxanthin are 
exited in the same wavelengths as GFP. This filter setup does however only allow for the capture 
of fluorescence within the range of the emission filter (BA535/50). This filter value is on the low 
side of the emission peak for both β-carotene and astaxanthin where the fluorescence is low, cf. 
Figure 4.1. The data shows that all the carotenogenic strains exhibit fluorescence in small foci 
within each cell. This finding corresponds well with the finding by Davoli and Weber (2002), 
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who found that the β-carotene produced by S. roseus was stored within lipid droplets. 
Surprisingly, SimC013 also exhibits fluorescence even though lycopene is not reported to be 
fluorescent. These results suggest that the fluorescence observed in Figure 4.6: B, C and D are 
caused by the polyene backbone which all three carotenoids have in common. Carotenoids do in 
general exhibit very low fluorescence [Davies 1976], which would explain the high exposure 
time required to obtain the fluorescent images. The high exposure time does of course raise the 
issue of photo bleaching, but no photo bleaching was observed; at lower exposure times the 
fluorescence was too weak to obtain proper images. A possibility could be that the fluorescence 
is caused by other molecules produced by S. cerevisiae. However, this is probably not the case 
since the negative control does not display any fluorescence, and naturally occurring molecules 
known to exhibit fluorescence such as NAD
+
, NADH, tyrosine and tryptophan do not fluoresce 
noticeable in the applied wavelengths [Lohmann et al., 1988]. If the fluorescence cannot be 
attributed directly to the production of the carotenoids it has to be caused by another fluorescent 
molecule induced by the production of the carotenoids. The most likely explanation is that the 
fluorescence wavelengths inspected with the filter setup for GFP mainly has to be attributed to 
the polyene backbone. An et al. (2000) applied confocal laser microscopy to determine the 
carotenoid concentrations of individual X. dendrorhous cells. In this endeavor they applied 488 
nm argon ion laser and a 515 LP filter. They found a correlation between total carotenoid content 
and the carotenoid-mediated fluorescence. Their choice of excitation wavelength corresponds 
well with our choice of excitation filter, but their emission filter allowed for higher wavelengths 
to be examined. Our emission filter should be best suited for β-carotene since astaxanthin has a 
maximum emission at higher wavelengths. We were unable to test higher emission wavelengths 
at the same excitation wavelengths since the filters for our fluorescence microscope are 
constructed in fixed sets encompassing an excitation filter and an emission filter. It will be 
possible to address this issue when analyzing the strains by flow cytometry. 
 
4.4.3 Flow cytometry of carotenoid producing S. cerevisiae 
The constructed strains together with the negative control CEN.PK113-7D were subjected to 
analysis by flow cytometry. The analyzed populations were gated based on their forward and 
side scatter. For each strain, 15,000 occurrences within the gate were recorded. The results can 
be seen in Figure 4.7. 
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Figure 4.7: Flow cytometry results. SimC013, SimC014, SimC015, and CEN.PK113-7D were 
subjected to analysis by flow cytometry. The results are show as histograms for the forward and 
side scatter together with the fluorescence filtered using the following filters: 530/30, 585/42, 670LP, 
and 660/20. 
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From the forward scatter and side scatter histograms, it can be seen that the width of the 
distributions are the same for all four strains which is due to the populations being gated based 
on these two parameters. The distribution of the three carotenogenic strains for the forward 
scatter and side scatter are very similar, whereas the distribution for CEN.PK113-7D is very 
different from these three. This suggests that the production of carotenoids impact the yeast cell 
morphology. How carotenoids mediate this effect on cell morphology is unknown. 
For the 530/30 filter it can be seen that SimC014 has a distribution with slightly higher 
fluorescence. This corresponds well with the fluorescence spectra of β-carotene. At this filter 
SimC015 does not show any difference from CEN.PK113-7D. SimC013 actually has a lower 
fluorescence than the CEN.PK113-7D which does not correspond with the result obtained from 
fluorescence microscopy. What the cause is for this decreased fluorescence is unknown, but it 
could have to do with the light absorbing properties of lycopene. Only very small differences in 
the distributions of the strains can be observed with the 585/42 filter, which is quite surprising 
since this is the range of wavelengths where astaxanthin and hereby SimC015 were shown to 
fluoresce. SimC015 has a bit higher fluorescence than SimC014 and CEN.PK113-7D but a 
fluorescence distribution similar to SimC013. For the 670LP filter SimC015 stands out from the 
three other strains with a slight increase in fluorescence. This corresponds well with the shift in 
fluorescence towards higher wavelengths caused by the keto moieties added to β-carotene in the 
formation of astaxanthin. No differences between the strains are observed for the 660/20 filter. 
However, it appears that each strain is encompassed by two discrete populations, namely one 
with high fluorescence and one with low fluorescence. It is unknown what the cause of this 
bifurcation is, but it appears to be unrelated to carotenogenesis since it is also exhibited by 
CEN.PK113-7D. The populations can also be viewed in 2D-cytograms of the aforementioned 
parameters. We tested all possible combinations of the parameters (data not shown), but none of 
these allowed efficient discrimination between the strains.  
The differences observed between the populations are too minute to distinguish between the 
strains, hereby making the sorting of cells using FACS almost impossible. The flow cytometer 
was operated at its most sensitive setting which means that it will be impossible to improve the 
separation of the population by changing the settings of the voltages and gains of the 
photomultiplier tubes. FACS has never been applied to carotenogenic S. cerevisiae, but examples 
of its application in selecting carotenoid overproducers from chemical mutagenesis libraries of X. 
dendrohous have been published. An et al. (1991) used a 530/30 filter for which they obtained 
cytograms as functions of forward scatter. This range of wavelengths corresponds best with the 
fluorescence of β-carotene but overlaps with the lower end of astaxanthin’s fluorescence 
wavelengths. The application of cytograms as functions of forward scatter allowed them to 
assess the fluorescence as a function of cell size. This is important when screening for carotenoid 
overproducers because carotenoids are stored intracellularly and larger cells therefore should be 
able to accumulated higher amounts of carotenoids; however, it does not necessarily means that 
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they exhibit a higher biomass yield of the carotenoids. By applying this technique they were able 
to isolate X. dendrohous carotenoid overproducers, but they did not discriminate between the 
produced carotenoids. Their results correspond with our data showing a higher fluorescence for 
the β-carotene-producing SimC014 strain when we applied the 530/30 filter. However, we were 
unable to discriminate between the populations when we plotted our data in a forward scatter: 
530/30 cytogram. 
Ukibe et al. (2008) applied several filters (FL1: 490-550, FL2: 570-580, FL3: 600-620, and FL4: 
665-685 nm) to analyze chemical mutant libraries of X. dendrohous. By applying diphenylamine 
to inhibit the conversion of β-carotene to astaxanthin, they showed that FL1 correlates well with 
β-carotene content, whereas the astaxanthin content correlated best with the FL4. They then 
applied a FL1:FL4 cytogram to select for astaxanthin overproducers. This method does not take 
cell size into account and thereby not directly assess the astaxanthin biomass yield, but rather the 
conversion of β-carotene to astaxanthin. Their FL1 and FL4 results do correlate well with our 
FL1 and FL3 results, cf. Figure 4.7. Their method was not direct sorting where only the best cells 
are obtained but rather a way of enriching the population after which they had to go through a 
manual selection step where the best astaxanthin producers were picked from agar plates based 
on their increased coloration. The low fluorescence of carotenoids seems to hamper the 
application of FACS for efficient sorting of carotenoid overproducers, which is supported by our 
results, and until an isoprenoid molecule with higher fluorescence is identified, FACS will 
probably remain solely a way of enriching a library. The ideal situation would be if the biomass 
yield of the fluorescent compound could be effectively assessed using a forward 
scatter:fluorescence cytogram and hereby sorted. If this is not possible enrichment by FACS has 
to be coupled with other methods which in conjunction would allow the efficient screening for 
isoprenoid overproducers. Based on our results we decided not to pursue this screening method 
any further since the gain of applying this method would be too small and the method by itself 
would not be effective enough. It was therefore decided to pursue other methods for screening 
for isoprenoid-overproducing S. cerevisiae mutants. 
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5.1 Abstract 
5.1.1 Background 
Despite some decades of various chemical and biological approaches to the search for novel 
pharmaceutical lead compounds, secondary metabolites remain a strong focus for this activity. 
Most secondary metabolites are only scarcely available in their native production organism, a 
fact that can be resolved by production in engineered microbes. Fortunately, most secondary 
metabolites are biosynthesized from very few precursor metabolites. The largest group of 
secondary metabolites known today is the isoprenoids, encompassing more than 55,000 
identified compounds. The main target in optimizing microorganism for production of 
isoprenoids is to generate microorganisms with a high flux towards the ubiquitous isoprenoid 
precursor isopentenyl pyrophosphate (IPP). In this endeavor the isoprenoid surrogate red 
pigment lycopene has been extensively applied in Escherichia coli due to the relative ease of 
which the red phenotypes caused by its production can be screened. However, visual inspection 
in this approach is labor intensive and subject to errors caused by individual perception of colony 
color. In addition, colonies of many microorganisms, e.g., Saccharomyces cerevisiae, are less 
transparent than those of E. coli, a fact that further hampers visual inspection. 
 
5.1.2 Results 
We have developed a simple image analysis method based on a digital camera for image 
acquisition and the open source software ImageJ 1.44 capable of identifying S. cerevisiae 
colonies with increased red colony coloration due to increased production of lycopene. We found 
that the lycopene production correlates with the extracted color intensities using a strain 
engineered to produce lycopene at various levels as a function of the copper concentration in the 
medium. We finally used the method to screen 15,000 transformants diversified with a 
Saccharomyces kluyveri cDNA library. 
 
5.1.3 Conclusions 
The method presented here is capable of selecting colonies with increased lycopene production 
from images of agar plates with 300 individual colonies. We expect that the demonstration of 
effectiveness of this method will lead to the development of novel isoprenoid production host 
systems and aid in the proof-of-concept for new methods and techniques. We see the method as a 
first step towards a fully automated screening process for microbes overproducing IPP. 
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5.2 Background 
In view of the limited success of approaches like combinatorial chemistry in providing novel 
pharmaceutical lead compounds, natural products have received renewed attention as a hunting 
ground for novel chemical scaffolds that can be modified into the next blockbuster 
pharmaceuticals. It is realized that there is an increased probability of identifying biologically 
active compounds from a pool of molecules that during the course of evolution have been 
selected for based on their ability to interact with biological systems [1,2,3]. The redirected 
search strategy in combination with the inherent complexity of secondary metabolites, as well as 
the low amounts available from the native production organisms, has created a number of 
challenges related to the need of obtaining sufficient amounts of the desired compounds. One of 
the most promising strategies for their large-scale production is biosynthesis through 
fermentation with microorganisms engineered with heterologous genes. This approach offers 
several advantages over chemical synthesis, e.g. environmental friendliness and stereo selectivity 
[4]. 
Since evolution has structured the production of secondary metabolites to occur from common 
ubiquitous precursor metabolites, microorganisms already have most of the metabolic machinery 
required for heterologous biosynthesis. However, the engineered microorganisms still require 
optimization of the supply of precursor metabolites available for product biosynthesis, but since 
the secondary metabolite generally does not give any growth advantage, selection of improved 
production phenotypes becomes difficult or infeasible. In fact, heterologous production of 
secondary metabolites frequently results in a growth disadvantage, since it removes precursors 
needed elsewhere in the cell, thereby creating a metabolic burden. Even though selection is 
preferred over screening, the absence of secondary metabolites with selectable properties 
necessitates the use of surrogate compounds that can facilitate screening [5]. A microorganism 
can through genetic modifications and screening based on the properties of the surrogate 
compound be converted into a production platform organism with a high metabolic flux towards 
a common precursor that can subsequently be diverted to the biosynthesis of the actual product 
of interest. A wealth of methods for creating genetic modifications and diversity has been 
developed, which encompasses both combinatorial and random approaches [6]. However, within 
this field the use of screens based on surrogate compounds is less developed. 
One of the most often applied isoprenoid surrogate compound is lycopene, which owes its red 
color to the 11 conjugated double bonds absorbing light within the visual range yielding the red 
phenotype of microorganisms producing it [7]. Lycopene has as a reporter metabolite been 
instrumental for the success of several metabolic engineering studies, proof-of-concept studies 
and development of new methods. Lycopene has been applied in studies spanning all the way 
from random mutagenesis of single protein targets [8], over the effect of chromosomal mutations 
on plasmid copy number [9], stoichiometric modeling [10], combinatorial effects of deletions 
and overexpression targets [11], to the screening of gDNA- [12], cDNA- [13], transposon 
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mutagenesis- [14], and global transcription factor engineering-libraries [15]. All the 
aforementioned studies were performed in E. coli by visual inspection of the degree of red 
colony coloration caused by changes in the amount of lycopene produced. Lycopene and other 
carotenoids have also been heterologously produced in S. cerevisiae [16], but they have to our 
knowledge not been used for identification of novel targets for improving isoprenoid production 
in this organism. The reason may be that S. cerevisiae forms more opaque colonies, in which it is 
more difficult to visually assess the lycopene coloration level. Therefore a more sensitive method 
for assessing colony coloration becomes imperative. 
We here present a simple image analysis method for identifying S. cerevisiae colonies with 
increased red pigmentation due to increased production of lycopene. The method is based on 
acquisition of digital images of yeast colonies on agar plates with a standard digital camera and 
analysis with the open source image analysis software ImageJ 1.44 [17]. Besides showing the 
relationship between the yield of lycopene on biomass yield and the colony coloration calculated 
by the software, we also apply this method for screening of a Saccharomyces kluyveri cDNA 
library expressed in S. cerevisiae. 
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5.3 Results 
5.3.1 Construction of a yeast strain capable of controlled lycopene production 
To be able to vary the levels of lycopene produced by S. cerevisiae, we constructed strain 
SimC001, in which the three genes encoding the lycopene pathway are integrated in the URA3 
locus with the first step, geranylgeranyl pyrophosphate (GGPP) synthase, encoded by the CrtE 
gene, under control of the Cu
2+
 inducible CUP1 promoter. The strain was tested for its ability to 
produce increasing amounts of lycopene as a function of the Cu
2+
 concentration by streaking it 
out on SC-URA plates containing different concentrations of copper sulfate, between 0.25 and 
200 μM. Colonies were compared to those of the prototrophic non-lycopene producing isogenic 
control strain CEN.PK113-7D. Figure 5.1 shows that the red colony coloration caused by 
lycopene indeed increases as the copper sulfate concentration is increased. Furthermore, it can be 
seen that the colony color of the control strain changes from white to brownish at the highest 
copper sulfate concentration. This may potentially interfere with the color intensity assessment, 
since for the SimC001 the coloration at this concentration would be a result of both the lycopene 
and the stress induced coloration. However, the SimC001 strain should enable us to establish a 
relationship between the lycopene yield on biomass and the colony coloration. 
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Figure 5.1 - Induced changes in lycopene mediated colony coloration. Colonies of SimC001 (A) and CEN.PK113.7D (B) grown on SC-
URA with different copper sulfate concentrations. The copper sulfate concentrations in the agar plates applied are indicated above the 
respective colony-pictures. 
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5.3.2 Image acquisition and analysis 
To compare the color intensities in digital images of yeast colonies growing on agar plates we 
made a simple setup based on a standard digital camera, camera mount, black cardboard 
background and extra ambient lighting (Figure 5.2). This setup allowed us to acquire images of 
the Petri plates under constant conditions. 
 
Figure 5.2 - Camera setup. Setup for acquisition of images of agar plates. A, digital camera; B, 
camera mount; C, black background; D, lights. 
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To generate agar plates with approximately 300 yeast colonies on each, strain SimC001 was 
grown in liquid SC-URA until OD600 = 1, diluted and spread on large SC-URA Petri plates (150 
mm diameter) with the same copper sulfate concentrations as indicated in Figure 5.1. Plates were 
incubated at 30 °C for 3 days and photographed. Figure 5.3 shows an example of a plate image 
and its processing. The images were analyzed using the ImageJ 1.44 software as follows. The 
original image (Figure 5.3A) was split into its RGB-channels, which resulted in grayscale images 
(Figure 5.3B, 5.3C and 5.3D), corresponding to the red, green and, blue channels, respectively. 
Hereafter the green and the blue image were subtracted from the original image, which resulted 
in an image that in this example can be seen in Figure 5.3E. In order to enable ImageJ to analyze 
the images a threshold has to be specified, which resulted in final images corresponding to the 
example in Figure 5.3F. 
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Figure 5.3 - Image processing by ImageJ 1.44. Images showing the steps of the algorithm for 
processing the original picture to obtain the final picture, which can be analyzed for the red color 
intensities of the colonies. A, Original image of an agar plate with SimC001 growing on SC-URA + 
100 μM CuSO4. By splitting the original image into its RGB channels the images corresponding to 
the red (B), green (C), and blue (D) channels were obtained. Image E was obtained by subtracting 
the green (C) and blue channel (D) from the original image (A). Image F was obtained by defining 
the threshold required for further analysis of the image. 
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Using ImageJ’s built-in function called ‘Analyze Particles…’ we obtained values for the size (in 
pixels), and the average color intensity (intensity units per pixel) of each colony together with 
coordinates describing its location (Figure 5.4). 
 
Figure 5.4 - Output image of colonies analyzed for size and red color intensity. After processing to 
obtain red color intensities, the ‘Analyze Particles…’ function in ImageJ 1.44 yields an image as the 
one shown here, where all the analyzed elements are numbered, as well as a table that shows values 
for size and average red color intensity corresponding to each of the numbered elements. 
 
These operations were performed for all plates with the different copper sulfate concentrations 
and we calculated the mean of the average color intensity values and standard deviation thereof 
at each copper sulfate concentration. The results (Figure 5.5A) fit a linear relation between the 
logarithm of the copper sulfate concentration and the mean of the average red colony color 
intensities at all concentrations except 200 μM. 
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5.3.3 Correlation of the yield of lycopene with red colony color intensity 
To correlate colony color intensities with the amount of lycopene produced we grew SimC001 in 
triplicate liquid SC-URA cultures with each of the copper sulfate concentrations used for the 
colony color intensity analyses. The strain was grown until stationary phase, and the lycopene 
was extracted with acetone and quantified by absorbance at 474 nm and converted to 
concentrations by the use of a standard curve made from pure lycopene dissolved in acetone. 
Figure 5.5B shows that also the lycopene yield correlates almost linearly with the logarithm of 
the copper sulfate concentration, except at 200 μM. 
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Figure 5.5 - Colony color intensity and lycopene yield as functions of Cu
2+
 concentrations. S. 
cerevisiae strain SimC001 was studied for its ability to produce lycopene and for the associated 
colony color intensities as functions of Cu
2+
 concentrations in liquid and solid media, respectively. 
A: plates containing copper sulfate at concentrations of 1.5625, 3.125, 6.250, 12.50, 25.00, 50.00, 
100.0 and 200.0 μM, respectively, were inoculated with approximately 300 colony forming units of 
SimC001. Images were recorded and analyzed, and the average red color intensity of all the 
colonies on each plate was plotted as function of the Cu
2+
 concentration (error bars indicate 
standard deviation of the mean; the number of colonies analyzed were 287, 326, 376, 358, 358, 358, 
337 and 201, respectively. B: strain SimC001 was grown in triplicate in 5 ml liquid SC-URA with 
each of the Cu
2+
 concentrations applied for the agar plates. After all growth had ceased the 
lycopene concentration normalized with OD600 was measured for each culture and plotted as a 
function of the Cu
2+
 concentration (error bars indicate standard deviation of the mean, n=3). 
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We plotted the red color intensities of the colonies as a function of the lycopene concentration 
(Figure 5.6A) and found that a second-order polynomial can approximately describe their 
relationship. However, one can choose a large sub-interval of lycopene concentrations where this 
relation can be taken to be linear (Figure 5.6B). These results show that our image analysis 
method can pick up differences in colony coloration as function of the different amounts of 
lycopene produced and thus that the method has the potential of being used for screening 
libraries for colonies with increased lycopene production. 
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Figure 5.6 – Correlation of colony color intensity with lycopene yield. Red colony color intensity 
and lycopene concentration normalized with OD600 were plotted against each other for each of the 
eight Cu
2+
 concentrations. Error bars indicate standard deviations of the means. A: entire interval 
of tested values fitted to a second order polynomial relation between red color intensities and 
lycopene concentrations normalized with OD600. B: After removal of the outermost value from each 
side the relation can be fitted to a linear equation. The vertical line indicates the value of the 
reference strain SimC002 transformed with the pRS414TDH3 control plasmid. 
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5.3.4 cDNA library screening 
In order to challenge our method in an actual library screening, we constructed a cDNA library 
from S. kluyveri, inserted in a single-copy vector under control of the TDH3 promoter. The 
plasmid furthermore carried the TRP1 gene for auxotrophic selection. To test the quality of the 
library, 20 E. coli colonies were picked during the library construction, whereof 14 were found, 
by sequencing, to harbor a plasmid containing S. kluyveri cDNA (result not shown). 
Furthermore, the library was tested in S. cerevisiae by transforming strain CEN.PK113-5D with 
the cDNA library; by plating the transformants on SC-URA we selected 6 colonies from all of 
which plasmids harboring the S. kluyveri URA3 gene were identified by sequencing (results not 
shown). 
To investigate the effects of the cDNA library on the production of lycopene in an engineered S. 
cerevisiae, we constructed strain SimC002, which has the trp1 auxotrophic marker and carries 
the genes encoding the lycopene pathway, inserted in the URA3 locus, with the first step under 
control of the constitutive TEF1 promoter. Strain SimC002 was transformed with the cDNA 
library, and the pRS414TDH3 empty vector as a control, and the transformed cells were spread 
on 55 large (150 mm diameter) Petri dishes containing SC-TRP-URA, 50 plates for the library 
and 5 for the control. The plates were incubated for 3 days at 30 °C, whereafter they were 
photographed for analysis as described above. The 5 colonies scoring highest in the analysis 
were picked from each plate together with 5 randomly picked colonies. These colonies were 
transferred to new SC-TRP-URA plates and incubated for 2 days at 30 °C. Each isolate was 
inoculated into 5 ml of liquid SC-TRP-URA and grown at 30 °C for 2 days. The OD600 was 
measured and 5 ml of fresh SC-TRP-URA were inoculated at OD600 = 0.1 from each pre-culture. 
These cultures were grown until all growth had ceased; the OD600 was measured, and the 
lycopene was extracted and quantified. The mean lycopene concentration normalized with OD600 
for the randomly selected strains transformed with the empty vector (pRS414TDH3) can be seen 
plotted as a vertical line in Figure 5.6B. Figure 5.7A presents a box-plot of the measured 
lycopene concentrations normalized with OD600 for both the software-selected and the randomly 
selected control and library strains. It is seen that the software works better than random 
sampling of colonies. This is more pronounced for the strains transformed with the library than 
with the empty vector, as expected due to the higher variation. To test how significant these 
differences are, we conducted a two-sample t-test from which it for the strains transformed with 
the control plasmid was found that the software selected isolates have a higher mean value with a 
p-value of 4.65 %, whereas for the library transformed strains as well were found that the 
software selected isolates have a higher mean than the randomly selected with a p-value of 3.23 
.
10
-35
. This shows that to the software selection allows isolation of transformants with a higher 
yield of lycopene on biomass. Figure 5.7B shows that the colonies selected from the strain 
transformed with the library using the software in general gives a higher lycopene yield on 
biomass. 
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Figure 5.7 – The ability of software-aided selection to pick out S. cerevisiae colonies with increased 
lycopene yield. 25 colonies randomly picked and 25 colonies picked by software-aided selection 
from the SimC002 strain transformed with the pRS414TDH3 plasmid were analyzed for their level 
of lycopene production. The same was done for 250 colonies randomly picked and 250 colonies 
picked by software-aided selection from the SimC002 strains transformed with a S. kluyveri cDNA 
library. A: Box-plot of the lycopene concentrations normalized with OD600. B: Sorted values for the 
library screen; red bars indicate the values for the colonies randomly selected; blue bars indicate 
the values for the colonies picked by software-aided selection. 
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5.4 Discussion 
Strain SimC001, capable of producing lycopene at variable levels as a function of the cupric ion 
concentration in the medium, has helped us investigate the relationship between lycopene 
production and red colony coloration. However, this strain still contains the BTS1 gene, encoding 
S. cerevisiae’s native GGPP synthase, which means that the production of lycopene cannot be 
fully turned off. Nevertheless, this has little impact on the overall strain performance since the 
activity of the native GGPP synthase is much lower than the codon optimized CrtE gene within 
the range of copper sulfate concentrations relevant in this study. However, it may explain why 
linear extrapolation of the curves presented in Figure 5.5 does not intersect the y-axis in the 
origin. It turned out that red color intensities and lycopene concentrations normalized with OD600 
are linear with the logarithm of copper ion concentration within most of the tested range. A 
reason for the limited range of linearity could be the characteristic sigmoidal transcription profile 
of the CUP1 promoter [18], which would explain the linearity at intermediate Cu
2+
 
concentrations and deviations from linearity at both high and low concentrations. This should 
however not impact the linearity of red colony color intensities as function of lycopene 
production, since the color intensity should be a function of the produced lycopene. Figure 5.6B 
shows that an interval of lycopene concentrations normalized with OD600 can be chosen for 
which the red color intensity can be taken to be linear (0.15 – 0.4 mg/l/OD600). Verwaal et al. 
[19] demonstrated that carotenoids produced in high amount in S. cerevisiae triggers the 
pleiotropic drug resistance genes, probably due to membrane stress, which could also impact the 
relationship between lycopene production and the intensity of red colony coloration. At high 
lycopene values it would also be expected to find some deviations due to saturation of light 
absorption. 
Figure 5.6B shows that strain SimC002 transformed with a control vector produced lycopene 
within the linear range and hereby serves as a good starting point for the testing of the ability of 
our methods to screen a cDNA library. Within this range a response factor can be calculated as 
the reciprocal value of the slope of the fitted line, i.e., the change in lycopene production 
required to increase the intensity of red colony coloration by 1 intensity unit, calculated to be 
0.0306 mg/l/OD600. We tested the ability of the method to screen a population of lycopene 
producing yeast strains either transformed with the empty vector or the S. kluyveri cDNA library 
made with the same vector and indeed found a higher variation for the library, which should 
create a more diverse population, than for the control plasmid, which should give a more 
homogenous population (Figure 5.7A and the result of the t-test). Even though the cells within 
the control population are all transformed with the same plasmid, small differences do occur. The 
fact that we with the software were able to pick 25 colonies from this transformation that had a 
slightly higher mean lycopene production than 25 randomly picked colonies shows the 
importance of clonal selection. For the library transformants it was expected that most of the 
plasmids would either have a negative effect or no effect on lycopene production, which was in 
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agreement with the lycopene production values shown on the box-plot (Figure 5.7A). The t-test 
shows with a very low p-value that the mean lycopene production for the colonies picked using 
the software from the library transformants is definitely higher than the ones picked randomly. 
From Figure 5.7B it is also clear that the majority of the colonies picked by the software are in 
the high end, whereas the majority of the randomly picked colonies give low production. In 
general, the highest lycopene producers were identified using the software. However, we were 
only able to identify mutants with a marginal increase in lycopene production from the cDNA 
library over the control strain. This was probably due to the lycopene pathway being limiting, as 
the experiments with the CUP1 promoter showed that a higher lycopene production can be 
obtained, and suggested that the CUP1 promoter at high Cu
2+
 concentrations was stronger than 
the TEF1 promoter. Whether this limitation can be alleviated by increasing the copy number by 
e.g. using a 2μ-based vector for the expression of the genes encoding the lycopene pathway was 
not investigated. 
Image analysis has been used in a wide array of applications from determination of heterogeneity 
of cultured strawberry-cells [20] to identification of Penicillum species [21]. However, image 
analysis has not yet gained footing within surrogate compound screening for identification of 
secondary metabolite overproducing microorganisms, but with high resolution digital cameras 
becoming a commodity, and with high availability to image analysis software, simple approaches 
like the method we have presented here will definitely become more widespread.  
Visual screens with lycopene as surrogate molecule have been extensively applied; cf. 
introduction part of this article, but they are laborious, requiring inspection of many agar plates 
to assess the lycopene mediated colony coloration. With the method presented here screening is 
faster, and one does not have to worry about the subjective color perception of the person 
performing the screen. Nevertheless, our method cannot be considered a high-throughput 
method. We screened approximately 15,000 transformants from the cDNA library, which even 
with this method is a laborious task. However, the method should be easily automated, and if 
combined with a colony picking robot, it would result in a true high-throughput screen. 
Another screen which relies on colony coloration is for the primary metabolite L-tyrosine. In that 
screen the L-tyrosine is converted to the black pigment melanin, which enables visual 
identification of over-producing E. coli colonies [22]. Such screens can be adapted with the 
image analysis method presented here, thereby improving the throughput.  
Many colored metabolites can be found in nature and many of these could potentially serve as a 
surrogate molecule for screening for increased precursor availability of a certain group of 
secondary metabolites. The method presented here should be applicable to most metabolites that 
give a change in colony color correlating with its production level when expressed in a colony 
forming microorganism could potentially be screen via our method. 
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5.5 Conclusions  
We have shown that the method presented here can be applied for screening a population of 
microbial colonies producing the red pigment lycopene and hereby selecting the individual 
colonies with increased red coloration. The method could easily be automated and could 
therefore serve as the initial step towards a fully automated screen. Lycopene has previously 
demonstrated its worth as a surrogate molecule in several manual screens by visual inspection of 
E. coli colonies, and with the method presented here this approach can easier be applied not only 
for E. coli but in a wide range of microorganisms. 
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5.6 Methods 
5.6.1 Enzymes, chemicals and media 
All enzymes were purchased from New England Biolabs Inc., Ipswich, MA and all chemicals 
from Sigma-Aldrich®, St. Louis, MO, unless otherwise stated. E. coli was grown in BD Difco
TM
 
LB broth from BD Diagnostic Systems, Sparks, MD, and for plasmid selection ampicillin was 
added to a final concentration of 100 mg/l. S. cerevisiae was grown on SC medium with the 
appropriate nutrient(s) omitted. This medium was composed of 6.7 g/l Yeast Nitrogen Base 
(YNB) without amino acids, and also without copper for the copper induction experiment, 
Sunrise Science Products, Inc., San Diego; CSM – amino acid dropout mixture (amount 
according to manufacturer’s recommendation), Sunrise Science Products, Inc., San Diego, CA; 
and 20 g/l dextrose. In order to make solid medium for the copper induction experiment, 
SeaKem LE agarose, Lonza Group Ltd. Basel, Switzerland was applied to avoid copper 
contamination from regular agar. S. kluyveri was grown in YPD, composed of 10 g/l Bacto
TM
 
yeast extract, BD Diagnostic Systems; 20 g/l Bacto
TM
 peptone, BD Diagnostic Systems; and 20 
g/l dextrose. 
 
5.6.2 Plasmids and strains 
All plasmids and strains applied in this study are presented in Table 5.1. The E. coli strains listed 
therein were only used for cloning purposes. Plasmid pSC203 was obtained from the plasmids 
collection at Center for Microbial Biotechnology at the Technical University of Denmark (DTU). 
This plasmid is based on the pRS406 plasmid from Mumberg et al., 1995 [23] and contains 
cassettes for expression of the three genes encoding the lycopene biosynthesis, namely the 
TEF1p-CrtE-ADH1t, PGK1p-CrtB-ACT1t and TDH3p-CrtI-CYC1t. The three genes were codon-
optimized for S. cerevisiae and synthesized by Entelechon GmbH, Regensburg, Germany, based 
on the following protein sequences from Pantoea agglomerans, CrtE (GGPP synthase) - 
GenBank: AAA24819.1, CrtB (phytoene synthase) - GenBank: AAA24821.1 and CrtI (phytoene 
dehydrogenase) - GenBank: AAA24820.1. Plasmid pRS414TDH3 was obtained as starting point 
for the construction of a S. kluyveri cDNA library. 
Strain SimC001 was constructed by transforming CEN.PK113-5D with plasmid pSC203 which 
was integrated in the ura3 locus and in the same time had the plasmid based TEF1 promoter 
substituted with the CUP1 promoter. This operation was performed using homologous 
recombination directly in S. cerevisiae, with three DNA fragments. The first two fragments were 
obtained by digesting pSC203 with StuI and ApaI endonucleases followed by purification by 
gel-electrophoresis. The StuI cleaves the URA3 marker to facilitate the genomic integration and 
the ApaI cleaves just downstream of the TEF1 promoter. The third DNA fragment was amplified 
from CEN.PK113-7D gDNA by PCR with primers containing adaptamers homologous to the 
Image analysis and lycopene production as tools in semi-high-throughput screening for isopentenyl 
pyrophosphate overproducing colonies of Saccharomyces cerevisiae 
 
 
178 
 
backbone of pSC203 just upstream of the ApaI recognition site and downstream of the TEF1 
promoter, respectively. It was verified by PCR that this transformation resulted in the integration 
of the three joined fragments in the ura3 locus of CEN.PK113-5D and the exchange of the TEF1 
promoter with the copper inducible CUP1 promoter. Strain SimC002 was constructed by 
transforming CEN.PK 113-9D with pSC203 which prior to the transformation had been digested 
with endonuclease StuI and purified by gel electrophoresis. 
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Table 5.1 - Strains and plasmids. Acquired and constructed strains and plasmids applied in this 
study. 
Strain Genotype Source 
Saccharomyces cerevisiae  
CEN.PK113-7D MATα MAL2-8c SUC2 Dr. P. Kötter, Frankfurt, Germany. 
CEN.PK113-5D MATα MAL2-8c SUC2 ura3 Dr. P. Kötter, Frankfurt, Germany. 
CEN.PK113-9D MATα MAL2-8c SUC2 trp1 ura3 Dr. P. Kötter, Frankfurt, Germany. 
SimC001 MATα MAL2-8c SUC2 
ura3::(CUP1p-CrtE-ADH1t 
PGK1p-CrtB-ACT1t TDH3p-CrtI-
CYC1t URA3) 
This study. 
SimC002 MATα MAL2-8c SUC2 trp1, 
ura3::pSC203 (TEF1p-CrtE-
ADH1t PGK1p-CrtB-ACT1t 
TDH3p-CrtI-CYC1t URA3) 
This study. 
Saccharomyces kluyveri 
NRRL12651 Wild type Dr. Felix Lam and Dr. Gerald Fink, 
Whitehead Institute, MIT, Cambridge, 
MA. 
Escherichia coli  
MAX 
Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rk-, 
mk+) phoA supE44 λ- thi-1 
gyrA96 relA1 
Life Technologies, Grand Island, NY. 
ElectroMAX™ 
DH10B™ T1 
Phage-Resistant 
Competent 
Cells 
F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZ ΔM15 ΔlacX74 recA1 
endA1 araD139 Δ(ara, leu)7697 
galU galK λ- rpsL nupG tonA 
Life Technologies, Grand Island, NY. 
   
Plasmid name Origin/reference 
Image analysis and lycopene production as tools in semi-high-throughput screening for isopentenyl 
pyrophosphate overproducing colonies of Saccharomyces cerevisiae 
 
 
180 
 
pSC203 Center for Microbial Biotechnology 
plasmid collection, DTU*. 
pRS414TDH3 Mumberg et al., 1995 [23]. 
* Constructed by Simon Carlsen as part of his Ph.D. thesis work. 
 
5.6.3 Image acquisition and analysis 
Images were acquired applying the setup shown in Figure 5.2. The setup is based on a camera 
mount to keep the distance between the camera and the agar plate constant, a Canon EOS Rebel 
XTi digital camera, extra lights to illuminate the agar plate, hereby avoiding the use of a flash, 
and a black background to minimize light reflected from the background. The camera was used 
with manual, constant settings. The images were saved in .jpg format. 
Images were analyzed with the ImageJ 1.44 software, using the standard functions available, 
which in the following are referred to with the functions and parameters shown in quotation 
marks. First the image was split into its red, green and blue (RGB) channels using the “Split 
Channels” function, and the green and blue images were subtracted from the original image 
using the “Image Calculator…” function. The resulting image was adjusted using the 
“Threshold…” function to remove any remaining background light. This was done by changing 
the threshold of the “Brightness” and keeping the settings for “Hue” and “Saturation” constant. 
We found that we got the best result with a “Brightness” threshold at 20, but this varies 
depending on the images so it should be determined for each series of images and hereafter kept 
constant for the analysis of this series of images. To analyze each of the colonies, we applied the 
“Analyze Particles…” function. Prior to applying this function we specified the desired output 
values in the “Set Measurements…” function. Here we checked the following options: Area 
(area of the analyzed particle), Mean gray value (the mean color intensity of the particle), 
Standard deviation (standard deviation corresponding to each of the mean color intensities), 
Shape descriptors (values for circularity, aspect ratio, roundness and solidity) and Limit to 
threshold (ensuring that only pixels with light intensities above the threshold are analyzed). The 
area and shape descriptor values are only used to determine the best value for identification of 
the colonies which needs to be specified in the “Analyze Particles…” function, thus allowing for 
the analysis of single colonies and the discarding of joined colonies and other artifacts occurring 
in the image. The main value of interest is the mean gray value, which is the value used directly 
as the red color intensity of each colony. We found that the following settings gave the best 
results when we applied the “Analyze particle…” function: Size range of the analyzed particles = 
200 – infinity (pixels) and circularity range = 0.7 – 1.0 (circularity is calculated as       
          
, 
where 0 corresponds to an infinitely elongated polygon and 1 to a perfect circle. We furthermore 
specified that the function should “show overlay masks” and checked the following boxes: 
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Display results (opens separate window with a results table), Clear results (removes results from 
the results table from previous analysis) and Exclude on edges (excludes particle touching the 
edge of the image from the analysis). After applying the “Analyze Particles…” function the 
results were transferred from the results table into Microsoft Excel for further analysis. The 
values were sorted using Excel to identify colonies with the highest red color intensity which 
was subsequently picked for further analysis. For further information please refer to the ImageJ 
1.44 user guide: http://rsbweb.nih.gov/ij/docs/user-guide.pdf. 
 
5.6.4 Lycopene extraction and quantification 
S. cerevisiae cultures producing lycopene were grown until stationary phase in 5 ml liquid SC 
medium with the appropriate nutrient(s) omitted. One ml from each culture was transferred to a 2 
ml FastPrep® tube, MP Biomedicals LLC, Solon, OH, and spun down at 18,000 g for 2 min. 
Medium was carefully removed with a pipette, and the cells were re-suspended in 1 ml acetone 
containing 100 mg/l 2,6-di-tert-butyl-4-methylphenol. One fifth ml acid washed glass beads 
(425-600 μm, Sigma-Aldrich®) was added and the tubes capped. Lycopene was extracted in a 
Savant FastPrep® FP120 Cell Disrupter, MP Biomedicals LLC, at maximum speed for 3 times 
45 sec with 1 min cooling on ice between each run. The acetone extracts were filtered using a 1 
ml syringe equipped with a 13 mm, 0.2 μm PTFE filter, VWR, Radnor, PA and quantified by 
measuring the absorbance at 474 nm and relating the measurement to a standard curve made 
from authentic lycopene dissolved in acetone with 100 mg/l 2,6-di-tert-butyl-4-methylphenol. 
 
5.6.5 cDNA library construction and screening 
Total RNA was extracted using the Savant FastPrep® FP120 Cell Disrupter, MP Biomedicals 
LLC, glass beads (425-600 μm), Sigma-Aldrich®, 500 μl acidic phenol:chloroform:isoamyl 
alcohol 125:24:1), pH 4.5, Life Technologies, Grand Island, NY, and 500 μl nuclease free water, 
Qiagen, Valencia, CA, from the cells harvested from 5 ml culture of S. kluyveri grown in YPD 
until OD600 = 1. Four hundred and fifty μl of the aqueous phase were transferred to a micro-
centrifuge tube. Total RNA was precipitated by addition of 45 μl 3 M sodium acetate, pH 5.2 and 
450 μl isopropanol. The RNA was spun down, rinsed twice with 500 μl 80 % ethanol and re-
dissolved in 200 μl nuclease free water. mRNA was purified from the total RNA with Oligo 
d(T)25 Magnetic Beads from New England Biolabs Inc., Ipswich, MA, but instead of eluting the 
mRNA, the following steps were performed with the mRNA bound to the magnetic beads which 
aided in the buffer and reagent changes. The protocol was inspired by [24] and [25]. The mRNA 
was reverse transcribed using the M-MuLV reverse transcriptase and the poly T from the 
magnetic beads as primer, whereafter T4 DNA polymerase was applied to remove oligo dTs that 
had not bound mRNA and thereby not been used for primers in the synthesis of cDNA. The 
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mRNA strands were removed by treating the mRNA/cDNA hybrid mixture with RNase H. The 
now single stranded cDNA was treated with terminal transferase (TdT terminal transferase, NEB 
catalog# M0315) and dCTP, hereby creating a 3’ poly C tail on the cDNA. The single stranded 
cDNA bound to the magnetic beads was then applied as template for a standard PCR reaction 
setup using the Phusion® High-Fidelity DNA Polymerase together with a poly G primer and a 
poly T primer with adaptamers containing the PacI and AscI endonuclease restriction sites, 
respectively, which resulted in the formation of double stranded cDNA flanked by the PacI and 
AscI restriction sites. The cDNA was size separated by gel electrophoresis, recovered in a 1-10 
kb size range and treated with the PacI and AscI restriction endonucleases. The cDNA was 
purified using the PCR purification kit (Qiagen) ligated into the pRS414TDH3 plasmid which 
had been engineered to harbor the same restriction sites within its multiple cloning site. The 
plasmid was prior to the ligation treated with the same two restriction endonucleases and purified 
by gel electrophoresis. The 50 μl ligation mix was precipitated with the addition of 5 μl 3 M 
sodium acetate, pH 5.2 and 50 μl isopropanol, washed twice with ice cold 80 % ethanol and re-
dissolved in 5 μl nuclease free water, Qiagen. A half microliter of the library was transformed 
into ElectroMAX™ DH10B™ T1 Phage-Resistant Competent Cells and plated on large (150 
mm in diameter) LB + ampicillin plates and incubated overnight at 37 °C. Twenty colonies were 
picked onto new LB + ampicillin plates for analysis of the library quality. The rest of the 
colonies were scraped of the plates using 1 ml ice cold LB medium per plate and a Drigalski 
spatula. Plasmids from the collected cells were purified using the Plasmid Midi Kit, Qiagen and 
hereafter constituted the library while the remainder of the concentrated ligation mix was stored 
at -20 °C as a master library in case more library has to be generated. 
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5.7 List of abbreviations 
GGPP - Geranylgeranyl pyrophosphate 
IPP - Isopentenyl pyrophosphate 
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6.1 Abstract  
Transposons have been modified to create novel tools for molecular biology and genetics. 
Several systems have been developed for transposon mutagenesis of Saccharomyces cerevisiae, 
but all of these suffer from drawbacks limiting their usefulness. We here demonstrate the design 
and construction of a novel transposase, based on the Tn5 transposase, which should exhibit 
increased functionality in S. cerevisiae, hereby remedying the drawbacks of previous systems. 
Our results show that this novel transposase locates to the nucleus of S. cerevisiae. Furthermore, 
we applied this new version of the transposase to develop a novel plasmid-based tool for random 
in vivo mutagenesis of S. cerevisiae. The construction of this plasposon system and its control 
plasmids are described here together with the initial testing of the system. The preliminary 
results for the testing of the system suggest that it is functional. However, further experiments 
are required to demonstrate that the system works correctly and performs the task for which it 
was designed. 
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6.2 Introduction 
Since the first transposon was discovered in maize more than 60 years ago by Barbara 
McClintock [McClintock, 1950], for which she in 1983 was awarded the Nobel prize, 
transposons have been developed as versatile tools for genetic engineering and molecular 
biology [Vizváryová and Valkov, 2004]. The two most commonly applied types of transposon 
tools for mutagenesis of S. cerevisiae are the systems based on one of the native Ty-retro-
transposons [Curcio and Garfinkel, 1991] and the shuttle mutagenesis systems utilizing bacterial 
transposons [Seifert et al., 1986]. Of the two, the Ty retro-transposition system is the only one in 
which the actual transposition event takes place in vivo in S. cerevisiae; the shuttle mutagenesis 
system relies on the transposition to take place in vivo in E. coli into cloned DNA fragments 
which subsequently can be shuttled back to S. cerevisiae where chromosomal insertions are 
mediated by homologous recombination. As such, the drawback of shuttle mutagenesis is the 
requirement for construction of a library of cloned gDNA fragments before the transposition 
mutagenesis can be carried out. The Ty based systems also suffer from several drawbacks, e.g. 
the transpositions have been found to occur into non-random targets [Natsoulis et al., 1989], 
especially with integration preference upstream of genes transcribed by RNA polymerase III 
[Devine and Boeke, 1996]. Furthermore, as native transposon elements in S. cerevisiae, the Ty 
elements, and scars from them being looped out of the genome, can be found throughout all the 
chromosomes of S. cerevisiae [Kim et al., 1998]. This creates a bias towards loci-specific 
insertion by homologous recombination instead of transposition. 
To remedy these problems, several in vitro transposition systems based on bacterial transposons 
have been created (for a comprehensive list see Smith, 2007). These systems can be applied in 
mutagenesis of yeast by transposition of the desired DNA into randomly fragmented yeast 
gDNA followed by transformation of the yeast gDNA donor. However, these systems rely on 
purified transposase enzymes which have to be purchased or manually purified. It would be 
desirable to have a system independent of in vitro transposition and thus the requirement to 
obtain purified transposase enzyme. A solution for this problem could be the construction of a 
plasmid-based system both carrying both the gene encoding the transposase and the DNA to be 
delivered into the genome of the target organism. Such a system has been developed for E. coli 
based on the bacterial Tn5 transposase. Dennis and Zylstra (1998) constructed what they coined 
as a plasposon system. The system’s main components were the gene encoding the Tn5 
transposase, the transposase 19 bp recognition sequences, an antibiotic selection marker and a 
conditional origin of replication. A system like this has been created for yeast but only based on 
its native Ty transposon system, which as mentioned above suffers from several drawbacks. 
In this work, we have pursued the construction of a plasposon system for yeast based on a 
bacterial transposon. We chose to base our system on a hyper-active version of the Tn5 
transposase, since the Tn5 system requires only its transposase and 19 bp recognition sequences 
for activity, whereas other bacterial transposons require either longer recognition sequences or 
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multiple components for functionality (discussed by Goryshin and Reznikoff, 1998). 
Furthermore, it has been demonstrated that upon transformation of S. cerevisiae, in vitro-
generated synaptic complexes, composed of Tn5 transposase dimers and DNA flanked by the 19 
bp recognition sequences, could be transposed into the genome [Goryshin et al., 2000]. 
Tn5 belongs to the class II ‘cut and paste’ transposons, and its transposition is composed of a 
multistep process. The Tn5 transposase first binds to its 19 bp recognition sequence, followed by 
dimerization to form the synaptic complex; next, the synaptic complex is cleaved from the donor 
DNA and inserted into its 9 bp target which is cleaved by a staggered cut and presumably 
repaired by host DNA repair proteins such as to create a 9 bp sequence duplication on each side 
of the insert [Reznikoff, 2002]. A schematic representation of this process can be seen in Figure 
6.1. For a more comprehensive description of the Tn5 transposon mechanism see Reznikoff, 
2002. 
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Figure 6.1: Model of Tn5 transposase-mediated transposition. The Tnp transposase binds its 19 bp 
target sequences followed by dimerization to form a synaptic complex. Subsequently, the synaptic 
complex is cleaved from the donor DNA molecule (this reaction requires Mg
2+
) and targeted into its 
destination. The insertion of the transposed DNA occurs by strand transfer into 9 bp staggered cuts 
which results in gaps in the opposite DNA strands on each side of the insert. Host functions are 
thought to be required to repair these gaps, and this process thereby creates 9 bp repeats on each 
side of the insert. The figure is adapted from Reznikoff (2002). 
 
Besides transformation with the pre-formed synaptic complexes, Tn5 transposition has not been 
tested in S. cerevisiae. However, excision of the full Tn5 transposon when integrated in 
auxotrophic markers in S. cerevisiae has been tested. It was shown that the Tn5 transposon could 
be removed from the auxotrophic marker, reverting it to its prototrophy, albeit at low frequency 
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[Gordenin et al., 1988 and Gordenin et al., 1991]. Because the focus of the study was the effect 
of the palindromic flanking sequences of Tn5 and the yeast factors contributing to its excision, it 
is unknown if Tn5 synaptic complexes can form in vivo in S. cerevisiae. Weil and Kunze (2000) 
demonstrated that another class II transposon, namely the Ac/Ds maize transposable element, can 
cause transposition in S. cerevisiae, in which class II transposons have not been found to 
naturally occur. However, the best frequency of transposition was 370 ADE prototrophic 
revertants per 10
7
 cells, which would be rather low if the system were to be used in large scale 
mutagenesis. Whether the transposition frequency will be higher for Tn5 is unknown, but a 
hyperactive version of the Tn5 transposase (Tnp) has been isolated. The hyperactivity is due to 
three point mutations causing the following changes to the amino acid sequence: E54K 
(increases binding activity for recognition sequences), M56A (avoids synthesis of inhibitory 
truncated version of the transposase), and L372P (is thought to increase dimerization potential) 
[Goryshin and Reznikoff, 1998]. Besides the Tnp transposase from Tn5 our system needs to have 
the following features: 
 
 The system needs be inducible, so transposition can be turned on when a desired cell 
density has been reached. 
 The plasmid harboring the system needs to be able to eliminate itself to avoid any further 
transposition (i.e., needs to be a suicide vector). 
 The plasmid needs to have minimal transcription of transposase and suicide function in E. 
coli, so the plasmid can be amplified therein. 
 The proteins need to be targeted to the nucleus to effectively reach their plasmid target 
since the nuclear envelope of yeast stays intact during the cell cycle [Moore et al. 1998]. 
 The plasmid needs to contain the Tnp recognition sequences flanking the part of the 
plasmid which is intended for transposition into the genome of S. cerevisiae. 
 The system needs to contain markers allowing for auxotrophic selection in yeast for 
plasmid-harboring cells, selection for cells where a transposition event has occurred, and 
selection for cells that have lost the plasmid. 
 The system requires markers for selection in E. coli during amplification and selection for 
retrieving DNA fragments targeted by the transposon system. 
 The system requires the ability to remove the inserted marker from the genome, enabling 
further rounds of mutagenesis. 
 Finally the DNA fragments encompassing the system need to have a low degree of 
homology to the S. cerevisiae genome in order to limit homologous recombination. 
 
We here describe a synthetic biology approach to create a novel random mutagenesis tool that 
includes all of the above listed features and therefore can effect in vivo mutagenesis by site-
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unspecific delivery of almost any DNA sequence into the genome of S. cerevisiae. These 
characteristics allow for it to be utilized for a wide array of applications. 
As the backbone plasmid for our transposon system we chose to use the pESC-URA plasmid 
from Stratagene 
(http://people.pharmacy.purdue.edu/~thazbun/Vectors%20&%20Protocols/pESC-URA.pdf), 
which contains a dual promoter system composed of the GAL1 and GAL10 promoters and thus 
allows for galactose induction of two genes. The first of these genes is the gene encoding Tnp, 
and the second is the gene encoding a nuclear-directed version of I-SceI [Lisby et al., 2003]. By 
introducing an I-SceI cleavage site in the plasmid, we converted the plasmid to a suicide vector. 
The cleavage site was introduced between the gene encoding the I-SceI and the promoter 
facilitating its transcription, hereby ensuring that I-SceI will be produced until no circular 
plasmid is present in the cell. Each of the genes encoding I-SceI and Tnp was spaced with an 
intron from Kluyveromyces lactis to eliminate its transcription in E. coli due to leakiness of the 
GAL promoters [Gibbs et al., 2004]. Furthermore, the gene encoding Tnp was C-terminally 
extended with the codons for the simian virus 40 nuclear localization signal (NLS) to ensure its 
transport into the nucleus [Lee and Melese, 1989]. The pESC-URA contains URA3 which 
permits auxotrophic selection for yeast cells harboring the plasmid; it also permits counter-
selection after transposition using 5-Fluoroorotic acid (5-FOA), in which case only cells having 
lost the plasmid will be viable. 
For amplification in E. coli pESC-URA contains the ampicillin resistance marker. The part of the 
plasmid designed to transpose into the genome of S. cerevisiae needs to be flanked by 19 bp 
recognition sequences; these sequences were obtained from the pMOD
TM
-2<MCS> plasmid 
from Epicentre Biotechnologies, which is designed to create DNA fragments for Tn5 
transposase-mediated in vitro transposition. This plasmid harbors hyper-active versions of the 
recognition sequences known as mosaic end (ME) sequences. These sequences, in combination 
with the Tn5 transposase, have been found to mediate transposition of DNA fragments between 
0.29 and 7 kb (upper limit is the largest fragment size tested in vitro) 
[www.epicentre.com/catalog/pmod2.htm]. To ensure efficient transposition, we kept the part of 
the plasmid intended for transposition below this upper limit. For selection of yeast colonies 
which have obtained our synthetic transposon, we included the K. lactis ADE1 gene with its 
corresponding promoter and terminator. Furthermore, for retrieval of gDNA fragments which 
have had our transposon inserted, we included a kanamycin resistance marker. We also included 
loxP sites just within the ME sequences to be able to remove the majority of the transposed 
DNA, thereby allowing for subsequent rounds of transposon mutagenesis. The above listed DNA 
pieces comprise the features of the aforementioned criteria for a S. cerevisiae in vivo plasposon 
mutagenesis system. A schematic representation of our design for the system can be seen in 
Figure 6.2. This chapter describes the assembly of the system together with preliminary results 
suggesting that our transposon system is functional. 
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Figure 6.2: Schematic representation of the designed plasposon. This representation highlights the 
most important features of our design. The dual galactose inducible promoters, Gal1p and Gal10p, 
control the expression of the modified Tn5 transposase and the I-SceI suicide function of the 
plasmid, respectively. The part of the plasmid designed for transposition is flanked by the mosaic 
end (ME) sequence to which the transposase binds and the loxP sites to enable looping out of the 
majority of the transposed DNA. Furthermore, the transposable part of the plasmid contains the 
marker for kanamycin resistance in E. coli and the ADE1 gene from K. lactis for auxotrophic 
selection in S. cerevisiae. The URA3 marker allows for auxotrophic selection for cells containing the 
plasmid as well as counter-selection for cells having lost the plasmid. The 2μ origin of replication 
results in the plasmid being present with high copy number in S. cerevisiae, and the pUC origin of 
replication allows for efficient amplification in E. coli. 
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6.3 Materials and methods 
6.3.1 Enzymes, chemicals and media 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich®, St. Louis, MO, 
and all enzymes from New England Biolabs Inc., Ipswich, MA. E. coli cells were grown in BD 
Difco
TM
 LB broth from BD Diagnostic Systems, Sparks, MD. For selection and maintenance of 
plasmids, ampicillin was added to a final concentration of 100 mg/l. S. cerevisiae cultures that 
required no auxotrophic selection were grown on YPD, composed of: 10 g/l Bacto
TM
 yeast 
extract, BD Diagnostic Systems; 20 g/l Bacto
TM
 peptone, BD Diagnostic Systems; and 20 g/l 
dextrose. For auxotrophic selection, S. cerevisiae was grown on SC-medium with the appropriate 
nutrient(s) omitted. SC medium was composed of 6.7 g/l Yeast Nitrogen Base (YNB) without 
amino acids, BD Diagnostic Systems; CSM – amino acid dropout mixture (amount according to 
manufacturer’s recommendation), Sunrise Science Products, Inc., San Diego, CA; and 20 g/l 
dextrose or galactose. All media components and media besides YNB were sterilized by 
autoclaving. YNB was sterilized by filtration. 
 
6.3.2 Plasmid and strain construction 
The components of the system were individually constructed and subsequently pieced together to 
form the final constructs which were used to transform S. cerevisiae. The plasmids used as 
starting points and the constructed plasmids, together with the strains applied in this study, are 
listed in Table 6.1. Cloning for the construction of the plasmids described below was done by 
treating the recipient plasmids with endonuclease(s), purification by gel-electrophoresis and 
recovery by gel extraction using the PureLink™ Quick Gel Extraction Kit, Life Technologies, 
Grand Island, NY, followed by ligation to the insert using T4 DNA ligase. The inserts were 
prepared either by removing it from the plasmid harboring it, via endonuclease digestion and gel-
purification in the same way as the plasmid recipient, or amplified by PCR, purified using the 
QIAquick PCR Purification Kit, Qiagen, Valencia, CA, treated with endonucleases and purified 
again using the QIAquick PCR Purification Kit, Qiagen. PCR amplifications were performed 
using the Phusion® High-Fidelity DNA Polymerase. All constructs were verified by sequencing. 
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Table 6.1: Strains and plasmids. 
Strain Genotype Source 
S. cerevisiae  
F1702 MATa ade1 arg4 his2 leu2 trp1 
ura3 
Dr. Gerald Fink, Whitehead 
Institute, Cambridge, MA 
SCX020 MATa ade1 arg4 his2 leu2 trp1 -
pSCX020 
This study 
SCX021 MATa ade1 arg4 his2 leu2 trp1 -
pSCX021 
This study 
SCTn009 MATa arg4 his2 leu2 trp1 - 
pSCTn009 
This study 
SCTn010 MATa arg4 his2 leu2 trp1 - 
pSCTn010 
This study 
SCTn011 MATa arg4 his2 leu2 trp1 - 
pSCTn011 
This study 
SCTn012 MATa arg4 his2 leu2 trp1 - 
pSCTn012 
This study 
   
Escherichia coli  
MAX 
Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rk-, 
mk+) phoA supE44 λ- thi-1 
gyrA96 relA1 
Life Technologies, Grand 
Island, NY 
Other   
Kluyveromyces 
lactis, CLIB209 
(ATCC8585) 
a [k1+ k2+] Dr. Gerald Fink, Whitehead 
Institute, Cambridge, MA 
   
Plasmid name Origin/reference 
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pESC-URA Stratagene, La Jolla, CA 
pMOD2
TM 
Epicentre Biotechnologies, 
Madison, WI 
pKT127 EUROSCARF – [Sheff and 
Thorn, 2004] 
pWJ1320 [Lisby et al., 2003] 
pZE-kanFRT-tyrAaroG Dr. Parayil Kumaran 
Ajikumar 
MIT062 Bio Basic Inc., Markham, 
Ontario, Canada 
pSCMOD005 This study 
pSCMOD006 This study 
pSCMIT This study 
pSCX020 This study 
pSCX021 This study 
pSCTn001 This study 
pSCTn002 This study 
pSCTn003 This study 
pSCTn004 This study 
pSCTn007 This study 
pSCTn008 This study 
pSCTn009 This study 
pSCTn010 This study 
pSCTn011 This study 
pSCTn012 This study 
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6.3.3 Component donor plasmids 
The gene encoding Tnp was purchased codon optimized for S. cerevisiae from Bio Basic Inc., 
Markham, Ontario, Canada and delivered in the MIT062 plasmid. The K. lactis intron 
KLLA0A09801g was amplified from K. lactis, CLIB209 gDNA by PCR using phosphorylated 
primers (primers 1 and 2, Table 6.2). The intron was inserted in the synthetic Tnp gene by 
treating MIT062 with MscI endonuclease and Antarctic phosphatase followed by T4 DNA 
ligase-mediated ligation. The insert direction was verified by PCR, and the plasmid with the 
intron inserted in the correct direction was named pSCMIT. The sequence for the intron was 
obtained from a list of K. lactis introns published at 
http://genome.jouy.inra.fr/genosplicing/Seq/KLLA_introns.tfa. 
The transposable cassette was constructed based on the pMOD2
TM
 plasmid from Epicentre 
Biotechnologies, Madison, WI. The K. lactis ADE1 gene was amplified from CLIB209 gDNA 
by PCR using primers 3 and 4; these primers contain adaptamers with the loxP sites flanked by 
SalI and BamHI restriction sites, respectively. The amplified DNA fragment and pMOD2
TM
 
were treated with SalI and BamHI, purified, and ligated together using T4 DNA ligase. The 
constructed plasmid was named pSCMOD005. The KanR gene encoding kanamycin resistance 
was amplified from the pZE-kanFRT-tyrAaroG plasmid by PCR using primers 5 and 6. The 
amplified KanR fragment and pSCMOD005 were treated with MluI and purified. KanR was 
ligated into pSCMOD005 using T4 DNA ligase to create pSCMOD006. This plasmid serves as 
donor DNA for the transposable part of the final plasmid. 
 
6.3.4 Plasmids for verification of nuclear localization of the Tnp transposase 
The main component of the system, the transposase, has to be located in the nucleus to be able to 
catalyze the transposition of part of the plasmid into the genome. We therefore chose to C-
terminally extend the gene encoding it with a 21 bp sequence encoding the simian virus 40 NLS 
composed of 7 amino acids (Pro-Lys-Lys-Lys-Arg-Lys-Val) [Kalderon et al., 1984]. For 
verification that the NLS-fused transposase does indeed localize to the nucleus, we constructed a 
plasmid harboring Tnp-NLS fused to the 3’ of the gene encoding the yeast enhanced GFP 
(yeGFP). This was done by first amplifying yeGFP from pKT127 using primers 7 and 8. The 
adaptamer of primer 8 contained a DNA stretch encoding a 16 amino acid linker, based on the 
linker tested by Chang et al. (2005). The yeGFP fragment was inserted in the pESC-URA 
plasmid in between the BamHI and NheI endonuclease cleavage sites. The resulting plasmid was 
named pSCX020. The Tnp gene, spaced with the K. lactis intron, was amplified from pSCTn007 
(see below) using primers 9 and 10 and inserted in the NheI site of pSCX020 to create pSCX021. 
The insert directionality was verified by PCR. pSCX020 and pSCX021 were used to test whether 
the GFP transposase co-localizes with the nucleus, which we stained with 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI). 
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6.3.5 Complete system 
The construction of the final plasmid containing all the aforementioned components, and the 
control plasmids, were based on the pESC-URA. pESC-URA was modified by inserting I-SceI 
in between the EcoRI and PacI restriction sites. I-SceI was amplified by PCR from the pWJ1320 
plasmid using primers 11 + 13 and 12 + 13. The fragments amplified with primers 11 and 13 
contained the I-SceI cut-site upstream of the open reading frame. Thus the insertion of the two 
fragments created two plasmids, one with the I-SceI cut-site and one without it, named 
pSCTn001 and pSCTn002, respectively. These two plasmids were both modified by inserting the 
KLLA0A09801g intron in the SfoI site, to create pSCTn003 and pSCTn004, respectively. The 
intron was amplified by PCR from K. lactis, CLIB209 gDNA, using primer 1 and 2. pSCTn003 
and pSCTn004 were modified by inserting the intron-modified Tnp gene in between the BamHI 
and SacII restriction sites to create pSCTn007 and pSCTn008. The Tnp fragment was amplified 
by PCR from pSCMIT applying primers 14 and 15. Primer 15 contained an adaptamer 
containing a DNA sequence encoding the simian virus NLS and a new stop codon, hereby 
modifying the Tnp gene further before it was inserted in the two plasmids. The cassette destined 
for transposition was amplified by PCR from pSCMOD006 using primers 16 and 17. The 
forward and reverse primers contained adaptamers containing sequences identical to the 
sequences of each side of the MfeI restriction site, respectively, located in the pSCTn003, 
pSCTn004, pSCTn007, and pSCTn008. The amplified cassette was then inserted in pSCTn003, 
pSCTn004, pSCTn007, and pSCTn008 treated with MfeI by gap-repair in S. cerevisiae to create 
pSCTn009, pSCTn010, pSCTn011, and pSCTn012, respectively. 
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Table 6.2: Primers. Restriction sites used for cloning are underlined. 
# Name Sequence (5’-3’) 5’-Modification 
1 KL09801g-
intron-for 
GTATGTTAAACCATGTATGCGTTTACTATTA
TT 
Phosphorylated 
2 KL09801g-
intron-rev 
CTGGGGAGATAAGTGGGATTTC Phosphorylated 
3 K.l.ADE1-for-
loxP-SalI 
GACTTAGTCGACataacttcgtataatgtatgctatacgaagtt
atGTAACGCGTGTATAAATATATCTCTG
1 
None 
4 K.l.ADE1-rev-
loxP-BamHI 
TATGACGGATCCataacttcgtatagcatacattatacgaagtt
atCAAGTCGGTGAAATGCTAGAACA
1 
None 
5 KanR-for-MluI GACTTAACGCGTAGAGCGCTTTTGAAGCTC
ACGC 
None 
6 KanR-rev-MluI TATGACACGCGTAAGATCCCCTTATTAGAA
GAACTCGTC 
None 
7 GFP-for-BamHI GACTTAGGATCCATGTCTAAAGGTGAAGAA
TTATTCACTGG 
None 
8 GFP-rev-linker-
NheI 
TATGACGCTAGCtgcagcttcaccagcaccagctgcagatg
cagcagaaccagaagtTTTGTACAATTCATCCATAC
CATGGGTAATA
2
 
None 
9 Tn5-for-NheI GACTTAGCTAGCATGATAACATCTGCTTTA
CATAGAGCCG 
None 
10 Tn5-rev-NheI TATGACGCTAGCTTAACCAACTTTTCTCTTT
TTCTTTGGTATCTTTAT 
None 
11 I-SceI-for-EcorI-
CS 
GACTTAGAATTCttacgctagggataacagggtaatatagcg
ATGGGATCAAGATCGCCAAAAAAGAAG
3
 
None 
12 I-SceI-for-EcorI GACTTAGAATTCATGGGATCAAGATCGCCA
AAAAAGAAG 
None 
13 I-SceI-rev-PacI TATGACTTAATTAATTATTTCAGGAAAGTTT
CGGAGGAGATAG 
None 
14 Tn5-for-BamHI GACTTAGGATCCATGATAACATCTGCTTTA None 
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CATAGAGCC 
15 Tn5-rev-SV40-
SacII 
TATGACCCGCGGTTAACCaacttttctctttttctttggTA
TCTTTATTCCTTGAGCCATCAAATCC
4 
None 
16 pMOD006-for ttatcccattccatgcggggtatcgtatgcttccttcagcactaccctttag
ctgttctatatgctgccactcctGCGCGTTGGCCGATTCA
TTAAGA
5
 
None 
17 pMOD006-rev atgtcatgataataatggtttcttagtatgatccaatatcaaaggaaatgat
agcattgaaggatgagactaatcCGGGCCTCTTCGCTAT
TACGA
5
 
None 
Features included in the adaptamers marked with lowercase letters: 
1
 loxP sites. 
2
 Linker sequence. 
3
 I-SceI endonuclease cleavage site. 
4
 Simian virus 40 NLS. 
5
 Sequences for homologous recombination with pSCTn003, pscTn004, pSCTn007 and pSCTn008. 
 
6.3.6 Strains 
All transformations of S. cerevisiae were carried out using the lithium acetate/polyethylene 
glycol method according to Gietz and Woods [2002]. Transformants were selected on SC 
medium with the appropriate nutrient(s) omitted. The constructed strains were verified by 
extraction of total DNA using the Wizard® Genomic DNA Purification Kit, Promega, Madison, 
WI, followed by PCR verification that the plasmid DNA was present therein. All the constructed 
strains were based on the F1702 strain. Each transformant was named after the plasmid used to 
transform it by removing the initial ‘p’ of the plasmid name, e.g. the resultant strain of F1702 
being transformed with pSCTn011 was named SCTn011. 
 
6.3.7 Evaluating nuclear localization 
The potential for nuclear localization of the modified Tnp gene was tested in silico before the 
actual construct was made. For this purpose the NLS mapper available at http://nls-
mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi was applied [Kosugi et al., 2009]. To test 
if the modified Tnp transposase in vivo localizes to the nucleus of S. cerevisiae, the SCX020 and 
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SCX021 strains were grown in SC-URA (glucose) overnight. The cells were harvested by 
centrifugation, washed with 5 ml sterile dH2O and resuspended in 5 ml sterile dH2O. The OD600 
of each of the cell suspensions was measured, and the cells were inoculated into SC-URA 
(galactose) and incubated for 5 h at 30 °C. After the first four hours of the incubation the tubes 
were covered with aluminum foil and 5 μl DAPI (1 mg/ml) was added. After the last hour of 
incubation the cells were inspected by fluorescence microscopy; 5 μl of each cell suspension was 
transferred to a microscope slide and examined using the Nikon Eclipse TE200-S microscope, 
Nikon Inc., Melville, NY, equipped with 100x objective, GFP band-pass filter (GFP-B: 
EX480/40, DM505, BA535/50) and DAPI band-pass filter (UV-2E/C: EX340-380, DM400, 
BA435-485). Fluorescent images were acquired using the following exposure times: 60 msec for 
bright field, 3 sec for DAPI, 150 msec for GFP images of SCX020, and 6 sec for GFP images of 
SCX021. The images were processed using the SPOT Advance
TM
 software, SPOT
TM
, Imaging 
Solutions, a division of Diagnostic Instruments, Inc., Sterling Heights, MI. 
 
6.3.8 Plasposon system testing 
All of the cells from each of the F1702 transformants with pSCTn009, pSCTn010, pSCTn011, 
and pSCTn012 were scraped off the SC-URA (glucose) plates on which they had been selected 
using 1 ml of cold water and a Drigalski spatula. The cells were transferred to 250 ml shake 
flasks each containing 50 ml SC-ADE (galactose) medium. The initial OD600 were measured, 
and the shake flasks incubated at 30 °C with 250 rpm orbital shaking. The growth of the four 
cultures was monitored by measuring the OD600. 
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6.4 Results and discussion 
6.4.1 Nuclear localization 
The designed Tnp gene encoding the transposase engineered for nuclear localization was tested 
in silico using the online available NLS mapper to give an indication of its nuclear localization 
potential. The best NLS identified within the designed protein sequence was assigned a score of 
10.5, whereas the best NLS identified within the protein without the NLS was assigned a score of 
3. The NLS mapper was experimentally tested on different versions of the GUS-GFP fusion 
proteins, and it was found that these fusion proteins with a score higher than eight were 
exclusively located in the nucleus, whereas proteins with a score between three and five were 
located both in the nucleus and the cytoplasm [Kosugi et al., 2009]. 
After constructing the gene encoding the nuclear directed Tnp, it was tested for its ability to 
localize to the nucleus by tagging it with yeGFP and using fluorescence microscopy (Figure 6.3). 
Comparing the two strains, the result of the DAPI stain is very similar, whereas the GFP images 
are very different. GFP expressed in SCX020 is not linked to the nuclear Tnp transposase and 
can therefore be seen throughout the cell. In SCX021, where GFP has been linked to the 
transposase, the GFP signal can be seen to co-localize with the DAPI signal. In conclusion, we 
discovered that the yeGFP-tagged protein localizes to the nucleus stained with DAPI (Figure 
6.3). The yeGFP expressed by SCX020 was located throughout the cell. These results show that 
our engineered Tnp localizes to the nucleus. 
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Figure 6.3: Fluorescence microscopy images. All images were acquired with 100X objective. The 
first and second rows correspond to images of SCX020 and SCX021, respectively. The first column 
contains the bright field images; the second column is the result from DAPI staining; and the third 
column is the result of GFP fluorescence. 
The exposure times used to acquire the bright field and DAPI images were the same for both the 
SCX020 and SCX021. However, the exposure time used to acquire the GFP image of SCX021 
cells was 40 times longer than for the SCX020. The reason for this is probably caused by lower 
expression of the GFP-tagged transposase. The lower expression can be caused by the position of 
intron within the gene. Yoshimatsu and Nagawa (1994) found that the expression level of 
proteins in S. cerevisiae could be changed by inserting an intron. The closer the intron was 
located to the start codon of the gene encoding the protein, the higher the expression. By tagging 
our transposase N-terminally we shifted the relative position of the engineered intron away from 
the start codon, hereby potentially causing lower expression of the entire fusion protein. We 
could have avoided the lower expression by tagging the transposase C-terminally, but this would 
have positioned the NLS between GFP and Tnp, creating the possibility that the fusion protein 
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could be degraded by proteases or in another way fragmented such that the NLS would only 
direct the GFP part of the protein to the nucleus. We chose not to construct and test the C-
terminally tagged Tnp since any result obtained thereof would be inconclusive due to the 
increased risk of having false positives. 
 
6.4.2 Plasposon system 
The plasmid pSCTn011 encompasses our design for a plasposon system based on the bacterial 
Tn5 transposase. Besides this plasmid we constructed 3 control plasmids, namely pSCTn009, 
pSCTn010, and pSCTn012. Maps for the four plasmids can be seen in Figure 6.4. pSCTn009 is 
designed to test the effect of the suicide function engineered into the plasmid without the effect 
of the transposase; pSCTn010 is designed as the negative control of the system, having neither 
suicide function nor transposase; and pSCTn012 is designed to test the effect of the transposase 
without the suicide function. When S. cerevisiae cells harboring the plasmid containing the 
suicide function are induced on galactose, all plasmids should be linearized and unable to 
propagate or to be passed on to subsequent generations of cells; therefore, only cells capable of 
mobilizing the K. lactis ADE1 gene to a locus outside the plasmid should be viable. On the other 
hand, cells harboring the plasmids without the suicide function should be unaffected by galactose 
induction unless the transposase has a detrimental effect on the cell growth. 
To test how the cells transformed with the four plasmids would be affected by induction on 
galactose, for each individual transformation all cells were inoculated into 50 ml SC-ADE 
(galactose) and the growth was monitored. The resulting growth curves can be seen in Figure 
6.5. It can be seen that SCTn011 grows much faster than SCTn009 and almost as well as the 
negative control SCTn010 and SCTn012, which indicates that the transposase has a positive 
effect on growth by alleviating some of the detrimental effects caused by the suicide mechanism. 
This result indicates that the transposase is active and can mobilize the cassette containing the K. 
lactis ADE1 gene from the plasmid to the genome. By comparing SCTn10 and SCTn012 it can 
be seen that the transposase by itself has very little effect on growth, whereas comparing 
SCTn009 and SCTn010 shows that there is a large impact on growth by the suicide mechanism. 
Late in the course of the growth experiment SCTn009 starts to grow even though it should be 
incapable of growth. This can be caused by linearized plasmids being integrated into the genome 
by non-homologous end joining or any other mechanism thwarting the auxotrophic selection. 
Genomic integration of the linearized plasmid will not be a problem when the cells are finally 
selected on SC-ADE+5-FOA since these hereby will be eliminated. A schematic representation 
of the method of application and possible outcomes of applying the system can be seen in Figure 
6.6. 
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Figure 6.4: Plasmid maps. Plasmid maps for the pSCTn009, pSCTn010, pSCTn011, and pSCTn012 plasmids used to test the functionality of the two 
main components of the plasposon system, namely the transposase and the suicide mechanism. 
Teaching old DNA new tricks: Engineering an in vivo transposon mutagenesis system for Saccharomyces 
cerevisiae based on the bacterial Tn5-transposase 
 
 
206 
 
 
Figure 6.5: Growth curves for SCTn009, SCTn010, SCTn011, and SCTn012. The cells were 
scraped off the plates used for selection of the transformants harboring the plasmid and inoculated 
in 250 ml shake flask containing 50 ml SC-ADE (galactose) medium. The growth of the strains was 
monitored by measuring the OD600 and plotted as a function of sampling time. 
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Figure 6.6: Schematic representation of the application of the plasposon system for in vivo 
mutagenesis of S. cerevisiae. The plasposon is first transformed into the S. cerevisiae strain chosen 
as starting point for the mutagenesis, followed by amplification of the cells and propagation of the 
plasposon on SC-ADE-URE (glucose) medium. Subsequently the transposition is induced by 
shifting the cells to SC-ADE (galactose) medium which only selects for the transposable part of the 
plasmid. Four different outcomes of this induction can occur: transposition with the cells 
maintaining the plasmid, transposition with plasmid loss, no transposition with the cells 
maintaining the plasmid, and no transposition with plasmid loss. If these cells are transferred to 
SC-ADE+5-FOA medium, only the desired outcome, where cells experiencing transposition and 
plasmid loss, will be viable. These random insert mutants can then be screened for a secondary 
phenotype for which one wants to elucidate the causative genotype. 
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6.4.3 Further experiments 
The results presented in this chapter are preliminary and only suggest that the system is 
functional. To develop this system and prove that it works, further experiments are required. The 
first experiment required will be to repeat the growth experiment previously performed with all 
cells from the transformation and carry it out with cells picked from single colonies. Secondly, 
an experiment proving that the introns inserted in the two genes are efficiently spliced out should 
be performed. This could be done by growing the SCTn012 cells on SC-ADE-URA (galactose) 
from which cDNA could be purified. The purified cDNA could then be probed using PCR with 
primers annealing on each site of the intron. If only one band occurs, the size of the band will 
indicate whether the intron is efficiently spliced out, whereas if two bands occur, the ratio 
between the bands will indicate the proportion of mRNA molecules without the intron compared 
to mRNA molecules with the intron. Finally, a gDNA library in an E. coli plasmid should be 
created from gDNA isolated from strains found, by PCR, not to harbor the plasmid backbone, 
but only the sequence designed to be transposed. The kanamycin resistance marker should allow 
for E. coli cells transformed with the library to be selected, so only cells transformed with a 
plasmid containing a transposon fragment will be viable. The plasmids isolated from these 
transformants should be sent for sequencing to test whether the insert is flanked by 9 bp repeats. 
If the sequencing results confirm that the insert is indeed flanked by 9 bp repeats, it proves that 
our plasposon system is functional. If the system is found to be functional, an experiment to test 
the frequency of transposition could be carried out to benchmark our system against other 
transposition systems. All together these experiments could prove the functionality of our system 
and allow for the system to be implemented as an efficient tool for random DNA delivery into 
the genome of S. cerevisiae. 
Since the loci of genomic integration have been found to affect the expression level of the 
inserted genes [Flagfeldt et al. 2009], our system could be used to probe the entire genome of S. 
cerevisiae for ‘expression hotspots.’ The system could be set up to deliver a GFP expression 
cassette into the genome, and the resulting mutants could be selected by FACS for those 
exhibiting the highest degree of fluorescence. Such an experiment would demonstrate the 
applicability of our system.  
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7.1 Abstract 
The triterpene compound squalene is of great commercial interest due to its unique properties 
which makes it amenable for application in a wide variety of products. Squalene has traditionally 
been isolated from shark liver oil. Environmental concerns and lack of success in obtaining this 
commodity chemically have stimulated the search for alternatives such as plant extraction and 
production by microbial fermentation. Especially the latter has gained a lot of attention as this 
may yield a sustainable alternative resource of squalene. Until recently only microorganisms that 
naturally produce squalene, such as yeasts, have been applied in this endeavor. However, the use 
of a native host might not be the best choice as production organism due to its intrinsic metabolic 
regulation. To by-pass this native regulation we decided to engineer Escherichia coli for the 
production of squalene by expression of squalene synthase encoded by the ERG9 gene from 
Saccharomyces cerevisiae together with the overexpression of the native E. coli farnesyl 
pyrophosphate (FPP)-synthase, encoded by the ispA gene. We here demonstrate that both the 
full-length and the 24 amino acids C-terminally truncated ERG9 gene can be used for 
heterologous production of squalene. Furthermore, the results indicate that squalene exhibit an 
inhibitory effect on E. coli cell growth. The plasmid mediating squalene production was 
introduced into three strains with different levels of methylerythritol 4-phosphate pathway 
expression, of which the best strain produced 3.04 mg/l/OD600. 
 
Keywords: Escherichia coli, squalene, metabolic engineering, ERG9, squalene synthase.  
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The triterpene molecule squalene was first identified in 1916 by M. Tsujimoto, who isolated this 
hydrocarbon, with the empirical formula C30H50, from shark liver oil (Tsujimoto 1920). One of 
the main applications of squalene is as an emollient in cosmetics and pharmaceuticals. 
Furthermore squalene is used in industrial products such as magnetic tape and low-temperature 
lubricants (Bhattacharjee et al., 1993). Squalene has also been found to have beneficial effects in 
the protection against cancer, coronary heart disease, aging, and bacterial infections. For a 
review on the healthcare aspects of squalene see Reddy and Couvreur (2009); for a more general 
review on squalene, see Spanova and Daum (2011). Problems with high mercury concentrations 
in shark liver, environmental/marine protection concerns, and animal rights groups (e.g. PETA 
and Oceana) urging consumers to boycott products containing squalene derived from animals, 
have prompted the search for alternative production processes of squalene (Bondioli et al., 1993; 
Bhattacharjee et al., 2001; He et al., 2002). 
Besides its occurrence in shark liver oil, a wide range of organisms such as bacteria, fungi, algae, 
plants and mammals have been found to synthesize squalene. Squalene belongs to the group of 
secondary metabolites known as isoprenoids or terpenoids. It is biosynthesized from isopentenyl 
pyrophosphate (IPP), which is the universal precursor of all isoprenoids. In nature, IPP is 
synthesized from central carbon metabolites via two pathways: the mevalonate (MVA)-pathway 
and the methylerythritol phosphate (MEP)-pathway. IPP is then isomerized to form dimethylallyl 
pyrophosphate (DMAPP). Subsequently DMAPP reacts with IPP and another molecule of 
DMAPP to form farnesyl pyrophosphate (FPP), the precursor of sesquiterpenoids such as 
squalene (Ajikumar et al., 2008). This reaction is catalyzed by the enzyme FPP synthase (EC 
2.5.1.10), which in E. coli is encoded by the ispA gene (Fujisaki et al., 1990). Next, two 
molecules of FPP are condensed head-to-head to form squalene. This reaction occurs via the 
intermediate pre-squalene, which is finally reduced by NADPH to form squalene. This final step 
is catalyzed by the enzyme squalene synthase (EC 2.5.1.21) (Agnew and Popják, 1977). The first 
squalene synthetase to be isolated and characterized was from the microsomes of Saccharomyces 
cerevisiae (Lynen et al., 1958), later discovered simultaneously by Fegueur et al. (1991) and 
Jennings et al. (1991) to be encoded by the ERG9 gene from S. cerevisiae. Since squalene 
synthase catalyzes the first committed step in sterol biosynthesis, it is an obvious target for the 
treatment of hypercholesterolemia, and the initial efforts were therefore directed towards 
obtaining purified soluble squalene synthase for in vitro characterization, which could aid the 
identification of novel therapeutics. The squalene synthase was found to be anchored to 
microsomal membranes in part by a C-terminal stretch of 24 hydrophobic amino acids. By 
removing the codons for these amino acids and expressing the truncated gene in E. coli, it has 
been possible to produce a soluble version of the enzyme which has been thoroughly 
characterized in vitro (LoGrasso et al., 1993; Zhang et al., 1993). Both the full-length and the 
truncated ERG9 have been expressed in E. coli for the purpose of purification and 
characterization. However, neither of the two has so far been tested for the ability to mediate in 
vivo synthesis of squalene when heterologously expressed. 
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To investigate whether the ERG9 gene from S. cerevisiae can be used to engineer E. coli, which 
does not naturally, synthesizes squalene, in order to produce squalene, we constructed two 
plasmids, p10T5T10-ERG9 and p10T5T10-ERG9t, harboring synthetic operons for expressing 
the full-length and truncated ERG9 gene, respectively, in conjunction with the E. coli ispA gene. 
Each of the two plasmids were used independently to transform the E. coli strains K-12 
MG1655, K-12 MG1655 TRC-MEP, and K-12 MG1655 T7-MEP, previously used by Ajikumar 
et al. (2010) for high-titer production of taxadiene. The last two of these strains have been 
engineered to express a chromosomally integrated operon containing the dxs, idi, ispD and ispF 
genes under the control of the TRC- and T7-promoter, respectively. All plasmids and strains 
used in this study are listed in Table 7.1. 
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Table 7.1: Strains and plasmids. 
Strain Genotype Source 
Escherichia coli  
K-12, MG1655 ΔrecA ΔendA DE3 Dr. Parayil Kumaran Ajikumar* 
K-12, MG1655 TRC-MEP ΔrecA ΔendA DE3 Dr. Parayil Kumaran Ajikumar* 
K-12, MG1655 T7-MEP ΔrecA ΔendA DE3 Dr. Parayil Kumaran Ajikumar* 
MAX Efficiency® 
DH5α™  
F- φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17 (rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 
Life Technologies, Grand Island, 
NY 
   
Saccharomyces cerevisiae  
F1702 MATa ade1 arg4 his2 leu2 trp1 
ura3 
Dr. Gerald Fink, Whitehead 
Institute, Cambridge, MA 
   
Plasmid name Origin/reference 
p10T5T10 Dr. Parayil Kumaran Ajikumar 
p10T5T10-ERG9 This study 
p10T5T10-ERG9t This study 
* (Ajikumar et al., 2010) 
 
To evaluate the constructed strains they were inoculated at OD600 = 0.01 from pre-cultures, 
induced with 0.1 mM IPTG at OD600 = 0.1 and grown for 3 days at 20 °C followed by extraction 
into acetone. The cell extracts were analyzed by GC-FID and GC-MS. By comparison to an 
authentic squalene standard it was verified that the six strains were able to produce squalene, cf. 
Figure 7.1 and Figure 7.2. These results show that the major compound extracted has the same 
retention time and MS-spectrum as the squalene standard, hereby verifying that the strains are 
capable of producing squalene. 
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Figure 7.1: GC-FID chromatogram of squalene. Red graph – squalene standard and blue graph – E. coli cell extract. 
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Figure 7.2: MS-spectra of squalene. A: Squalene standard and B: Squalene produced by E. coli and analyzed using GC-MS. 
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In order to further modulate the synthetic squalene pathway and to identify the best squalene 
producer, the six strains were tested in triplicate, each with three different concentrations of 
IPTG (0.05, 0.1 and 0.2 mM). OD600 of the cultures was measured prior to extraction, and the 
squalene content was quantified by GC-FID. Figure 7.3A-C shows that the strains engineered to 
overexpress crucial steps of the MEP-pathway gave higher production of squalene. Furthermore 
the results show that the truncated ERG9 gene is better at mediating squalene production 
compared to the full-length gene, suggesting that absence of membrane association of squalene 
synthase is beneficial. This higher squalene synthesis is associated with an impediment of growth 
in E. coli. 
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Figure 7.3: Performance of engineered E. coli strains. The following parameters were measured in 
triplicate after growth for 3 days at 20 °C subsequent of induction with 3 different concentrations 
of IPTG (0.05, 0.1 and 0.2 mM) at OD600=0.1 : A: Cell growth by OD600, B: Squalene titer and C: 
Squalene yield on biomass (calculated based on the values in A and B). Figure 7.3D shows the same 
three parameters for MG1655 T7-MEP transformed with the p10T5T10-ERG9t grown for 5 days 
at 20 °C subsequent to induction at various OD600 with 0.2 mM IPTG. 
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To investigate this bottleneck and further improve the squalene synthesis the E. coli K-12 strain 
MG1655 T7-MEP transformed with the p10T5T10-ERG9t plasmid was tested for uncoupling the 
growth and production phase. Thus, the strain was inoculated at OD600 = 0.01 and induced with 
0.2 mM IPTG at various OD600 in the interval 0.5-6.0. The incubation time at 20 °C was 
extended to 5 days; where after the squalene was extracted and quantified. Figure 7.3D shows 
that the production of squalene has an optimum induction OD600 of around 2-4. The highest 
squalene titer obtained was 8.82±2.8 mg/l with titers of individual quantifications reaching up to 
11.85 mg/l; the highest titer normalized with OD600 was 3.04±0.42 mg/l/OD600 (the numbers 
after the (±)-sign are the standard deviations, n=3). This uncoupling of the growth and 
production phase resulted in a two-fold increase in squalene titer. 
In previous studies, terpenoids synthesized in E. coli have been secreted into the medium and 
hereby partly lost by evaporation due to their highly volatile character (Ajikumar et al., 2010; 
Newman et al., 2006). In our experiment no squalene could be observed above the detection limit 
(0.1 mg/l) by GC-FID from hexane extracts of used growth medium with the E. coli cells 
removed by filtration prior to the extraction (results not shown). Thus all the produced squalene 
remains intra-cellular or cell-associated in E. coli.  
Our best result corresponds well with the best titer of 11.8 mg/l squalene heterologously 
produced in E. coli presented by Ghimire et al. (2009). They also overexpressed limiting steps in 
the MEP-pathway, hereby using a similar approach to ours for the strain engineering. However, 
they tested their strains on a different medium and did not report their squalene production as a 
biomass based yield, which makes further comparison difficult. Assuming that they obtained a 
similar biomass compared to our study it would seem that there is an upper limit to how much 
squalene can be produced before it becomes detrimental to the growth. This notion is further 
supported by the results of our induction-timing experiment, which shows that there is an 
optimal biomass at which E. coli should be induced to get the highest production. This optimum 
may be a result of an increased storage capability or a dilution of squalene within the cells as a 
function of cell growth and the trade-off of nutrients being utilized for biomass formation instead 
of squalene production. The C-terminal sequence removed in the truncated version of ERG9 has 
been found to bind the squalene synthase to the membrane of the ER. The localization of this 
enzyme probably facilitates the conversion of the water soluble FPP into the water insoluble 
squalene, of which derivatives (e.g. ergosterol) will finally end up in the cell membrane of S. 
cerevisiae, regulating membrane fluidity, permeability, the activity of membrane bound 
enzymes, and growth rate (Zhang et al., 1993). Hence, the produced squalene is very likely 
stored within the cell membrane or in lipid inclusion bodies in E. coli. The negative effect of 
squalene on growth might therefore be caused by a detrimental effect of squalene on the cell 
membrane. We furthermore tried to produce higher amounts of squalene by overexpressing the 
truncated ERG9 using the T7 promoter, which is stronger than the applied T5T10-promoter. This 
did however not result in an improvement in the squalene production (result not shown), which 
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strengthens the case for an upper limit of squalene per biomass which can be produced. Zhang et 
al. (1993) experienced problems with sub-cloning ERG9 into an E. coli expression plasmid. They 
were only able to obtain plasmids containing the gene when the tac promoter tightly regulated by 
the lac repressor was applied. This also suggests an adverse effect of squalene. 
Our best strain produced 7.8 mg/gDCW squalene. The wild-type yeasts S. cerevisiae and 
Torulaspora delbrueckii were found by Bhattacharjee et al. (2001) to produce 41.16 and 237.25 
μg/gDCW squalene respectively, which shows that our engineered E. coli can indeed outperform 
wild type yeasts. However, Donald et al. (1997) estimated that the S. cerevisiae strain that they 
engineered by overexpressing the truncated HMG-CoA reductase encoded by HMG1 could 
produce up to 20 mg/gDCW squalene, which is almost 3-fold higher than our best strain. 
However, squalene in yeasts is required for production of the essential membrane constituent 
ergosterol; hereby some squalene is lost for growth. Besides yeasts, both algea and Gram 
positive bacteria have been found to produce squalene (Amdur et al., 1978; Okada et al., 2000), 
suggesting the possibility of bio-prospecting to identify a microorganism with high production of 
squalene, hereby creating a favorable starting point for further genetic engineering. In fact the 
most promising microorganism identified to date is the micro-alga Aurantiochytrium sp. 18W-
13a, which was found to produce up to 198 mg/gDCW squalene (Kaya et al., 2011). This alga is 
not well characterized, and whether it is amenable to genetic engineering is unknown; however, 
it could serve as a source of novel genetic engineering targets which could be identified through 
an inverse metabolic engineering scheme. These novel targets could probably heterologously 
mediate further improvement in squalene production in more well characterized microorganisms 
such as E. coli. 
An ideal production organism will have high tolerance towards squalene, high storage capability 
for lipid compounds, and it may be advantageous if it does not require squalene for production of 
any essential compounds. If it is impossible to obtain such a production organism, a fed-batch 
fermentation scheme could be considered in combination with decoupling the cell growth phase 
and the squalene production phase, hereby allowing for required storage capability to be created 
before product formation is allowed to occur, and also supplying the required nutrients to each of 
the phases. For our engineered E. coli strain this approach resulted in doubling of squalene titers. 
The search for a microbial system capable of producing high amounts of squalene, thereby 
making this approach an economical viable solution in the search for an environmental friendly 
alternative to the shark liver oil, is still in its infancy, but this study shows that the construction 
of a microbial platform for squalene production is realistic and highlights that the full-length and 
truncated ERG9 genes from S. cerevisiae are useful tools for this endeavor. Moreover, we 
showed that E. coli is an appropriate production host for squalene synthesis that can compete 
with eukaryotic production hosts. Besides being a commercially interesting product, squalene is 
also the gateway molecule for biosynthesis of hopanoids, and our engineered strains thereby 
become an ideal starting point for heterologous production of hopanoids (Tippelt et al., 1998).  
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7.2 Materials and methods 
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich®, St. Louis, MO, 
and all enzymes from New England Biolabs Inc., Ipswich, MA. All PCR reactions were 
performed using the Phusion® High-Fidelity DNA Polymerase, and all ligations were performed 
using the T4 DNA ligase. To express ERG9 and the truncated ERG9 gene (ERG9t) in 
combination with ispA, two plasmids were constructed namely p10T5T10-ERG9 and p10T5T10-
ERG9t, respectively. To construct p10T5T10-ERG9, ERG9 was amplified from S. cerevisiae 
F1702 gDNA by PCR using the following primers: 5’-
TAGACCATGGGAAAGCTATTACAATTGG-3’ and 5’-
TATGTCGACCTCGAGGCGGCCGCGAGCTCTAAAGGGCCGGCCTAAACGAATTCTCA
CGCTCTGTGTAAAGTG-3’ treated with NcoI and SalI endonucleases (endonuclease 
recognition sequences are underlined in the primer sequences) and ligated into p10T5T10 which 
had also been treated with NcoI and SalI, and purified by gel electrophoresis followed by gel 
purification. The ispA gene was amplified from E. coli K12 - MG1655 gDNA using the 
following primers: 5’-
GAATTCGTTTAGGCCGGCCTTAAATAAGGAGGAATAACATGGACTTTCCGCAGCAA
CTCG-3’ and 5’-ACTGGTCGACGCTTATTTATTACGCTGGATGATG-3’, treated with the 
appropriate enzymes, and inserted between the FseI and SalI sites of the previous plasmid, to 
construct p10T5T10-ERG9. The full-length ERG9 gene was excised from p10T5T10-ERG9 by 
NcoI/FseI digestion and substituted with the truncated ERG9 gene to construct plasmid 
p10T5T10-ERG9t. The C-terminally truncated ERG9 gene was obtained by PCR from F1702 
gDNA using the following primers: 5’-TAGACCATGGGAAAGCTATTACAATTGG-3’ and 
5’-TATGACGGCCGGCCTAAACGAATTCTTAGTACTCTTCTTCTTGTTGGGTTG-3’. E. 
coli MAX Efficiency® DH5α™ was transformed with the constructs and subjected to selection 
on BD Difco
TM
 LB broth from BD Diagnostic Systems, Sparks, MD supplemented with 
chloramphenicol to a final concentration of 34 mg/l. This medium was also used for plasmid 
propagation, and the purified plasmids were verified by sequencing. Strains and plasmids used in 
this study are listed in Table 7.1. Plasmids p10T5T10-ERG9 and p10T5T10-ERG9t were 
individually introduced into E. coli strains K-12 MG1655, K-12 MG1655 TRC-MEP, and K-12 
MG1655 T7-MEP. The 6 transformants were tested for their ability to produce squalene by 
growing them on medium composed of 5 g/l yeast extract, 10 g/l tryptone, 15 g/l glycerol, 100 
mM HEPES and 34 mg/l chloramphenicol with pH adjusted to 7.6, according to Ajikumar et al. 
(2010). The cells were inoculated at OD600 = 0.01 and incubated at 20 °C with 250 rpm orbital 
shaking and induced at OD600 = 0.1 with 0.05, 0.1 or 0.2 mM IPTG. Five ml of each culture were 
harvested by centrifugation at 3000 g for 10 min, washed with 1 ml phosphate-buffered saline 
(Cellgro®, Mediateach, Inc., Manassas, VA) and transferred to a 2 ml FastPrep® tube (MP 
Biomedicals LLC, Solon, OH). The cells were spun down at 18,000 g for 1 min and the 
supernatant removed. Two hundred μl acid washed glass beads (425-600 μm, Sigma-Aldrich®) 
and 1 ml of acetone were added to each FastPrep® tube. The cells were disrupted using a Savant 
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FastPrep® FP120 Cell Disrupter (MP Biomedicals LLC.), and the extract was filtered using a 13 
mm syringe filter (w/ 0.2 μm PTFE, VWR, Radnor, PA). Eight hundred μl of the extract were 
then transferred to a 1.5 ml microcentrifuge tube, evaporated to dryness in a vacuum centrifuge 
and re-dissolved in 100 μl hexane. The squalene content of the samples was quantified by GC-
FID equipped with a Varian Factor FOUR YF-1ms, 15 m, 0.25 mm capillary column (Agilent 
Technologies, Santa Clara, CA), with helium as carrier gas. The temperature of the oven was 
adjusted according to the following program: 220 °C for 2 min, ramp to 250 °C (10 °C/min) and 
hold at 250 °C for 15 min. The quantification was performed based on a standard curve made 
from authentic squalene diluted in hexane. For further verification of the extracted compound the 
extract was analyzed by GC-MS. A sample of 1 μl was analyzed using splitless injection on a 
DB-35ms, 30 m, 0.25 mm, 0.25 µm column (Agilent Technologies, Santa Clara, CA), with 
helium as carrier gas. The temperature of the oven was initially held a 160 °C for 30 sec, then 
increased to 320 °C at 10 °C/min and finally held at 320 °C for 3 min.   
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Since all the chapters of the thesis are written in article format most of the results have already 
been discussed and concluded upon. However, this way of structuring the thesis would, if 
nothing was added, leave little room for speculations regarding what could have been done 
differently and what other strategies could have been applied to obtain the same objectives. This 
is especially true for the chapters intended for publication, so the main emphasis in this chapter 
will be on the further discussions for the chapters intended for publication. This chapter has been 
incorporated to allow for these speculations to be included; for the core discussions, on the other 
hand, the reader is referred to the individual chapters. Besides the speculations some results 
outside the scope of the individual chapters were obtained based on experiments conducted after 
comparing the results from the chapters. These results will also be briefly presented and 
discussed here. This chapter is to some extent subdivided according to the individual chapters to 
which the additional speculations and results pertain. Finally, this chapter will contain an overall 
conclusion for the entire thesis. 
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8.1 Chapter 2 
The expression of the MEP pathway was only partially successful, and in order to functionally 
express the entire pathway another approach could in principle be applied. A solution for 
functionalizing the MEP-pathway could be to target the MEP-pathway to the mitochondria, 
taking advantage of the ISC-assembly machinery located there being fairly similar to the ISC-
assembly machinery of E. coli [Mühlenhoff and Lill, 2000]. The E. coli frataxin homolog CyaY, 
which is a [2Fe-2S] ISC-protein, can partially complement the S. cerevisiae yfh1 deletion when 
targeted to the mitochondria [Bedekoviks et al., 2007], so perhaps also other E. coli ISC-proteins 
targeted to the mitochondria can be converted to their functional holo-form. Mitochondrial 
targeting of proteins in S. cerevisiae by targeting peptides, which upon fusion to the protein of 
interest directs the protein to the mitochondria, is established [Hurt et al., 1985]. Furthermore, 
ferredoxin and ferredoxin reductase have been found in the mitochondria to be involved in the 
synthesis of ISC-proteins and heme biosynthesis [Barros et al., 2002], and these enzymes could 
possibly transfer the reducing equivalents required by ispG and ispH. Farhi et al. (2011) 
increased production of isoprenoids by exploiting both the mitochodrial and the cytosolic FPP 
pools, thus showing that utilizing mitochondria in the pursuit for increased isoprenoid production 
is a viable strategy. Whether FPP is produced in the mitochondria or imported from the cytosol 
in S. cerevisiae is unknown, but several eukaryotes harbor a FPP synthase targeted to their 
mithocondria [Martín et al., 2007]. These examples are encouraging that it may be possible to 
functionalize the MEP-pathway in the mitochondria of S. cerevisiae to supply IPP, which either 
by a native FPP synthase or a FPP synthase engineered for mitochondrial targeting could boost 
the mitochondrial FPP pool, hereby improving the isoprenoid production capability within the 
mitochondria of S. cerevisiae. However, the MEP-pathway precursor G3P is not present in the 
mitochondria [Förster et al., 2003] and it is very doubtful that any of the phosphorylated 
intermediates of the MEP-pathway will be able to traverse the mitochondrial membrane without 
engineering of a so far unknown transporter activity. Therefore G3P would have to be 
synthesized in the mitochondria. G3P might be synthesized by mitochondrial targeting of the S. 
cerevisiae native phosphoenolpyruvate (PEP) carboxykinase, phosphopyruvate hydratase, 
phosphoglycerate mutase, 3-phosphoglycerate kinase, and glyceraldehyde-3-phosphate 
dehydrogenase which are encoded by the PCK1, (ENO1 and ENO2), GPM1, PGK1, and (TDH1, 
TDH2, and TDH3) genes, respectively. and makes part of the gluconeogenesis, hereby 
converting some of the oxaloacetate from the TCA cycle through PEP to G3P. 
As mentioned in Chapter 2, holo-ferredoxin is required for ISC-assembly machinery 
functionality, which cannot be obtained heterologously in S. cerevisiae as long as the machinery 
itself is inactive. This creates a “chicken & egg”-situation, which could be one of the main 
reasons for the inactivity of the last two steps of the heterologously expressed MEP-pathway. To 
remedy this problem, one could try to “kick start” the ISC-assembly machinery by introducing 
holo-ferredoxin into S. cerevisiae. Goryshin et al. (2000) found that DNA/protein complexes can 
be introduced into S. cerevisiae by transformation. However, since ISC-proteins are oxygen 
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labile, the entire operation has to be performed anaerobically, which further complicates the 
procedure. We tried to transform S. cerevisiae (SCMEP-FeS2-IS-ΔERG13) with a crude E. coli 
cell extract using the lithium acetate method. All operations were performed in a glow box under 
an inert atmosphere. Cells were plated on medium without mevalonolactone, but no colonies 
were formed, suggesting that either ISC-proteins from crude cell extract cannot be introduced 
into S. cerevisiae in this way, or that the heterologously expressed ISC-assembly machinery 
cannot be “kick started” this way. Whether the use of purified and concentrated holo-ISC-
proteins could solve the problem was not investigated. 
Heterologous expression of proteins tends to induce an increased burden on the host cell by 
removing resources for additional DNA, RNA and protein synthesis [Glick 1995]. Cellular stress 
may also be caused by misfolding of heterologously expressed proteins [Kauffman et al., 2002]. 
In our system the heterologous genes were integrated in the chromosome, which, compared to 
plasmid based expression systems, creates the lowest burden. However, all the genes were 
expressed using strong constitutive or glycolytic promoters, and with 24 genes being expressed 
simultaneously in this manner the cells ought to be experiencing an increased metabolic burden. 
Since the HscA gene was the largest of the heterologously expressed genes, the metabolic burden 
may explain why it was impossible to detect transcripts hereof. Another possible explanation 
could be low mRNA stability of the HscA transcript. Furthermore expression of the MEP-
pathway removes G3P and pyruvate from the primary metabolism, which thereby will be 
unavailable for essential processes. G3P and pyruvate are correspondingly converted to MEP-
pathway intermediates that could be toxic to S. cerevisiae. These effects cannot be dramatic since 
S. cerevisiae can still grow albeit slower. Nonetheless, the fully engineered strain must 
experience an increased metabolic burden and stress, thus in order for the MEP-pathway to 
become an integral part of the metabolism it will probably require some adaptation and pathway 
balancing. 
The heterologous expression of the MEP-pathway holds great potential for heterologous 
microbial production of isoprenoids but so far nobody has been able to unlock this potential. We 
have narrowed down a major problem to the last two steps of the pathway, hereby pinpointing 
targets for further engineering efforts. Whether it will be possible to functionally express these 
two ISC-proteins remains to be demonstrated but our leuC/leuD complementation result 
definitely encourages further investigations. Expression of the MEP-pathway in S. cerevisiae 
would not only benefit research into heterologous isoprenoid production, but also aid more 
generally in the understanding of ISC-cluster proteins and their associated assembly machinery. 
This could help delineate the proteins encompassing the assembly system and define which are 
truly essential. 
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8.2 Chapter 3, 4 and 5 
Figure 5.6B shows that it is possible to increase lycopene production compared to the control 
strain (SimC002 - CEN.PK113-9D transformed with the pSC203 plasmid) by inducing the 
CUP1 promoter controlled GGPP synthase with high copper concentrations. This suggests that a 
limiting step in lycopene biosynthesis in the SimC002 and SimC008 (SimC002 transformed with 
the pRS415TDH3 plasmid) is encoded by CrtE. This corresponds well with the findings of 
Nishizaki et al. (2007). If this step is indeed a limiting step in the SimC002 strain, which was 
applied for screening the genetic libraries, the pathway leading to IPP formation is not the 
constraining factor and it hereby becomes very difficult to identify targets within the native 
metabolism that will improve lycopene production. This also corresponds well with the notion 
that the FPP level is well regulated because of the feedback inhibitions of the mevalonate 
pathway metabolites. For a review on mevalonate pathway regulation see Maury et al. (2005). 
Several essential compounds for S. cerevisiae cell growth such as ergosterol are produced 
through the mevalonate pathway reflected by the rigid control of this pathway ensuring sufficient 
supply of these molecules, so when prenyl precursor molecules are utilized for production of 
heterologous isoprenoids, some of the feedback inhibition is alleviated, resulting in a greater flux 
through the upper part of the mevalonate pathway. This in turn creates a homeostatic situation 
were precursor availability will remain constant as long as the heterologous pathway is the 
limiting pathway, and the flux of the pathway leading to ergosterol is governed by competition 
between the heterologous pathway and the native downstream pathways for precursor molecules. 
Thus, not until the pathway leading to ergosterol and/or other pathways upstream of FPP become 
the limiting factor, should it be difficult to identify metabolic targets that could remedy 
heterologous lycopene production. However, this also means that the lycopene production should 
be increasable by further overexpression of the CrtE gene to improve the competition with the 
other pathways utilizing FPP as precursors. On the other hand, there is evidence for some 
limitations in the upper part of the mevalonate pathway, e.g. the overexpression of the truncated 
HMG1 gene can significantly improve isoprenoid production due to deregulation of the 
mevalonate pathway [Asadollahi et al., 2010]. Even though Verwaal et al. (2007) demonstrated 
that their highest β-carotene production was achieved using genes integrated in the genome, we 
decided to try to overcome the limitation that seem to exist at crtE of the lycopene pathway by 
creating a 2μ-based multicopy version of the pSC203 plasmid. The plasmid was based on the 
pRS426 plasmid from Mumberg et al. (1995) and the constructed plasmid was named pSCM002 
and can be seen from Figure 8.1A. When pSCM002 was introduced into CEN.PK113-9D and the 
transformation mixture was plated on SC-URA medium, colonies exhibiting two discrete 
morphologies were observed (Figure 8.1B). The two main differences in morphology of the two 
phenotypes were the colony size and orange-red color intensity; the small colonies exhibited 
more intense orange-red coloration compared to the large colonies. 
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Figure 8.1: A: plasmid map for 2μ based plasmid named pSCM002 which carries the carotenogenic 
genes for lycopene biosynthesis. B: The resulting phenotypes of CEN.PK113-7D transformed with 
pSCM002. 
These two morphologies were also observed in the beginning of this Ph.D. project when the 
SimC002 strain was created. At that point it was hypothesized that the intense color of the small 
colonies was caused by multiple tandem integrations of the pSC203 plasmid which can occur 
when the “ends-in” method is used for genomic integration, and a small, more intense red 
colored colony was picked as the final strain from the transformation since it was desired to have 
a starting point with the highest lycopene yield on biomass. The combination of slower growth 
and increased red coloration corresponds well with the competition theory, since less ergosterol 
would be available for growth because the FPP was directed to lycopene. An integration copy 
number based effect can of course not be the cause for the differences in phenotype when an 
episomal plasmid is applied; even though the plasmid copy number varies from cell to cell, it 
should not be able to cause the observed discrete phenotypes of the colonies. To further test 
which of these two phenotypes would be the best background for screening the DNA libraries, 
we picked two colonies, one representing each phenotype (from here on just referred to as small 
and big – based on their colony size). These two strains were then transformed with the cDNA 
library applied in Chapter 5 and the pRS414TDH3 control plasmid. By visually inspecting the 
plates with the colonies resulting from the transformations it was observed that the transformants 
based on the small colonies only gave rise to colonies exhibiting the small phenotype, whereas 
transformants based on the big colonies were of both types. Ten colonies from each of the colony 
sizes transformed with either the S. kluyveri cDNA library or the pRS414TDH3 plasmid were 
isolated and tested in 5 ml liquid SC-TRP-URA for growth and ability to produce lycopene. 
Figure 8.2 shows that after 2 days of incubation at 30 °C the cultures inoculated from the big 
colonies grew better but produced less lycopene, just as observed on the solid medium. 
Furthermore, it could be seen that the strains transformed with the library as expected exhibited 
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greater variance in lycopene production compared to the strains transformed with the control 
plasmid. 
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Figure 8.2: Boxplot indicating range, median and quartiles for testing of two phenotypically 
different carotenogenic S. cerevisiae strains isolated from a transformation with a multi-copy 
carotenogenic plasmid (pSCMOD002) and transformed with either a Saccharomyces kluyveri cDNA 
library or the appertaining control plasmid. BL: big colony phenotype transformed with library, 
BC: big colony phenotype transformed with control plasmid, SL: small colony phenotype 
transformed with library, SC: small colony phenotype transformed with control plasmid. A: OD600 
measured for ten colonies of each type. B: Lycopene production measured for the same strains as in 
A and normalized with OD600. 
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It was suggested that the difference in phenotype could be caused by the formation of respiratory 
deficient mutants, also known as petites. To test if this was the case the original two isolated 
strains were tested for their ability to respire by inoculating them on SC-URA with glycerol as 
primary carbon source instead of glucose. The result can be seen from 8.3, which shows that the 
small colony phenotype was indeed caused by respiratory deficiency. 
 
Figure 8.3: Test of respiratory deficiency in carotenogenic S. cerevisiae strains. Left side: big colony 
phenotype. Right side: small colony phenotype. The strains were tested for their ability to grow on 
SC-URA medium with glycerol. 
 
It is unknown why petite yeast strains would produce more lycopene, but the lower growth rate 
is a typical characteristic of them. Ergosterol has an association with respiration: limitation for 
ergosterol by growth at high temperature increases the frequency of formation of respiratory 
deficient mutants [Parks and Casey, 1995]; ergosterol is also one of the main components of the 
mitochondrial membrane, and this could be the cause for this impairment. It is unknown whether 
the lycopene production perturbs the mevalonate pathway enough to increase the frequency of 
petite formation, or the petites requires less ergosterol, hereby leaving more precursor molecules 
available for lycopene synthesis. 
The carotenogenic strains described in Chapter 4 were also based on the small phenotype and 
must therefore also be assumed to be petite. This could explain the difference in the forward and 
side scatter cytograms compared to the wild type strain, c.f. Figure 4.7. This does however not 
affect the conclusion that the fluorescence signal could not be applied to sort the cells since the 
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petite strains as mentioned above produce higher amounts of carotenoids per biomass. The 
inducible strain applied in Chapter 5 for testing of the image analysis system was selected on 
plates without copper, hereby not inducing lycopene biosynthesis, and this strain did not exhibit 
the small colony phenotype, so the results from Chapter 5 are unaffected by this finding. 
During my master thesis work, I constructed several S. cerevisiae strains in which I implemented 
several of the perturbations known from the literature to improve isoprenoid production. None of 
these had the reported effect. However, they were all implemented in a strain with the small 
colony phenotype, which I just discovered is caused by a respiratory deficiency. These facts, 
combined with the results from Chapter 5 where strain SimC001 (copper inducible) could 
produce greater amounts of lycopene than strain SimC002, which was probably petite, suggests 
that the flux and regulation of the mevalonate pathway varies greatly between the normal and the 
respiratory deficient strain. It appears very difficult to further improve lycopene production in the 
petite strains, and this could explain the difficulties that we have experienced with isolation of 
novel genotypes affecting lycopene production. If the strains transformed with the libraries were 
plated on non-fermentable medium, the formed petites could be eliminated, and this could 
increase the probability of identifying novel genotypes from these libraries. One just has to be 
careful when applying another carbon source than glucose for recovery of transformants since 
the type of carbon source might affect the transformation efficiency. It should be possible to 
overcome this potential difficulty by recovering the transformants in liquid medium with glucose 
as carbon source for a couple of hours before washing the cells and plating them on glycerol 
based medium. The genotypes isolated using this way of recovery might be specifically 
improving isoprenoid production during growth on glycerol, and thereby the effect of the 
isolated genotype on isoprenoid production when the strains are grown on glucose is unknown. 
The identified genotypes would therefore have to be tested on medium based on both glycerol 
and glucose. This better way of screening the created DNA libraries in conjunction with the 
image analysis technique could facilitate the isolation of novel genotypes which could improve 
isoprenoid production in S. cerevisiae, hereby improving this organism’s potential as a microbial 
isoprenoid production platform. 
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8.3 Chapter 6 
Since it has not been proven that the plasposon system is functional, it is difficult to speculate 
further regarding its use than has already been done in the Chapter itself. But if it should turn out 
to function as intended, it would ease of random engineering of S. cerevisiae. Due to limited time 
and funding, I was unable to perform the final experiments delineated in Chapter 6 which should 
reveal whether the system works, but I am trying to make sure that this project will be finished 
by setting up the final testing of the system as a master thesis project at our department in 
collaboration with Assistant Prof. Rasmus John Normand Frandsen. It is my great hope and 
expectation that this system will be demonstrated to work in yeast to thereby open the possibility 
for construction of analogous systems for other eukaryotes. 
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8.4 Chapter 7 
The conspicuous problem appearing in Chapter 7 is the negative effect of squalene biosynthesis 
on cell growth. This could be caused by the metabolic burden of converting FPP to a compound 
not used by the bacteria, hereby reducing FPP availability for formation of essential compounds 
such as dolichols and ubiquinones. However, this is unlikely since we observed an increased 
negative effect on growth when the MEP-pathway was overexpressed. Furthermore, other 
studies, such as the taxadiene production in E. coli presented by Ajikumar et al. (2010), have 
reported isoprenoid yields and titers substantially higher than the ones observed in our study 
without E. coli cell growth being affected, strengthening the possibility that the growth 
impairment is mediated by squalene itself. Verwaal et al. (2007) found that production of 
carotenoids in S. cerevisiae triggered the pleiotropic drug response. The combination of these 
findings suggests that the production of very hydrophobic metabolites has a negative effect on 
microbes. Some microbes, e.g. the yeast Yarrowia lipolytica are however found to produce large 
amounts of lipids stored within the cells as lipid particles. These microbes hold great potential 
for production of hydrophobic isoprenoids since they must be assumed to have great tolerance 
towards hydrophobic molecules. Furthermore, the intracellular lipid particles could offer a great 
storage capacity for the produced isoprenoids. However, the more molecules produced by the 
cells with similar properties to the molecule of interest the more difficult it will be to purify the 
desired compound, hereby increasing the cost of downstream processing. There could thus be a 
tradeoff between storage capacity and cost of purification. Ideally squalene should be secreted to 
the growth medium where it would form a separate hydrophobic phase which could easily be 
separated from the aqueous fermentation broth. This would however require specialized 
transporters, since the transport of hydrophobic molecule to an aqueous medium must be 
assumed to be thermodynamically unfavorable. A way to alleviating some of this reluctance of 
secretion could be to utilize a bi-phasic fermentation setup. This has been done with great 
success to capture volatile isoprenoids that would otherwise have been lost in the off-gas from 
the bioreactor [Asadollahi et al. 2008]. If E. coli could be engineered to secrete squalene, it 
would probably alleviate the negative effect on growth, so to further engineer E. coli for 
production of squalene one could focus on either improving the tolerance towards squalene 
production or the secretion of squalene. Improving the tolerance towards squalene would 
probably be the easier approach engineering-wise. 
Several patents have been published on squalene production in yeast, especially S. cerevisiae, but 
this approach has to our knowledge so far still not manifested itself as an actual industrial 
production. With the discovery of novel microorganisms producing high amounts of squalene, in 
conjunction with the application of methodologies such as metabolic engineering, the setup of 
and cost competitive industrial scale production for environment-friendly manufacturing of 
squalene based on microbial fermentation appears achievable within the near future. Several of 
the big cosmetic companies have due to consumer awareness switched their production to be 
based on non-animal derived squalene. This has in conjunction with other industries starting to 
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see the potential in squalene’s unique properties increased the demand for this commodity. This 
demand will drive the search for alternative manufacturing processes and the improvement of 
existing ones to be able to meet the global demand. Our research constitutes a small step in this 
direction and the demonstration of heterologous squalene production in E. coli based on the S. 
cerevisiae ERG9 gene can be seen as another tool being made available to researchers and 
scientists working to achieve the goal of cost-efficient heterologous production of squalene. 
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8.5 Conclusion 
The liberation of the global economy from fossil fuel based manufacturing of goods requires 
alternative methods which cost-competitively can be used to produce chemicals, fuels and 
materials in order to replace the processes applied today. The research presented in this thesis 
and the ongoing research within scientific areas such as metabolic engineering, systems biology, 
etc. represent tiny steps towards a more bio-based economy which could increasingly be a 
replacement for the economy of today. However, this requires that the cost of the bio-based 
processes becomes so low that they can directly compete with the existing ones or the cost 
difference in manufacturing becomes so small that it will be insignificant compared to the gain 
of utilizing a more environment-friendly production method. To close the cost gap between the 
two types of processes, scientists and engineers face great challenges for optimizing existing 
processes and inventing new ones. Microbial production is one of the leading methods in this 
quest, but the optimization of the microbes is made difficult due to the high complexity of cell 
metabolism and its regulation. Therefore, both rational and combinatorial/random methods need 
to be combined to maximize the probability of success. In this thesis, including manuscripts to be 
published, my coauthors and I have explored both types of approaches for the optimization of the 
two model organisms S. cerevisiae and E. coli for isoprenoid production, some with better results 
than other. Nonetheless, the effort put into this work to overcome the challenges faced and the 
results hereof, clearly demonstrate some of the problems one could generally expect to encounter 
and the solutions required to solve them. The results of this thesis contribute novel findings and 
results which will aid in the endeavor towards optimizing microorganisms for isoprenoid 
production. This can be seen as a small step towards obtaining efficient production of the largest 
group of secondary metabolites identified to date, which encompasses both chemicals, fuels and 
materials and hereby also as a small step towards a more bio-based economy. It would be utopia 
to expect the world economy would change on a day-to-day basis, so the results of this thesis 
combined with all the other research performed within this and related areas of research should 
be seen as progression towards a bio-based economy which will hopefully one day prevail and 
enable mankind to obtain a sustainable and environment-friendly way of life. 
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9.1 gDNA library construction protocol 
The following is a protocol for gDNA library construction based on the method used in this 
thesis for construction of yeast gDNA libraries in a S. cerevisiae/E. coli-shuttle vector. This 
method can easily be adapted to be used for other organisms and vector systems. The protocol is 
comprised of three parts; a short overview of the operations, a list of the required equipment, etc. 
and the actual protocol. The list has been written in general terms since several vendors provide 
kits, equipment and enzymes capable of performing the same operations. However, the vendors 
and catalog numbers for the equipment, etc. that was used in the work performed for gDNA 
library constructions in this thesis have been added so the list also can serve as a shopping list. 
This should enable persons who are interested in constructing gDNA libraries to quickly obtain 
the required things. The concentrations and volumes applied depend on the individual kits and 
enzymes, and the obtained DNA concentrations also vary between experiments, so we have as 
guidelines provided examples on how we set up the different reactions. However, individuals 
following this protocol are recommended to optimize the reactions depending on the DNA 
concentrations that they obtain for the individual steps. 
9.1.1 Overview 
 gDNA preparation 
o Prepare gDNA from organism of choice. 
o Partially digest the gDNA. 
o Treat partially digested gDNA with Klenow fragment to avoid self-ligation. 
 Recipient plasmid preparation. 
o Linearize plasmid by endonuclease digestion. 
o Treat the digested plasmid with Klenow fragment to avoid self-ligation. 
 Library assembly and amplification. 
o Ligate the gDNA into the recipient plasmid. 
o Transform E. coli with the ligation mix to amplify the library. 
o Recover the amplified library from E. coli. 
  
Protocols 
 
 
252 
 
9.1.2 Equipment, kits, enzymes, etc.: 
 Gel-electrophoresis setup. 
 Equipment for staining and visualization of DNA in agarose gels. 
 Razor blades or scalpel. 
 Water bath with temperature control. 
 Drigalski spatula. 
 50 ml polypropylene tubes. 
 Plasmid containing SalI restriction site as gDNA recipient. 
 Organism serving as gDNA donor. 
 DNA ladder - Quick-Load® 1 kb DNA Ladder, New England Biolabs, catalog# N0468S 
Loading buffer - Gel Loading Dye, Blue (6X), New England Biolabs, catalog# B7021S 
(If the above mentioned DNA ladder is purchased, it will be unnecessary to purchase a 
separate loading dye since the ladder is supplied with excess loading dye). 
 0.5 M EDTA, pH 8.0. 
 Kit for purification of gDNA - Wizard® Genomic DNA Purification Kit, Promega, 
catalog# A1120. 
 Gel extraction kit - PureLinkTM Quick Gel Extraction kit, Life TechnologiesTM, catalog# 
K2100-12. 
 Buffer for dilution of enzymes - Diluent buffer A, New England Biolabs, catalog# 
B8000S. 
 SalI restriction enzyme and 10x buffer – New England Biolabs, catalog# R3138S. 
 Sau3AI restriction enzyme and 10x buffer – New England Biolabs, catalog# R0169S. 
 Klenow (3´→5´ exo–) fragment and 10x buffer – New England Biolabs, catalog# 
M0212S. 
 Ligase – T4 DNA ligase and 10x buffer, New England Biolabs, catalog# M0202S. 
 dCTP solution – 100 mM dCTP , Life TechnologiesTM, catalog# 10217016. 
 dTTP solution – 100 mM dTTP, Life TechnologiesTM, catalog# 10219012. 
 dATP solution – 100 mM dATP, Life TechnologiesTM, catalog# 10216018. 
 dGTP solution – 100 mM dGTP, Life TechnologiesTM, catalog# 10218014 
 PCR purification Kit – QIAquick PCR Purification Kit, Qiagen, catalog# 28104. 
 3 M sodium acetate pH 5.2. 
 Isopropanol. 
 80 % ethanol. 
 Nuclease-free water – Nuclease-Free Water (10 x 50 ml), Qiagen, catalog# 129114. 
 Competent E. coli cells – ElectroMAX™ DH10B™ T1 Phage-Resistant Competent 
Cells, Life Technologies
TM
, catalog# 12033015.  
 LB plates with antibiotic for appropriate selection according to the applied plasmid 
 Plasmid purification kit – Plasmid Midi Kit, Qiagen, catalog# 12143. 
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9.1.3 Protocol 
9.1.3.1 gDNA preparation 
Purify gDNA from the desired organism to obtain approximately 1 ml of 500 ng/μl gDNA (we 
used the Genomic DNA Purification Kit from Promega and obtained the desired amount of 
gDNA by pooling 20 reactions). 
Verify the quality of the gDNA by gel-electrophoresis on a 0.75 % agarose gel (the size of the 
DNA should be larger than 10 kb and gathered in a relative narrow band). 
Dilute the Sau3AI restriction enzyme with the buffer recommended by the enzyme supplier (we 
applied Diluent buffer A from New England Biolabs). 
Adjust a water bath to the temperature recommended for the Sau3AI restriction enzyme and let it 
stabilize. 
On ice, set up a 1:1 dilution series of Sau3AI keeping the gDNA concentration constant to 
determine the concentration of the diluted Sau3AI which will give the desired size range of 
gDNA (we used 100 μl reaction volumes). 
Prepare a 1:2 mix of 0.5 M EDTA, pH 8.0 and 6X gel loading dye and cool on ice (we prepared 
a total of 600 μl at a time of this mixture since excess solution can be stored and reused). 
Incubate the tubes containing the dilution series in the water bath for a set time (we used 30 
min). 
After the tubes has been incubated for the set time, immediately cool them on ice and add the 
EDTA/loading dye mixture (we added 30 μl to each 100 μl reaction). 
Test the size range of the digested gDNA by gel-electrophoresis and safe the remainder of the 
reactions with the desired size range on ice (we tested 10 μl from each reaction and saved the 
three reactions that had the largest overlap with the desired size range). Discard all the other 
reactions. 
Pool the fractions that have been saved and separate by gel-electrophoresis on a fresh gel. 
Gel purify the fragmented gDNA within the desired size range (we purified fragments within the 
range 1.5-10 kb using the PureLink
TM
 Quick Gel Extraction kit. Even though the kit protocol 
recommends that the number of columns has to be determined by weighing the gel piece from 
which the DNA has to be purified we pooled the dissolved gel on two columns to increase the 
concentration by centrifuging 700 μl of the solution through each of the columns per run). 
Measure the concentration of the purified gDNA. The amount of DNA obtained should as a 
minimum be 50 ng/μl in 50 μl. If this amount is not obtained, it will be necessary to fragment 
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and purify more gDNA. If the steps detailed above have to be repeated, only reactions with the 
concentration of Sau3AI giving the desired size distribution should be set up. 
Treat the purified gDNA with Klenow fragment, dATP and dGTP to fill in 2 bp of the 4 bp 
overhang generated by the Sau3AI digestion (we set up the following reaction: 50 μl fragmented 
gDNA (≈ 50 ng/μl), 5.8 μl buffer 2 (supplied with Klenow fragment), 0.35 μl dATP (10 mM), 
0.35 μl dGTP (10 mM), and 2 μl Klenow fragment (5,000 units/ml) and incubated it at 37 °C for 
30 min). 
Purify the Klenow treated gDNA using a PCR purification kit (we used the QIAquick PCR 
Purification Kit). The concentration of the DNA should preferentially be higher than 30 ng/μl in 
approximately 30 μl. 
 
9.1.3.2 Plasmid preparation 
As starting point, the desired vector has to be prepared from E. coli (we obtained 50 μl of 400 
ng/μl plasmid DNA). 
Digest the plasmid with SalI restriction enzyme overnight and purify by gel electrophoresis (we 
used the SalI-HF restriction enzyme from New England Biolabs and the PureLink
TM
 Quick Gel 
Extraction kit. The following reaction was set up: 30 μl plasmid, 10 μl buffer 2 (supplied with 
SalI-HF), 58 μl nuclease-free water, and 2 μl SalI-HF (20,000 units/ml)). 
Treat the purified gDNA with Klenow fragment, dTTP, and dCTP to fill in two of the four bp 
overhangs created by the SalI digestion (we set up the following reaction: 50 μl plasmid DNA (≈ 
100 ng/μl), 10 μl buffer 2 (supplied with Klenow fragment), 0.7 μl dTTP (10 mM), 0.7 μl dCTP 
(10 mM), 34,6 μl nuclease free water, and 4 μl Klenow fragment (5,000 units/ml) and incubated 
it at 37 °C for 30 min). 
Purify the Klenow treated plasmid using a PCR purification kit (we used the QIAquick PCR 
Purification Kit). The concentration of the DNA should preferentially be higher than 50 ng/μl in 
approximately 50 μl. 
 
9.1.3.3 Ligation and library amplification 
Apply the T4 DNA ligase to ligate the gDNA into the purified plasmid using the following 
criteria: final concentration 30 ng/μl and a molar ratio of 1:1 (we estimated the average size of 
the gDNA based on the images obtained during the purification of the gDNA by the gel-
electrophoresis and used it in combination with the concentration for calculating the molar ratio. 
We set up the following reaction: 13.4 μl gDNA, 13.6 μl plasmid, 15.0 μl nuclease free water, 5 
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μl ligase buffer, and 3 μl T4 DNA ligase (400,000 cohesive end units/ml)). Incubate the reaction 
at 16 °C overnight. 
Precipitate the ligation reaction with 5 μl 3 M, sodium acetate pH 5.2, and 100 μl isopropanol. 
Wash the precipitate 2 times with 100 μl 80 % ethanol and air dry for 1 hour. 
Add 5 μl nuclease free water to the dried DNA and incubate on ice for 1 hour. 
Use 0.5 μl of the re-dissolved DNA to transform competent E. coli cells (we used the ultra-
competent ElectroMAX™ DH10B™ T1 Phage-Resistant Competent Cells) and stored the 
remaining 4.5 μl DNA at -20 °C as a master library in case more working library needed to be 
generated. 
Plate the transformed E. coli cells on LB medium with the appropriate antibiotic selection 
pressure and incubate at 37 °C until colonies has formed (we used 10 large (150 mm in diameter) 
LB+amp plates). 
Estimate library size based on number of colonies formed and pick single colonies for testing of 
the library quality. 
Scrape the colonies off the plates using a Drigalski spatula and ice-cold LB medium, and transfer 
to a 50 ml polypropylene tube (we used 1 ml LB medium per plate). 
Purify the plasmids from the pooled colonies using a plasmid purification kit (we used the 
Plasmid Midi Kit). The result of this purification constitutes 1/10 of the entire library and can be 
considered as a working subset of the library.  
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9.2 Yeast cDNA library construction protocol 
The following protocol details how to construct a cDNA library based on mRNA isolated from 
yeast. The library construction is performed in a S. cerevisiae/E. coli-shuttle vector, but the 
method should be easily adapted to work for other vector systems and other organisms that 
polyadenylate their mRNA. The protocol is comprised of three parts; a short overview of the 
operations, a list of the required equipment, etc. and the actual protocol. The protocol has been 
shown to work with the enzymes and equipment listed below, so if the equipment or enzymes are 
substituted, we recommend that the affected reactions are optimized by the person choosing to 
make the substitution. It is important that all operations are performed in a manner to avoid 
contamination with RNases, and that the equipment has been cleaned prior to usage. 
Consumables and buffers should be purchased RNase-free from the supplier. 
 
9.2.1 Overview 
 Purify mRNA from the desired yeast using oligo d(T)25 magnetic beads. 
 Reverse transcribe the mRNA to form the first strand of the cDNA. 
 Degrade the mRNA. 
 Addition of oligo d(C) to the 3’ of the cDNA. 
 Second strand synthesis and amplification of the cDNA by PCR with primers containing 
restriction enzyme 8 bp recognition sites in their adaptamers. 
 Digestion of amplified cDNA and plasmid with endonucleases to facilitate ligation. 
 Ligation of cDNA into recipient plasmid. 
 Transform E. coli with the ligation mix to amplify the library. 
 Recover the amplified library from E. coli. 
 
9.2.2 Equipment, kits, enzymes, etc.: 
 Fast prep. tubes. 
 Savant FastPrep® FP120 Cell Disrupter, MP Biomedicals LLC. 
 Glass beads, acid-washed, 425-600 μm, Sigma Aldrich, catalog# G8772. 
 Nuclease free safe-lock Eppendorf tube 
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 Oligo d(T)25 magnetic beads, New England Biolabs, catalog# S1419S (the buffers 
required can be made from the recipies found here: 
http://www.neb.com/nebecomm/products/productS1419.asp, or ordered with the 
magnetic beads as a kit, catalog# S1550S. 
 Strong neodymium magnet. 
 Gel-electrophoresis setup. 
 Equipment for staining and visualization of DNA in agarose gels. 
 Razor blades or scalpel. 
 Water baths with temperature control. 
 Drigalski spatula. 
 50 ml polypropylene tubes. 
 Plasmid containing PacI and AscI restriction sites as cDNA recipient. 
 Organism serving as RNA donor. 
 Quick-Load® 1 kb DNA Ladder, New England Biolabs, catalog# N0468S. 
Loading buffer - Gel Loading Dye, Blue (6X), New England Biolabs, catalog# B7021S 
(If the above mentioned DNA ladder is purchased it will be unnecessary to purchase a 
separate loading dye since the ladder is supplied with excess loading dye). 
 Gel extraction kit - PureLinkTM Quick Gel Extraction kit, Life TechnologiesTM, catalog# 
K2100-12. 
 M-MuLV Reverse Transcriptase (RNase H–) and 10x buffer, New England Biolabs, 
catalog# M0368S. 
 T4 DNA polymerase, 10x buffer, and 100x BSA, New England Biolabs, catalog# 
M0203S. 
 RNase H and 10x buffer, New England Biolabs, catalog# M0297S. 
 RNase inhibitor, New England Biolabs, catalog# M0307S. 
 Terminal transferase (TdT), 10x buffer, and 10x CoCl2, New England Biolabs, catalog# 
M0315S. 
 PacI restriction enzyme and 10x buffer – New England Biolabs, catalog# R0547S. 
 AscI restriction enzyme and 10x buffer – New England Biolabs, catalog# R0558S. 
 Ligase – T4 DNA ligase and 10x buffer, New England Biolabs, catalog# M0202S. 
 Phusion® High-Fidelity DNA Polymerase and 5x buffer, New England Biolabs, catalog# 
M0530S. 
 dNTP solution – New England biolabs, catalog# N0447S. 
 dCTP solution – 100 mM dCTP , Life TechnologiesTM, catalog# 10217016. 
 PCR purification Kit – QIAquick PCR Purification Kit, Qiagen, catalog# 28104. 
 TE buffer. 
 Acidic phenol:chloroform:isoamyl alcohol (125:24:1). 
 3 M sodium acetate pH 5.2. 
 0.5 M EDTA, pH 8.0. 
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 Isopropanol. 
 80 % ethanol. 
 Nuclease-free water – Nuclease-Free Water (10 x 50 ml), Qiagen, catalog# 129114. 
 Competent E. coli cells – ElectroMAX™ DH10B™ T1 Phage-Resistant Competent 
Cells, Life Technologies
TM
, catalog# 12033015. 
 YPD medium. 
 LB plates with antibiotic for appropriate selection according to the applied plasmid. 
 Plasmid Midi Kit, Qiagen, catalog# 12143. 
 
9.2.3 Protocol 
All buffers should be prepared prior to starting this protocol and kept on ice. 
- Inoculate 10 ml of YPD with yeast at OD600 = 0.1. 
- Grow the cells at 30 °C until OD600 = 1. 
- Harvest 5 ml cells by centrifugation (3000 rpm for 10 min). 
- Wash the cells with 1 ml of TE buffer and transfer to a fast prep tube. 
- Spin down at max speed for 2 min and remove the TE buffer. 
- Re-suspend the cells in 0.5 ml TE buffer. 
- Add 0.2 ml glass beads. 
- Add 0.5 ml acidic phenol:chloroform:isoamyl alcohol (125:24:1) 
- Fast prep twice at max speed and cool 2 min on ice in-between the runs. 
- Centrifuge for 10 min at 16,000 g. 
- Transfer 450 μl of the aqueous phase to at nuclease free safe-lock Eppendorf tube. 
- Add 0.5 ml chloroform:isoamyl alcohol (24:1) 
- Invert tube a couple of times. 
- Centrifuge for 10 min at 16,000 g. 
- Transfer 400 μl of the aqueous phase to a new nuclease free Eppendorf tube. 
- Add 40 μl 3M sodium acetate (pH 5.2) and 800 μl 100% ethanol (-20 °C). 
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- Invert the tube a couple of times. 
- Incubate for 1 hour in -20 °C. 
- Centrifuge at 16,000 g for 25 min in 4 °C. 
- Remove the supernatant. 
- Add 0.5 ml of 80 % ethanol (-20 °C) and gently invert the tube a couple of times. 
- Incubate at -20 °C for 1 hour. 
- Centrifuge at 16,000 g for 25 min in 4 °C. 
- Remove the supernatant and air dry. 
- Dissolve the RNA in 200 μl TE buffer and measure the concentration (we obtained 
approximately 2 μg/μl). 
- Add 200 μl 2x lysis/binding buffer and gently mix. 
- Heat the mixture to 65 °C for 5 min and rapidly cool on ice. 
- To another tube add 100 μl of magnetic bead suspension (5 mg/ml). 
- Apply magnet and remove supernatant. 
- Add 200 μl lysis/binding buffer to the beads and agitate for 2 min. 
- Apply magnet and remove the lysis/binding buffer. 
- Add the RNA suspension to the beads and incubate with gentle agitation for 10 min at 
room temperature. 
- Apply magnet and remove the supernatant. 
- Add 500 μl wash buffer 1 and agitate for 1 min. 
- Apply magnet and remove supernatant. 
- Add 500 μl wash buffer 1 and agitate for 1 min. 
- Apply magnet and remove supernatant. 
- Add 500 μl wash buffer 2 and agitate for 1 min. 
- Apply magnet and remove supernatant. 
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- Add 500 μl wash buffer 2 and agitate for 1 min. 
- Apply magnet and remove supernatant. 
- Add 500 μl low salt buffer and agitate for 1 min. 
- Apply magnet and remove supernatant. 
- Add 500 μl ice cold RT M-MuLV reaction buffer. 
- Apply magnet and remove supernatant. 
- Add the following mixture to the beads and incubate for 2 hours at 42 °C: 
o 100 μl 10x RT buffer 
o 160 μl dNTP mix (10 mM of each nucleotide) 
o 12.5 μl RNase inhibitor (40,000 units/ml) 
o 10 μl M-MuLV Reverse Transcriptase (200,000 units/ml) 
o 717.5 μl nuclease free H2O 
- Periodically agitate gently by hand. 
- Apply magnet and remove supernatant. 
- For storage: 
o By applying the magnet, wash the beads 3 times with 500 μl cold DNase free TE 
buffer. 
o Add 500 μl TE buffer and store at 4 °C. 
- If not: Add 200 μl 1x buffer 2 and agitate for 1 min. 
- Apply magnet and remove supernatant. 
- Add the following, re-suspend the beads and incubate for 30 min at 12 °C: 
o 15 μl buffer 2 
o 1.5 μl 100x BSA (10 mg/ml) 
o 3 μl of T4 DNA polymerase (3,000 units/ml) 
o 3 μl dNTP (10 mM of each nucleotide) 
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o 127.5 μl H2O 
- Periodically agitated gently by hand. 
- Add 3 μl 0.5 M EDTA and heat for 20 min at 75 °C. 
- Apply magnet and remove supernatant. 
- Wash beads with 200 μl 1x RNase H reaction buffer (agitate for 1 min). 
- Apply magnet and remove supernatant. 
- Add the following mixture, resuspend beads and incubate at 37 °C for 2 hours: 
o 50 μl 10x RNase H reaction buffer 
o 20 μl RNase H (5,000 units/ml) 
o 430 μl nuclease free H2O 
- Periodically agitated gently by hand. 
- Incubate for 20 min at 65 °C. 
- Apply magnet and remove supernatant. 
- Add the following, re-suspend the beads and incubate for 2 hours at 37 °C: 
o 50 μl 10x TdT buffer 
o 50 μl 10x CoCl2 (2.5 mM) 
o 12,5 μl 100 mM dCTP 
o 382,5 μl H2O 
o 5 μl terminal transferase – TdT (20,000 units/ml) 
- Periodically agitated gently by hand. 
- Apply magnet and remove supernatant. 
- Add 500 μl TE buffer to the beads and agitate for 1 min. 
- Apply magnet and remove supernatant 
- Add 500 μl TE buffer to the beads and agitate for 1 min. 
- Store at 4 °C or use for Phusion PCR reaction. 
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- Amplify the cDNA using the suspension of magnetic particles in TE as template for eight 
PCR reactions using the Phusion® High-Fidelity DNA polymerase (since the TE buffer 
contains EDTA additional Mg
2+
 might need to be added depending on how much 
template is used). If the initial PCR reaction gives low yield, the entire 8 reactions can be 
used as template for additional 64 reactions which can be pooled and concentrated by 
using the PCR purification kit and a limited number of PCR purification columns. 
-  Size separate and purify the desired size range of the amplified cDNA using gel-
electrophoresis. 
- Digest the cDNA and recipient plasmid with PacI and AscI. 
- Purify the recipient plasmid using gel-electrophoresis and the cDNA using the PCR 
purification kit. 
- Determine the concentration of the cDNA and recipient plasmid. 
- Apply the T4 DNA ligase to ligate the cDNA into the purified plasmid using the 
following criteria: total volume 50 μl, final concentration 30 ng/μl and a molar ratio of 
1:1 (estimate the average size of the gDNA based on the images obtained during the 
purification of the cDNA by gel-electrophoresis, and use it in combination with the 
cDNA concentration for calculating the molar ratio). Incubate the reaction at 16 °C 
overnight. 
- Precipitate the ligation reaction with 5 μl 3 M sodium acetate pH 5.2, and 100 μl 
isopropanol. 
- Wash the precipitated gDNA 2 times with 100 μl 80 % ethanol and air dry for 1 hour. 
- Add 5 μl nuclease free water to the dried DNA and incubate on ice for 1 hour. 
- Use 0.5 μl of the re-dissolved DNA to transform competent ElectroMAX™ DH10B™ T1 
Phage-Resistant Competent E. coli Cells and store the remaining 4.5 μl at -20 °C as a 
master library in case more working library needs to be generated. 
- Plate the transformed E. coli cells on solid LB medium with the appropriate antibiotic 
selection pressure and incubate at 37 °C until colonies have formed. 
- Estimate library size based on number of colonies formed and pick single colonies for 
testing of the library quality. 
- Scrape the colonies off the plates using a Drigalski spatula and ice-cold LB medium (1 
ml LB medium per plate) and transfer to a 50 ml polypropylene tube. 
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- Purify the plasmids from the pooled colonies using the Plasmid Midi Kit. The result of 
this purification constitutes 1/10 of the entire library and can be considered as a working 
subset of the library.  
 
